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ABSTRACT 
Advances in controlled polymerisation strategies over the last decade have 
allowed chemists to create materials of defined structure and architecture to probe and 
mimic the greatest chemist of them all - mother nature. In this work poly-peptides 
have been synthesised by the polymerisation of amino acid N-carboxy anhydrides 
without the need for transition metal catalysts. Application of stringent reaction 
conditions and high-purity monomers allowed control to be imposed on the system 
and a series of novel homo- and block co-polypeptides to be synthesised and 
characterised fully. Their ability to assemble into nano- and micro-structures, 
apparently directed by P-sheet stacking has been investigated in the solid state by 
W AXS, electron microscopy and AFM. Organo-gelation was also observed and 
studied in dilute concentrations of the block-co-poly-peptides. 
A new and improved synthesis for N-carboxy anhydrides bearing carbohydrate 
motifs was developed without the need for extensive protecting group manipulation or 
toxic mercury compounds, which were used previously. 
Finally the possibility of using water soluble polypeptides and vinyl derived 
polymers as mimics of antifreeze glyco-proteins in the inhibition of the 
recrystallisation of ice has been evaluated. This showed that not all of the complex 
structural features present in the native protein are required to retain at least some 
activity. 
Matthew I. Gibson, Durham, December 2006 
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AIMS AND OBJECTIVES 
The initial atm of this project IS to investigate if comparatively simple 
polymers could be used as mimics to study the activity of antifreeze glyocoproteins, 
which have an extremely regular structure relative to the antifreeze proteins. In order 
to probe this activity it was decided to use the polymerisation of N-carboxy 
anhydrides (NCAs) to produce synthetic polypeptides, which do not bear the precise 
primary or tertiary structures of native proteins, but can exhibit secondary structures 
and side group functionality. The first objective is thus to synthesis and polymerise a 
range of NCAs which will result in a variety of side chain functionality allowing the 
effect of the water solublising group on antifreeze activity to be probed. This can then 
be compared to the activity of vinyl derived polymers, which do not posses rigid 
amide bonds. Importantly this allows, for the first time, the effect of backbone 
structure on antifreeze activity to be studied. Additionally a series of glycosylated 
NCAs will be synthesised to allow access to glycopeptide structures. 
-XVI-
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1.1 BIO-INSPIRED MATERIALS 
The terms biopolymers and biomaterials can be broadly defined as being those 
which can be interfaced with biological systems to evaluate, enhance, treat or replace 
tissue and functions within the body 1• Examples include the synthesis of scaffolds for 
cell growth ex-vivo in the name of tissue engineering, sutures for improved wo1.,1nd 
healing and lightweight joint replacement therapy2•3. There is also a desire to 
understand the underlying mechanisms which govern biological processes through the 
synthesis of new materials with systematic absences or inclusions. From this, new 
materials can be developed which incorporate the most desirable features with 
(ideally) improved activity, reduced immuogenicity (using recombinant human insulin 
in place of porcine insulin for example) and toxicity (shielding low molecular weight 
drugs). The synthesis of these new materials is also essential for establishing a route 
for the large scale production of new bioactive species, which may not be available in 
sufficient scale from biological sources (an excellent example are the fish antifreeze 
proteins covered in section 1.4). In terms of peptidic biomaterials the closest relatives 
available to the synthetic chemist are polymers. The search for systems where 
synthetic macromolecules can replace or augment their natural cousins is of great 
importance. Perhaps obviously, but it should be mentioned, is that the source of 
inspiration for these materials is always nature itself, which produces a wide array of 
diversity of both structure and function using very simple starting materials and under 
aqueous conditions and in response to environmental changes in: temperature, 
altitude, gas concentration, pressure, light and feedstuffs to name a few. 
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1.2 HYBRID PEPTIDE-BASED MATERIALS 
Peptides and proteins being natures own materials are a logical choice for 
design and synthesis of new biomaterials4. Through macromolecular self-assembly 
they produce nanometre and larger, structures whose properties are strongly 
dependant on not only their chemical reactivity, but their 3-dimensional spatial 
alignment. These elegant assemblies act as catalysts, recognition domains, provide 
structure and much more5. When producing new proteinic materials it is difficult to 
predict their biocompatibility, toxicity, immunogenicity and degradation 
characteristics due to their innate complexity. 
The synthesis of these materials remains difficult despite the many advances in solid 
phase peptide synthesis, mainly due to the inevitable truncations which occur over a 
large number of coupling steps and the subsequent purification and characterisation. It 
is thus unsurprising that synthetic polymers which share the characteristics of high 
molecular weight and side group functionality are attractive substitutes. Contrary to 
peptides the properties of polymers are characterised in terms of their inhomogeneity: 
even the most precise polymerisation methods gives rise to polydispersity, where as 
others have variability in backbone and end-group compositions. Synthetic polymers 
are capable of undergoing self-assembly, but is typically driven by the chemical 
incompatibility of two or more blocks or the formation of liquid crystalline phases, in 
both solution and solid states6·9. Recent advances m controlled radical 
polymerisation allow access to protein-polymer conjugates10 through either addition 
of a suitable initiator 11 ' 12 (grafting from) or reaction between peptide and end group 
functionality on the polymer 13 (grafting to). These materials have been coined as 
peptide-synthetic "hybrid" materials14 or "molecular chimeras" 15 . The synthesis and 
- 3-
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characterisation of new materials based upon, and containing, peptide sequences and 
their incorporation with synthetic macromolecules is of great interest for both 
academic and practical applications and has been the subject of numerous review 
articles 14- 18• 
1.2.1 DRUG DELIVERY 
Perhaps the most extensively studied synthetic polymer for biological 
applications is poly(ethyleneglycol), PEG (often referred to as poly(ethylene oxide), 
PEO). PEG is both non-toxic and non-immunogenic, along with being water soluble 
at physiological temperature and pH. Conjugation of PEG to therapeutically relevant 
peptides results in an increase in molecular weight and corresponding increase in 
hydrodynamic volume which is a pharmacologically useful property. Removal of low 
molecular weight compounds from the blood stream occurs rapidly due to glomerular 
filtration in the kidneys. Above a certain molecular weight (or more specifically 
hydrodynamic radius) filtration is reduced or prevented, thus these peptide(drug)-
polymer conjugates have increased blood circulation times relative to the free peptide. 
This field (which is dominated by but not limited to PEG19) is termed polymer 
therpaeutics20•21 and is particularly appealing for cancer therapy where through a 
process known as the EPR (enhanced permeation and retention) effect, 
macromolecules preferentially accumulate in cancerous tissue. As an example, 
dendrimers bearing two 1 OkDa PEG chains were cleared from the blood within 5 
hours of administration, whereas 20 % of a dendrimer with eight 20 kDa PEG chains 
remained in circulation after 50 hours22 . When implanted into mice a single dose of 
these dendrimers was capable of curing mice with colon cancer, whilst shielding the 
- 4-
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body from the harmful side-effects of the drug23 . The second benefit is the steric 
protection afforded by the presence a bulky polymeric chain. Enzymes, such as 
peptidases, are present in the blood serum which readily degrade polypeptide based 
pharmaceuticals. The steric hindrance of the conjugated polymer chain prevents 
enzymes from approaching the drug. The third property is the process of opsonisation, 
whereby proteins absorb onto foreign particles, which eventually leads to removal by 
the immune system, is also reduced by applying a surface coating of PEG24 • 
Kochendorfer et a!. have conjugated branched PEG to an EPO (erythropoiesis 
protein) mimetic (coined as SEP). This does not significantly reduce the activity of 
EPO, but results in vastly increased blood residency times and as such less of the 
active peptide has to be injected to achieve an equivalent therapeutic effect over an 
extended period of time25 . In order to create a single chemical entity, which is 
required for regulatory bodies, site specific ligation of the polymer was necessary. 
This was achieved by PEGylating small fragments of the peptide, which are easier to 
synthesise, and then assembling in such a manner which ensures the correct folding 
pattern is achieve thus maintaining the activity of the peptide, with the polymer chains 
in their desired locations (Figure 1 ). 
- 5 -
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Figure· 1- Schematic of SEP synthesis25; A, Linear assembly of peptide subunits which have !been 
site-specifically modified with branched PEG chains; B, Folding of peptide subunits to give the 
desired; active, tertiary structure. 
Brocchini and coworkers have recently developed a simple method to insert a 
PEG chain between native disulfide bonds: in proteins26 . The ~therapeutically useful 
interferon a-2b (IFN, hepatitis C treatment) was conjugated with a single 10 or 20kDa 
PEG chain. lfhere was a small reduction in bielegical activity (which was offset by a 
vastly superior blood residency time) which is attributable to the steric hindrance of 
~the polymer chain, rather than a change in the tertiary structure of the protein. The 
efficiency and general applicability of this strategy was extended to glutathione, 
somatostatin •and L-aspar:aginase27 ~ This method is particularly advantagemts in that 
the native peptides do not require the insertion .of an addition amino acid (normally 
cysteine) in the primary sequence as an 'anchor' point for conjugation. There exists a 
- 6 -
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huge range of strategies for the coupling of PEG to peptides. These are too numerous 
to be described here and have been extensively reviewed28-30 . 
Block copolymers of PEG and poly(L-lysine) spontaneously form micelle-like 
structures in the presence of DNA (due to co-operative electrostatic binding of anionic 
DNA, and cationic lysine residues). These nanostructures have enhanced circulation 
times, and with the appropriate surface ligands can deliver the genetic materials in 
vitro, followed by protein expression31 ·32 . The poly(peptide) segment is readily 
degraded allowing clearance of the foreign polymers post-delivery, with non-toxic 
side products. 
1.2.2 STIMULI-RESPONSIVE MATERIALS 
Attachment of a stimuli-responsive ( eg. that displaying either LCST, or USCT 
behaviour) synthetic polymer to a protein imparts a further level of complexity on the 
protein allowing modulation of the properties, when appropriate binding points are 
chosen33 • Hoffman and co-workers attached poly(N-isopropylacrylamide) in a site-
specific fashion near the biotin binding pocket of strepavidin34• Below the LCST the 
protein-biotin binding proceeded as with the wild-type. Upon increasing the 
temperature above the LCST the binding potential was reduced to less than 20%. This 
was attributed to the collapse of the polymer, effectively blocking the binding site. 
Increasing the distance ofthe polymer (in this case poly(N,N-diethylacrylamide) from 
the binding pocket resulted in the opposite behaviour: below the LCST the polymer is 
in its extended conformation which can block the active sites, whereas increasing the 
temperature induces contraction of the chain, exposing the binding pockee5. Similar 
results have been obtained with polymers whose solubility characteristics change with 
- 7-
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the wavelength of light irradiation used36• Selective isolation of proteins from 
complex mixtures using protein-thermoresponsive polymer conjugates has been 
demonstrated. First the protein of interest interacts specifically with the polymer-
protein conjugate and then upon addition of the stimuli the conjugate, along with 
bound substrate, is precipitated specifically. A similar strategy can be employed to 
recover enzymes from reaction solutions. The degree of substitution by the polymer 
can hugely influence the utility of these systems, with too much polymer preventing 
the recognition events or too little reducing the efficiency of precipitation37 • 
1.2.3 PEPTIDE DRIVEN SELF ASSEMBLY 
The specific self assembly of peptides, resulting from their precise primary 
structure, can be maintained following conjugation to a synthetic polymer allowing 
higher order structures to be formed, which could not be accessed simply by the phase 
separation of incompatible blocks. 
In 1998 Meredith et a!. used the central domain of a P-amyloid protein 
conjugated at the C-terminus with PEG to investigate their aggregation behaviour38•39 . 
The aggregation of these proteins is responsible for Alzheimer's disease via the 
formation of insoluble fibrils. The addition of a soluble polymer allowed the 
individual steps of fibrillogenesis to be characterised40• The initial steps in 
fibrillogenesis were shown to be thermodynamically reversible, but limited in the 
natural system by precipitation of the insoluble aggregates. The steric shielding and 
addition solubility associated with the PEG block allowed this to be observed. 
- 8 -
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Interest in this, and other P-sheet forming peptides, has resulted in many systems 
being studied for applications in (bio )nanotechnology 17•41 • 
A particular problem with the well documented (and desirable) physical 
properties of spider silk is that it suffers from considerable shrinkage and onset of 
rubber-like properties upon exposure to moisture42 (which is beneficial in nature as it 
allows spiders to re-shape their webs). A commercial high performance fibre must 
have consistent properties across a range of environmental conditions. The strength 
giving region of silk from N-clavipes is poly(L-alanine) which assembles into 
crystalline regions though the lateral alignment of P-sheets. A simple analogue of this 
was made by combining a short poly(L-alanine) core as the B block in an ABA 
triblock copolymer with flanking PEG chains, which mimic the amorphous regions 
contributing to the elongation properties43 • Crucially the lengths of the PEG chains 
were limited to prevent formation of a polymeric crystalline domain. In this system 
the P-sheet domain directed the solid state organisation as occurs with the natural 
material. Van Hest et al. used a modified silk-based peptide sequence [(alanine-
glycine)3glutamic acid-glycine] 10 with flanking PEG chains to direct self assembly of 
fibres shown in Figure 244 • An interesting variation of this strategy was to incorporate 
a single repeat unit of the P-sheet peptide as a methacylic monomer. An A-B-A block 
copolymer was synthesised where the A block represents the amorphous regions 
' 45 (poly(methylmethacrylate)) and the B block the crystalline P-sheet domain . 
---·· ----
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Figure 2- AFM height images of silk-like peptide-PEG 2000 triblock copolymer of van Hest et af4• 
By utilising A TRP the length of each block could be controlled and the 
amount of peptide synthesis minimised. IR analysis confirmed that the peptide 
assumed a P-sheet in the solid state. This side-chain approach has also been applied to 
peptides derived from the elastin sequence fragment [VPGVG]n (valine-proline-
glycine-valine-proline) which displays LCST due to the aggregation of the chains 
with the entropically driven expulsion of water46 . An ABA polymer in which a PEG 
chain was flanked with two units of poly(VPGVG-methacrylate) displayed an LCST 
which could be tuned from 20 to 60°C by varying the chain lengths of the peptide 
containing segment47 . Similarly polymers and dendrimers48 bearing fragments from 
the leucine zipper protein49 have been incorporated into self assembling, stimuli 
responsive materials50. 
A different class of assembling proteins are coiled-coils. These comprise of 2-
5 alpha helical protein strands, which assemble into a left handed 'super helix' and are 
estimated to form in 2-3% of all protein residues51 -53 . Whereas P-sheet peptides 
direct the formation of lateral stacks, the coiled-coil forming proteins form discrete 
- I 0-
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nano-structures which are almost uniform in size. Following conjugation of a polymer 
to a single terminus of these peptides the self-assembly behaviour is retained, as 
shown by AUC and CD ~observations. A core of coiled peptides is surroun.ded by a 
cm:ona of the synthetic polymer (Figure 3) ,retaining the same pH and temperature 
dependency of the original proteins54;55 . 1lf the peptide is also therapeuticaMy active 
then the system potentially behaves as a stimuli responsive (peptide) drug delivery 
vehicle. 
Figure 3- Model for the self organisation of peptide-block-'PEG blockcopolymer directed by 
coiled~coil formation 56• 
Nolte et al. suggested in2001 the idea ofcreating a ".giantamphiphile" from a 
polar protein head group and a lipid-like polymer chain. Strepavidin (a 60 kDa 
hydrophi1lic protein} was used as the head-gro1:1p though association with biotin-
terminated polystyrene and its surface activity studied' as with a low molecular weight 
surfactant57 . The enzyme ,horseradish peroxidase was conjugated with a 9000 Da 
poly(styrene) chain to give a giant amphiphile which formed vesicles in aqueous 
solution, as shown in the 'ifEM images in Figure 4, and the ability to internalise a 
- 11 -
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water soluble dye58. Interestingly the enzyme retained some, albeit much reduced, of 
its catalytic activity in this form. 
A B 
Figure 4- Horseradish peroxidase-block-poly(styrene)90•58 ; A, Computer generated image of the 
the conjugate; B, SEM (top) and cryoTEM (bottom) images of the aggregates formed in water 
showing the vescilular nature. Scale bar= 200nm. 
Other groups have made related amphiphiles by either coupling the reactive 
end group of a polymer, or an initiator for controlled radical polymerisation to the 
protein. Recently Haddleton et a/. utilised a protected maleimido functionalised 
A TRP initiator to give well defined polymers bearing alkyne groups in the side 13 . Free 
cysteine residues present in the commercial protein BSA (bovine serum albumin) 
were then allowed to react with the maleimide group in aqueous solution to give a 
water soluble polymer-protein conjugate. By making use of the highly efficient [3 + 
2] dipolar cycloaddition59•60 (Scheme 1 ), "click" reaction between an azide and the 
pendant alkynes it was possible to increase the hydrophobicity of the polymer chain to 
- 12-
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give a hydrophobic "giant amphiphile" which could self assemble into micelles with 
the protein head group at the periphery (Figure 5). 
Cu(l) .. 
Scheme J - Huisgen's 13 + 21 cycloaddition, or "click" reaction between an azide and an alkyne to 
give a disubstituted triazole. 
4~ ~ ~. ( ' Multi-functional Water-soluble 
~ " Biohybrid 
l "Click'' Chemistry Change of Hydrophobicity 
MuHifunctionat Triblock 
Giant Amphiphile 
Figure 5- Left, USA-hydrophilic conjugate, functionalisation by "click" chemistry to give giant 
amphiphile; Right, TEM images of micelles formed by the hydrophobic conjugate in wateru. 
Rather than using complex peptide fragments, homo(poly amino acids) can 
also be incorporated as the bio-inspired block 15•61 • The chemical composition of the 
synthetic block in this case is far more varied than has been achieved with the protein 
based hybrids. Gallott and co-workers showed in the 1970's that copolymers of 
poly(styrene) or poly(butadiene) with poly(y-benzyl-L-glutamate) or poly( E-
benzyloxycarbonyl-L-Iysine) phase separated in the solid state to give lamellar 
structures62 • They deduced that there was no dependence on the block copolymer 
composition on the structures formed. This was later re-investigated by Schlaad et al. 
using modern X-ray scattering techniques63 .64. They deduced that the length of the 
---·-----------------------------------------------------------------------
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peptidic block was important in the formation of new phases. Different lamellar 
structures were found depending on the secondary structure of the individual peptide 
segments. Poly(butadiene )s5-b/ock-poly(L-glutamic acid) 55 diblock copolymers were 
shown to form vesicles in aqueous solution. Interestingly the peptidic block showed a 
pH dependant coil-helix transition without any associated change in the size or 
structure of the vesicle. PB27-b-PLGA64 resulted in spherical micelle formation but 
PB4o-b-PLGA 10o formed vesicles. Polystyrene-block-poly(L-lysine), where the 
polystyrene was varied from 8-1.0 units formed, instead of micelles, cylindrical 
assemblies irrespective of the poly(L-lysine) block length65 . These subtle differences 
in chemical composition strongly affect the morphology and structure of assembled 
aggregates. Checot et at. also showed that poly(butadiene )-b/ock-poly(L-glutamic 
acid) vesicles exhibited pH dependant hydrodynamic radius66 . At high pH the acids 
were fully ionised and the polypeptide in a random coil, but at lower pHs the 
polypeptide were protonated giving rise to an a-helical conformation, which being a 
rigid rod led to expansion of the vesicle. Block copolymers containing a 
biodegradable polymer conjugated to homo(polypeptide), such as poly(lactic acid) 
and poly(e-caprolactone), have been synthesised67. The dependency of micelle size 
with pH, resulting from electrostatic interactions of a poly(aspartic acid) block, 
showed that larger micelles form in basic conditions when the carboxyl groups are 
fully deprotonated68 . These smart nano-objects9 have been suggested for drug delivery 
applications by the solubilisation of hydrophobic drugs in micelles or hydrophilic 
d . . I 21 rugs m vestc es . 
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Jl.3 GLYCOPOLYMERS 
Polysaccharides are amongst the most abundant organic molecules on earth. 
They have a variety of functions from providing structure (cellulose, chitin, collagen), 
energy storage (starch, glycogen), blood coagulation (heparin) and joint lubrication 
(hyaluran). A key feature of carbohydrates which allows for this diverse array of 
functionality is their huge potential for structural variety. For proteins and 
oligonucleotides the structure varies in the sequence of amino acids or nucleotide 
bases. For sugars there is not only sequence information, but also positional and 
stereochemical variability. This huge potential for information density is often 
referred to as the 'glycocode'. For instance 20 carbohydrate letters can combine to 
form 1.14x1015 different words69 . Glycopolymers70-72 as a general term refer to any 
polymeric material based upon carbohydrates whether naturally occurring or 
manmade. However, synthetic polymer chemists tend to interpret this in a narrower 
context as a polymer backbone with pendant carbohydrate groups. The incorporation 
of these biological markers into polymers allows many important cell-cell, ligand-cell, 
virus-cell and bacterial-cell interactions to be probed73 . Carbohydrate recognition is 
involved in such diverse biological process74-76 as inflammation, gamete fertilization, 
immune defence, endothelial barrier crossing and viral infection which are all key 
research areas of glycomics and glycobiology77 . The limiting step in preparing these 
materials is the inherent complexity of carbohydrate synthesis, requiring orthogonal 
protecting group strategies with multistep synthesis. Modern synthetic strategies and 
precise polymerise methodology are now allowing the traditional fields of organic and 
polymer chemistry to merge78 • 
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1.3.1 MULTIVALENCY: THE CLUSTER GLYCOSIDE EFFECT 
It was observed as far back as 1888 that red blood cells agglutinated upon the 
addition of an oil extract from caster beans. It has since been determined that this was 
due to a binding event between a protein and the cell surface carbohydrates resulting 
in cross linking and hence precipitation. This protein was later identified as being a 
member of the Lectin family79'80 : proteins which bind carbohydrates, which are not 
enzymes or antibodies. Lectins display high selectivity for specific carbohydrates and 
this property was instrumental in the assignment of blood groups according to their 
surface sugar decoration. The binding of a single sugar molecule to a lectin is in itself 
a very weak process81 • However, in biological systems multiple copies of the same 
carbohydrates are displayed. For instance red blood cells displace many copes of 
sialic acid which are recognised by the cell surface proteins on the influenza virus74 . 
These recognition and binding events eventually lead to cell endoytosis by the virus 
particle resulting in infection. This specific binding can be used detect or even remove 
influenza virus by the addition of synthetic compounds presenting multiple copies of 
the sialic acid residue82 . Assuming all the carbohydrates bind with equal strength, one 
would expect that an excess of the competitive, inhibiting, compound would be 
required. This is not the case however, due to the cluster glycoside effect: defined as 
being " the enhancement in the activity of a multivalent ligand beyond what would be 
expected due to the increase in local sugar concentration"83 . Polyvalent carbohydrate 
ligands display increased binding affinity per sugar unit than the free sugar and hence 
preferential binding. (It should be made clear that Lectins are not unique in binding 
carbohydrates, and many antibodies display this high specificity, along with proteins 
and small molecules73 '84). Many complex carbohydrates and glycopeptides have been 
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identified in cellular recognition processes. These have not been incorporated into 
polymers probably due to complex multistep synthesis required to isolated even small 
quantities of the carbohydrates85-87 . 
The relative strength of the binding increases with the length of the polymer 
chain and hence an increase in the number of repeated carbohydrate groups. 
Kiesseling et al. have investigated the effect of architecture on the interaction between 
multivalent compounds and Concanavalin A (a mannose specific lectin) which 
suggested that well-defined linear polymers were more effective inhibitors (ie. 
binding preferentially to the free sugar) than polydisperse polymers or those bearing a 
lower density of the carbohydrate moieties88 . Similarly, multivalent deindrimers have 
been investigated and shown to have increased binding affinities compared to the free 
sugar89-91 . The interaction between peanut nut agglutinin and a ~-D-galactose bearing 
polymer was shown to be 50 times greater than the parent carbohydrate92 and similar 
values have been obtained for lectins specific to other sugars showing the generality 
of this increased affinity93 . Finally, the effect of the linker between the polymer and 
the carbohydrate has been investigated. The results suggest that increasing the linker 
length and hydrophobicity of the linker may increase the binding94 . 
- 17-
Chapter 1 
1.3.2 GLYCOPOLYMER SYNTHESIS 
One of the first reports of a synthetic glycopolymers was made by Horejsi et 
al. in 197895 (Scheme 2). They copolymerised acrylamide with various allyl 
glycosides to give high molecular weight water soluble polymers by free radical 
methods and investigated their interaction with plant lectins (Section 1.3 .2). 
HO 
HoJfiJ-p 
HO-...v- I + 
0\, 
HO 
HO) Ho-rJ!-P 
HO-...v- I 
0 
Scheme 2- Copolymerisation of acrylamide and allyl-mannoside. Conditions; (i) TMEDA, 
ammonium pesulfate,H20, 100°C 10 mins. 
It is no surprise that attempts have since been made to utilise controlled 
polymerisation techniques to give control over the degree of polymerisation, chain 
end functionality and to reduce the polydispersity values. Initial work focused on 
ionic polymerisation methods96•97 (cationic and anionic). This approach is limited by 
the requirements of stringent reaction conditions with the rigorous exclusion of all 
moisture and oxygen98 . Furthermore it was necessary to fully protect all the 
monomers which would otherwise lead to side reactions. The well defined ruthenium 
based catalysts introduced by the Grubbs99 for Ring Opening Metathesis 
Polymerisation (ROMP) have been exploited for glycopolymers synthesis using both 
protected100 and unprotected 101 carbohydrate based monomers owing to the catalyst's 
excellent tolerance of functionality. However, the catalyst must be thoroughly 
removed prior to biological evaluations and the unsaturated backbone can potentially 
undergo further reactions. 
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)o~o 
0 0 
(C) X 
(D) 
Figure 6- Examples of monomers used for glycopolymers synthesis by various methods; (A) 
cationic, 2,4,6-tri-o-acetyl-2-deoxy-2-phtalimido-1-(2-vinyloxy ethyl)-D-glucopyranose; (B) 
cationic 1,2:5,6-Di-isopropylidene-3-(2-vinyloxy ethyl)-o-glucofuranose; (C) anionic, m-(1,2:3,4-
di-0-isopropylidine-u-D-glucopyranose-6-oxymethyl)styrene; (D) ROMP, 1-0-u-D-
mannopyranoside-7-oxanorbornene derivative. 
The introduction of controlled radical polymerisation has allowed polymer 
chemists to create a vast range of new polymers (and architectures) owing to high 
functional group tolerance and the choice of numerous systems for mediating the 
polymerisation. When radical methods are utilised it is possible to conduct the 
polymerisation in aqueous solution using monomers with no protecting groups. This 
results in homogenous materials rather than a mixture of products which can be found 
following deprotection102• Nitroxide Mediated Polymerisation (NMP) has been used 
to polymerise protected sugars103•104, but only a single example of the use of 
unprotected sugars has been shown, giving low conversions and no polymerisation 
when high the targeted DP was above 100105 . Side reactions due to the high 
temperature employed in NMP (> 1 00°C commonly) and transfer of the propagating 
chain to a hydroxyl group are to responsible for the reduced control. Atom Transfer 
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Radical Polymerisation (A TRP) is more versatile than NMP and can be conducted at 
ambient temperatures 106• Narrain and Armes demonstrated that unprotected monomer 
2-gluconamido-ethyl methacrylate (GAMA) could be polymerised at ambient 
temperature m MeOH/H20 and also thermoresponsive block copolymers 
poly(propylene oxide) 107•108 • Perhaps the most versatile CRP technique with respect to 
its tolerance of a range of monomer types is Reversible Addition-Fragmentation chain 
Transfer (RAFT) polymerisation109 (Figure 7). The first RAFT glycopolymer 
synthesis was by Lowe et al. in 2003 110, by the polymerisation of glucosyl 
methacrylate under basic aqueous conditions. Using appropriate RAFT agents and 
solvent combinations complex architectures can be synthesised such as block 
copolymers 111 , star-branched polymers 112•113 , surface immobilised polymer 
brushes 114•115 and glycosylated metal colloids116• 
--------------------------------------
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HO OH HO~o~)l/ 
HO IT (E) 
Figure 7- Monomers and initiators used for RAFT glycopolymer synthesis; (A) tetrafunctonal 
Xanthate; (B) (4-cyano-pentanoic acid)-4-dithiobenzoate; (C) a-o-galactopyranosyl-2-deoxy-2-
amethacrylamide, (D) (1-0-methyl-a-o-galactopryanosyl-6-0-methaacylate; (E) 2-(~-D­
galactosyloxy)ethyl methacrylate 
Post-polymerisation glycosylation offers an alternative route to 
glycopolymers 72 • Indeed nature produces glycopeptides by post -translational 
modification of peptides. For the synthetic chemist this removes the requirement for 
multistep monomer synthesis and can reduce the protecting group considerations. 
Poly( vinyl alcohol) was glycosylated with glycosyl oxazolines by Takasu et a/. 117 The 
degree of substitution of the hydroxyl groups was less than 40 %. This is in part is 
limited by the solubility of PV A in organic solvents, but mostly attributable to the 
steric hindrance of adding a large (acylated) carbohydrate moiety so close to the 
polymer backbone. Whitesides et a/. 118 used copolymers of acrylamide and N-
hydroxysuccinimide (Scheme 3, A) which were then substituted with sialic acid 
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residues to give polymers which could effectively bind to the Influenza virus. Muller 
et a/. 119 demonstrated that N-methacryloxysuccinimide can be polymerised by ATRP 
using Cu(l)/bipy in DMSO (owing to its low solubility in other organic solvents) to 
give narrow molecular weight reactive precursors 120, which were converted to their 
corresponding glycoconjugate polyacrylamides by addition of galactose- and 
glucosamine 121 (Scheme 3, B). 
A) 
R= 
+ 
(ii)~o 
HN 
~OH 
HO !'SO 
HO HO 
~H~ OH ~ 0 O 0 HN HO ) 0 H AcHN /"'o.. /"'o.. 0' ........_.., 'S 
n 
Scheme 3- Glycopolymer synthesis by post-polymerisation modification of N-hydroxy 
succinimide active esters; (A) (i) 2-hydroxyethyl-2-bromoisobutyrate, CuBr/bipy, 80"C; (ii) 
Galactosamine/NEt3 (1 :2), DMF; (B) (i) A IBN, (10 mol%) THF, SO"C, N2; (ii) R-H, DMS0/25"C. 
Other postpolymerisation methods include poly(fluorenes) with bromo-
sugars 122, poly( 1,2 butadiene) with thio-sugars 123, maleic anhydride residues with 
amino-sugars 124,t 25 or pendant amines with sugar-isocyanates 126 with efficiencies of 
60 to 98 %. Perhaps the most significant advancement was in 2001 when Sharpe less 
and co-workers59 introduced the idea of "click reactions" (Scheme 1 ), representing a 
family of high yielding, efficient reactions which require little (if any) purification and 
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can preferably be conducted under mild, aqueous conditions. One reaction in 
particular has been popularised by this: the Huisgens dipolar cycloaddition between 
alkynes and azides60 (Scheme 1 ). Haddlteon and co-workers 127 polymerised 
trimethylsilyl (TMS) protected alkynes by ATRP to synthesise galactasoyl and 
mannosyl chain functionality from the corresponding glycosyl azides (Scheme 4, A). 
Near 100% functionalisation was observed. This extremely efficient reaction is ideally 
suited for reactions at chain-ends which display lower reactivity due to steric 
hindrance 128•129• Hawker et a/. 130 prepared asymmetric dendrimers by addition of 
azido-sugars to alkyne terminated dendrimers, and a single species was seen in the 
MALDI-tof spectrum. Riguera used the opposite strategy to couple alkyne 
functionalised sugars to azido terminated dendrimers 131 •132 (Scheme 4, B). An 
interesting application of this reaction was to produce "click" glycopolymers 133, 
where the triazole linkage is incorporated into the polymer backbone134• The produced 
materials were thus biodegradable, but also bear a cationic charge for DNA binding. 
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j (iv) 
X= 
3 
Scheme 4- Use of the click reaction for post-polymerisation modification_o_f llnear (A) and 
dendritic (B) polymers; (A) (i) N-(n-ethyiF2-pyridylniethanimine/CuBr, toluene, 70"C; (ii) TBAF, 
AcOH, THF, -20 to +25"C; (iii) RN3, (PPh3) 3CuBr, DIPEA; (B) (iv) CuS04, Sodium ascorbate, t-
BuOH:H20 (1:1) 
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1.3.3 APPLICATIONS OF GLYCOPOLYMERS 
The importance of carbohydrates in so many biological events, along with the 
increased binding of multivalent carbohydrate ligands, lends glycopolymers many 
potential applications in glycoscience and medicine135 . Exploitation of receptor 
mediated endoytosis offers a promising route for macromolecular drugs to enter 
cells*. Spermatoza incubated with a polymer containing an antioxidant component (a-
tocopherol) and ~-D-galactose residues were shown to increase their viability 
following storage, shown to be due to the protective effects of the polymer. An 
equivalent polymer without the galactose residues showed no improvement in cell 
viability 137• Self-assembled block copolymer micelles containing a DNA core, were 
decorated with lactose and also show an increase in cellular uptake by endocytosis31 . 
Other self assembled systems have been indicated as potential drug delivery vectors; 
including glycosomes123 (carbohydrate decorated vesicles) and micelles where the 
hydrophilic block is a glycopolymer123 . Silica functionalised with 1st generation 
glycosylated dendrimers have been made for affinity chromatography of carbohydrate 
specific proteins such as the afore mentioned lectins. The multivalent architecture 
resulted in higher purity proteins than the corresponding monovalently functionalised 
silica following chromatography 138• 
Incorporation of a fluorophore into an influenza-inhibiting glycopolymer can 
be used for detecting the presence of viruses which bind to the selected 
carbohydrate 139• Poly(allyl glucoside) immobilised on a porous membrane was shown 
to be able to absorb lipase onto the surface by non-specific hydrophilic interactions140• 
Even following 10 cycles of catalysing hydrolysis and washing the enzyme remained 
'This uptake is distinct from the enhanced uptake of macromolecules by tumour cells by the "enhanced 
permeability and retention effect" (EPR) due to increase rates of extravasation, which has been 
exploited for drug delivery to cancerous tissue20•136. 
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82% efficient, indicating a strong binding to the surface. Glycopolymers bearing 
biotin end-groups have been immobilised by the highly specific binding a to 
streptavidin coated gold slides to create functionalised surfaces 141 . The binding of 
proteins to the surface can be monitored non-invasively by shifts in the surface 
plasmon resonance band. Similarly glycopolymers immobilised onto the surface of 
metallic nano-particles (particularly gold and silver) can be used to monitor biological 
recognition events in situ. Magnetic glyco-nanoparticles can be utilised for MRI 
contrast reagents or targeted delivery 116,142 • 
A glycosylated dendrimer, decorated with mannose residues has been shown 
to mimic the glycoalyx surface of cells, which reduces bio-fouling by blood-borne 
proteins, by minimising non-specific adhesion and maximising entropic repulsion 143 • 
The advantage of using a glycosylated structure here over conventional antifouling 
polymers, such as PEG, is the lack of temperature dependant aggregation (LCST). 
A surprising non-biological application of glycopolymers was shown by Ye et 
a!., who used glycopolymers amphiphiles as solublising agents in supercritical C02, a 
"green" solvent which many compounds are insoluble in 144 • 
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1.4 ANTIFREEZE GL YCOPROTEINS: AFGPS 
The annual sea temperature at McMurdo Sound, Antarctica is -1.87°C just 
above its freezing point of -1.9°C 145 ' 146 , which is low enough to freeze the blood 
serum of most terrestrial species. However, life is found to flourish despite the 
inhospitable environment147 . Marine mammals survive by virtue of being warm 
blooded: generating body heat and insulation provided by thick blubber. Cold blooded 
species, particularly fish, require other mechanisms to survive. In 1969 Wohlschlag 
and DeVries148 observed that the freezing point of three species of fish Trematonus 
borchgrevinki, Trematonus hansoni and Trematonus bernacchii was approximately -
2.0°C. Less than half of this depression was attributable to the dissolved sodium 
chloride, in comparison to that of temperate fish where 80% of the serum freezing 
point depression is due to dissolved salts. Raised levels of other solutes including 
sugars and proteins contributed to some of the remaining freezing point depression. It 
was found that a set of glycoproteins were responsible for the remaining 30% of this 
depression, far more than would be expected on the basis of colligative arguments. 
These proteins were coined as being antifreeze glycoproteins, or AFGPs for 
simplicity. The AFGPs require significantly lower molar concentrations to give an 
equivalent freezing point depression to NaCl therefore reducing the osmotic pressure, 
which can lead to cell leakage or rupture. The freezing point depression activity of 
AFGPs was later shown to actually be a thermal hysteresis: That is the freezing point 
was depressed but the equilibrium melting point remained unchanged. An ice crystal 
held in a solution of AFGP in this thermal hysteresis gap will not melt until the 
temperature is raised above the equilibrium melting point, even though it is above its 
freezing point. Ice crystals held in this manner will also tend to form pyramidal 
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crystals rather than circular149 (Figure 8, A). More recently proteins have been 
. I d r. b h . 1150 d I k' d 151 • I d' tso ate trom ot amma an p ant mg oms me u mg amongst many, 
insects 152· 153 , grasses 154, carrots 155 and bacteria156. These are commonly referred to as 
antifreeze proteins or AFPs. The effect of these two classes of proteins on sub-zero 
water may be similar, but their structural features are not. Antifreeze proteins can take 
many forms, with varying size, secondary structure and degree of glycosylation, in 
contrast to the AFGPs which retain a large amount of structural homogeneity. 
(Structure shown in Figure 1 0) 
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Figure 8. Antifreeze(glyco) protein activity summary149• A) Dynamic ice shaping in the hysteresis 
gap; B) Antifreeze proteins from various sources; C) Antifreeze glycoproteins • 7.9kDa, 0 
I 0.5kDa, T 28.8kDa 
A rather unique feature of AFGPs is the conservation of the polypeptide 
structure even amongst species with no common ancestors. Each species can have a 
unique gene coding the same protein 157' 158 making it a rare example of convergent 
evolution 159 . This fact in itself is enough to generate interest in this class of 
glycopeptide, but will not be discussed here. AFGPs comprise of a repeating 
tripeptide unit containing two alanines and a threonine bearing ~-o-galactosyl-(1,3)-a-
o-N-acetylgalactosamine160•161 (Figure 1 0) The number of repeat units ranges from 4 
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to 55, g1vmg a molecular weight range of 2.6 to 33 kDa. AFGPs are typically 
classified according to their size, with AFGP 8 being the shortest, and AFGP 1 the 
largest. These classifications are based on the initial studies where separation and 
identification was achieved by electrophoresis148 as sho\.vn in Figure 9. AFGP 1-4 
range from 20-30 kDA and 5 - 8 2.6 - 19 ·kDa. 
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Figure 9- Acrylamide gel electrophoresis of AFGPs isolated from the se~um of Tramatomus 
borcllgrevinki146• 
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Figure 10. Native ~FGP structur;e. 
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1.4.1 MODE OF ACTION 
The mechanism by which AFGPs act has caused much debate since their 
d. 162 163 A k d' . . b d . h h 'fi d d h . Iscovery · . ey Istmctwn to e rna e IS t at t e anti reeze epresse t e pomt 
at which a seed ice crystal will grow, rather than prevent its nucleation. Proteins 
which inhibit or promote nucleation of ice are also known to occur in nature 156. 
Observations of single ice crystals grown in solutions containing AFGP showed that 
hexagonal bipyramidal shapes were formed as opposed to the circular crystals 
normally observed. This dynamic ice crystal shaping gave the important insight that 
the AFGPs were acting on the surface of the ice, rather than within the bulk lattice. 
The most commonly accepted mechanism for the activity of biological antifreezes is 
one of absorption-inhibition 164 • This model suggests that the antifreeze molecules 
absorb to the surface of the growing ice crystal. Further growth can occur in between 
adjacent antifreeze molecules, resulting in a large radius of curvature 165 (Figure 11 ). 
Water Crystal growth 
Ice 
() = AFGP or AFP 
Figure 11 -Simple representation of absorption- inhibition of AF(G)Ps at ice surfaces by the 
mattress model 
Further addition of water molecules to these curved surfaces is energetically 
unfavourable, due to the Kelvin effect, or also known as the Gibbs-Thompson effect 
when specifically related to freezing point depression 166• This rationale fits well with 
the thermal hysteresis behaviour, as although addition of further water is difficult (FP 
depression) removal of water from the lattice is unaffected (No change in equilibrium 
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melting point). This mechanism is questioned by some, particularly the assumption 
that irreversible binding to the ice surface must be occurring. If this is so, then 
significant levels of absorption should be observed even at low levels of AFGP, which 
has not been found 163 . 
The binding to ice is expected to be directed by the hydrophilic hydroxyl 
groups of the disaccharide in one of two ways: (i) Absorption of the AFGPs to the ice 
by hydrogen bonds between the AFGP hydroxyl and surface water molecules (figure 
12, A); (ii) Incorporation of the AFGP hydroxyls into the ice lattice Figure 12, B). 
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Figure 12- Possible H-bonding interactions between AFGP and ice surface. A) Surface binding. 
B) Inclusion into ice lattice 
Previous modelling studies have suggested that only two hydroxyls per 
disaccharide unit are correctly aligned to form hydrogen bonds with the ice surface 167. 
In the case shown in Figure 12 A, each hydroxyl can only form one hydrogen bond to 
the ice, whereas when the carbohydrate hydroxyl is within the ice (Figure 12, B) three 
hydrogen bonds are possible167 . Thus, for AFGP 8 ( 4 tripeptide repeat units) model A 
would allow for 8 hydrogen bonds where modal B allows for 24. Taking into account 
the tight biding required for adsorption-inhibition it would seem that model B would 
be preferential. NMR results from Knight et a/. 161 agree with this hypothesis. 
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A technique known as hemispherical etching was used to determine which 
crystallographic faces, if any, the AFGP bound to on the ice 168•169. Briefly a single 
crystal of ice is frozen onto a cold finger and immersed into a thermostated solution of 
antifreeze. The seed crystal begins to melt to form a thin shell around the finger, 
before being allowed to grow out slowly to a single crystal that is hemispherical. Due 
to the symmetry of the crystal formed, all possible ice faces will be exposed within 
each experiment. The individual faces can then be isolated and allowed to evaporate 
(freeze dry) at a sub zero temperature. During this period the AFGP concentration 
increases at the surface, appearing as etches which can be then be viewed. If no 
absorption occurred then no etching will be visible. This method was used to 
unambiguously assign the binding characteristics of AFGP. 
c-axis 
A 
AFGP 
lll'vbttress mxlel 
0Q = AFGP and curved ice surface 
Figure 13- Specific binding of AFGP to hexagonal ice crystal faces. A hexagonal ice crystals with 
steps caused by inhibition of growth at pyramidal faces by increased curvature of ice front due to 
AFGP B) Hexagonal bipyramidal ice crystal formed by repeated addition of AFGP onto the basal 
steps. 
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If a hexagonal (1 h) ice lattice unit is considered (Figure 13) it has two basal 
faces which are perpendicular to the c-axis, hexagonal in shape and 6 prism faces, 
each perpendicular to an a-axis and parallel to the c-axis. The basal faces are also 
referred to as the c-face or (000 1 ). Normally ice crystals in the presence of pure water 
show limited growth on the basal face, growing at the prism faces (along a-axes). In 
the presence of AFGPs it is found that growth of the prism faces is halted completely 
with only slow growth along the basal plane observed at low degrees of overcooling. 
(ie. Just below the freezing point). As the degree of overcooling is increased to well 
below the freezing point explosive ice growth occurs from the basal face, to give long 
thin crystals. This can be explained by step pinning. Using the mattress model, 
described earlier one can consider a hexagonal ice crystal where the AFGP has 
absorbed onto a prism face, thus increasing the local degree of curvature and 
inhibiting the growth of ice along that face. As the system is cooled further some ice 
growth can occur along from the basal face, giving rise to a step, revealing another 
prism face, which AFGP can bind to. This process is repeated to give smaller and 
smaller steps until the crystal has a hexagonal bipyramid shape (Figure 14, A-C). By 
slowly warming and cooling the crystals, individual ridges can been viewed directly. 
------------~----
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Figure 14- Assay of antifreeze activity by ice crystal morphology170; (d) Adsorption of AF(G)Ps 
to the prism face inhibits the binding of additional water molecules, making it energetically 
favourable for growth in the c-axis as apposed to the basal planes; (e), At high concentrations the 
ice forms bipyramids with an hexagonal cross section; (1), Slow cooling and warming cycles allow 
visualisation of the ridges where the AF(G)P have bound. 
This specificity for the prism faces is observed in some 171 •172 (but not all 145) 
AFP species as well as AFGPs discussed here. This would suggest that factors such as 
secondary structure and hydrophillicitylhydrophobicity are more important than the 
actual chemical composition. 173 The mechanisms of adsorption of AFP peptides to ice 
is well understood and has allowed detailed models to be established, which describe 
h b. d' · f c · d · 174 11s E I f t e m mg process m terms o contormatwn an pnmary structure · . xamp es o 
AFP structures are shown in Figure 15. This has lead to the rational design of new 
AFPs 176• The effect of secondary structure on the effect of A.GFPs is less clear, due to 
the difficulties in assigning the conformation they assume before and during ice 
binding 177. 
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(A) 
(C) 
Figure J 5 - X-ray structure of selected AFPs; (A) a-helical HPLC6 from winter flounder 178; (B) 
P-helical AFP from daucus carota (carrot) 179 ; (C) P-helical spruce budworm AFP179 
Early studies on AFGP conformation concluded that they assumed a random 
coil , but this assignment was complicated by the fact that the CD spectra also bore a 
resemblance to a 3-residue-per-tum helix 180• Light scattering and Raman spectroscopy 
suggest a folded structure was present. More recently high field NMR has been 
employed to probe the structure. In combination with molecular dynamics 
calculations and IR spectroscopy 1 H NMR was used to show that AFGP 8 displayed 
no long range order, but significant local order as opposed to AFGPs 1-5 which had 
no long or short range order181 •182• It would appear that the increased activity of the 
larger AFGPs can be attributed to their increased chain length rather than 
conformational changes. 13C NMR suggested that a three dimensional folded 
conformation is formed in the presence of ice, but is also maintained once freeze 
dried 183• This disagreement does suggest a high degree of conformation flexibility 
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which is in contrast to the rigid structures of AFPs. To date no 3-D solution structure 
has been published of an AFGP. Though many reports do agree that the structure 
involves presentation of separate hydrophilic and hydrophobic faces 163,184 . 
1.4.2 STRUCTURAL MOTIFS REQUIRED FOR ACTIVITY 
Investigations into which features of AFGPs are essential for activity has been 
partially limited by the difficulty in synthesising them163 ' 184 , compared to AFPs which 
have been made in reasonable quantities by solid phase synthesis 185 ' 186 and 
recombinant methods in yeast187 or plants 170. 
The first structural feature on native AFGP to be modified was carbohydrate 
_ degradation 160• A series of structural modifications are shown in Figure 16. 
Unsurprisingly peracetylation of the hydroxyls removed all activity, most likely 
giving a water insoluble material. The selective oxidation of the C-6 hydroxyls to the 
aldehyde resulted in no loss of hysteresis activity, agreeing with the modelling data 
which suggested only certain hydroxyls bind directly to the ice. Further oxidation of 
the C-6 position to the bisulfite or carboxylic acid completely removed all activity. 
Introducing a negative charge at the C-4 and C-3 positions by addition of sodium 
borate resulted in reversible removal of activity, until the borate was displaced by a 
change in pH. This implies that the individual OH groups are not essential for at least 
some antifreeze effect, but that negatively charged species are not tolerated at any 
position. 
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Figure 16- AFGP carbohydrate degradation products which have been analysed for thermal 
hysteresis activity. R = thr-al-al tripeptide 
The most complete study to date on the effect of individual structural motifs 
on thermal hysteresis and ice shaping ability was undertaken by Nishimura et a/. 188-190 
(Figure 17). The number of repeat tripeptide units was varied along with the 
systematic replacement of various regions of the carbohydrate moiety. Increasing the 
chain length showed a corresponding increase in thermal hysteresis activity between 2 
and 5 tripeptide units (1257 - 3082 Da) at equal mass concentrations. At 6 and 7 
repeat units there was little change in the TH activity, though in molar rather than 
mass terms they are more active. All apart from the dimer showed significant ice 
crystal shaping. A peptide synthesised without any carbohydrate groups displayed no 
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activity, indicating that a carbohydrate moiety of some description is necessary. The 
sialylated analogue (Figure 17, B) displayed no activity, agreeing with earlier work 
that the introduction of negatively charged groups removes antifreeze activity. No 
thermal hysteresis was seen when lactose and galactose were substituted, but there 
was some reduced (relative to native AFGP) thermal hysteresis for LacNAc (Figure 
17, D) and GalNAc (Figure 17, C) indicating for the first time the importance of the 
acetamide group at the 2 position. The lactose derivative did display some ice shaping 
effect. The ~- linked equivalent of native AFGP showed no thermal hysteresis but 
retained the ice shaping effects. Substitution of threonine for serine resulted in no 
activity showing the importance of they-methyl. The loss or retention of activity was 
thus linked to the presence of the acetamide group and the conformation restrictions it 
places. All analogues containing an acetamide displayed similar CD spectra to that of 
native AFGP, assuming it has a poly (proline) type helix. It was thus surmised that 
conformation is of utmost importance for TH activity. 
r<O:n ~H OH
0 HO~O 
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Notiw-A HO~'j\~OHO 
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~OH OH OH ~H OH H02C ~ ~ 0 0 AcH O 0 0 
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HO 
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Figure 17- Carbohydrate moieties studied by Nishimura eta/. on the native AFGP backbone188• 
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1.4.3 POTENTIAL APPLICATIONS OF AF(G)Ps AND THEIR 
INTERACTIONS WITH BIOLOGICAL SYSTEMS 
The properties of AFGPs enable them to protect living cells in nature, so it is 
not surprising that efforts have been made to find medical applications for human use. 
The storage of tissues and organs is of particular interest. Currently, organs awaiting 
transplant are stored just above 0°C for only a few days before they are used. If the 
organ were cooled to liquid nitrogen temperatures ( -196°C) then cellular decay would 
become negligible. The problem is that water leaks from the cells during freezing into 
the space between cells where ice crystals form and damage organ structures such as 
blood vessels, even in the presence of cryo-protectants like ethylene glycol 191 • 
Protection of spermatozoa by freezing has been possible for some time however192• 
Thus it is not surprising that AF(G)Ps have been investigated for their usefulness in 
these applications193• Ovine embryos, porcine oocytes and bovine oocytes have been 
vitrified in the presence offish AFGP, resulting in improved storage194• 
A somewhat counterintuitive application of AF(G)Ps is in cryosurgery 195 : the 
process whereby disease tissue is killed by application of cryoscopic tempera_tures. In 
the presence of AF(G)Ps, below a critical temperature, bipyramidal crystals form 
resulting in long thing ice crystals. These can pierce the cell membrane resulting in 
cell death at the locations where cryoscopic temperatures are applied, which is 
desirable for anti-cancer therapy. Solutions of 1 Omg.mL" 1 of AFP injected into 
tumours in mice, followed by slow cooling resulted in 100% cell death, specifically at 
the tumour 196. This effect is important when considering cell preservation 
applications, as it could lead to negative effects during freezing. The investigation into 
the effect of a synthetic AFGP analogue, (bearing a monosaccharide a-D-galactose, in 
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place .of the native disaccharide) .0n the thawing of Isl'et cells following cryostorage 
showed two ·effects'197• At low concentrations (500 Jlg.mL- 1 ~ . cell death was reduced 
fr;om 46% ~to 12%, attributable to the inhibition of recrystallisation during warming. 
At 3000 ~l.mL- 1 , cell death was increased to 50% because of the formation of 
spiracles which can pierce the cell membranes. High concentrations(> I mg,mL- 1) of 
the low molecular weight native AFGP~8; is toxic to human kidney and l iver ceNs. A 
C-linked analogue, whichdoes not show any thermal hysteresis activity,but retains the 
recrystallisation inhibition properties, shows none of ,this toxicit/98 (Figure I8}. 
:Interestingly, non mammalian cells {fish gill endothelium) were not affected even at 
high concentrations. 
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Figure 18. l'oxicity evaluation of C-linked' AFGP by the caspase-3/7 assay on humankidney 
cells. Increase RFU (fluorescence) values represent increased cell death. Above, structure of C-
linked, AFGP analogue tested here198• 
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The final effect of AF(G)Ps on cellular protection is their interaction with cell 
membranes. During cooling of cells significant cell leakage often occurs due to the 
change in osmotic potential associated with extra-cellular ice formation which 
increases the concentration of dissolved salts. During the storage of pig oocytes at 4°C 
their membrane potentials were monitored199• The presence of AFGP (1 ~8) 
prevented any leakage of ions, probably due to blocking of the potassium and calcium 
ion channels during cooling200. Similar results are found with bull spermatozoa20 1. 
Blood platelets when cooled below 20°C loose membrane stability, thus they must be 
stored at raised (~22°C) temperatures which limits their 'shelf life' to 5 days. In the 
presence of AFGPs, platelets can be stored at 4°C for 21 days without losing their 
function202 . Conversely, addition of AFGPs to isolated rat hearts which were then 
stored at hypothermic temperatures resulted in increased damage at all AFGP 
concentrations203 . The interaction between various lipid membranes with AFGPs were 
investigated to draw insight into these processes204 . Dielaidoylphosphatidylcholine 
(DEPC) liposomes were incubated with AFGP 8 down to 0°C. Without the AFGPs, 
cooling the liposomes resulted in leakage of 50% of their contents, whereas this was 
completely halted upon addition of up to 10 mg.mL- 1 AFGP, with the higher 
molecular weight fractions showing a stronger effect205 (Figure 19). The leakage 
events were attributed to the membranes passing through their liquid-crystalline to gel 
phase transition, T m. increasing their permeability. It is proposed that the interaction of 
the proteins with the membrane alters its Tm sufficiently to reduce/prevent leakage206 . 
Those cells whose Tm's are unaffected such as galactolipids in plant thylakoids (or 
raised) by addition of AFGP suffer negative effects during cooling207 . A 
comprehensive list of cell types stored with AF(G)Ps at low temperatures has been 
collated208 . 
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Figure 19. Leakage of a dye (carboxyfluorescin) from DEPC liposomes in the presence of 
differing concentrations of AFGP at various temperatures204• 
The ability to reduce the size of ice crystals by AF(G)Ps has potential 
applications in the frozen food industry209• These proteins do not appear to be toxic210 
by ingestion (despite the toxic effects when incubated with liver cells, discussed 
above 198) with estimates that people living in northern climates consume up to 500 mg 
per day from fish and vegetation sources211 . Reduction of the ice crystal size in 
frozen foods as they thaw improves the texture relative to when large crystals are 
present, particularly in the case of ice cream. This also allows the fat content to be 
reduced, as this is normally required to obtain the desired texture. A species of heat 
stable antifreeze proteins with strong recrystallisation inhibition has been identified 
for this purpose by Unilever UK 154' 187 '210 '211 , and is already added to ice cream in the 
USA. The effects on frozen meats have also been investigated212. Addition of AF(G)P 
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resulted in decreased size of intracellular spaces following thawing, which are caused 
by ice crystals, which gives a more desirable texture. 
These observations indicate that although AF(G)Ps have many applications 
each individual effect of thermal hysteresis; dynamic ice shaping, recrystallisation 
inhibition and membrane interactions, must all be considered. Negative results, such 
as decreasing the viability of stored hearts, must not prevent the same tests being 
carried out on other model systems where positive results may be recorded. 
These wide ranging applications have led to estimates of the total worldwide 
market for AF(G)Ps as high as $40 billion in 1999213 and regularly attract media 
interest in specialist and popular publications214-216 • 
1.4.4 SYNTHESIS OF AFG Ps 
Despite the wealth of potential applications of the AFGPs, outlined above, 
there does not yet exist any method for obtaining significant quantities of these 
proteins for study or application. Invariably all the methods involve solid phase 
peptide synthesis at one point or another. There still exists very few methods for their 
synthesis, and they are briefly reviewed here. 
In 1988 Anderson et a!. used a convergent approach to synthesise a close 
analogue of the AFGP tripeptide, with ~-o-galactosyl-(1 ,3 )-a-D-galactose in place of 
the native disaccharide217, but larger polypeptides were not made. Later Filira et a!. 
used stepwise solid phase synthesis using glycosylated amino acid and protected L-
alanine to produce glycopolymers in a linear fashion218 shown in Scheme 5. 
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AFGP mimic 
Scheme 5. Linear solid-phase synthesis of an AFGP mimic by Filira et a/.218 
These two methods were later combined by Robert Ben's group to produce 
glycopeptides by the stepwise peptide synthesis using tripeptide building blocks219 
(Scheme 6). This convergent approach has been used for a variety of AFGP mimes 
including some with C-linked carbohohydrates which show higher enzymatic and 
h . 1 b'l' 220-222 c em1ca sta 1 Ity . 
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Scheme 6. Synthesis of glycopolypeptide by Benet a/.220 as an AFGP analogue. 
Nishimura et al. used conventional solid phase synthesis to create the 
tripeptide building block of native AFGP223 • Following removal of all the protecting 
groups, this tripeptide unit was polymerised in a condensation reaction using peptide 
coupling agents to yield polymers with the same structure of AFGPs, but with 
polydisperse chain lengths 190. This versatile strategy was extended to create a libraries 
of AFGP mimics with stepwise structural changes188•189 . 
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1.5 CONCLUDING REMARKS 
Recent advances in polymer synthesis, carbohydrate chemistry and the 
understanding of peptide structure and function is allowing the basic mechanisms of 
life to be understood and exploited for biomedical applications. The weak but highly 
specific binding of carbohydrates with protein receptors is enhanced in nature by the 
presentation of multiple copies of the relevant ligands. Multivalent glycopolymers 
mimic this effect to allow competitive binding between polymer and natures 
multivalent structures present on virus and bacterium amongst others. Other 
polymeric structures have been created to m1m1c the highly specific ordering 
associated with polypeptide secondary (and higher order) structures, while retaining 
the benefits of synthetic polymers: ease of synthesis, variable architectures and a 
plethora of possible functionalities. 
Glycoproteins present in nature have roles relating to both specific recognition 
via their carbohydrate groups and the 3-dimensional structure adopted by the peptide 
backbone, playing roles in catalysis, recognition and structure. There are currently 
few examples of synthetic materials which contain both these motifs due to the 
inherent difficulties their synthesis. Antifreeze glycoproteins are a particular 
interesting subset, in that their properties and biological importance are well 
understood on a micro- and macroscopic level but many questions remain regarding 
their solution conformation and the requirements of having the particular peptide 
backbone sequence and disaccharide. Recent work has suggested that both of these 
features are essential to maintain the thermal hysteresis and ice shaping effects but 
that the recrystallisation inhibition process can be retained even following major 
structural modification. Surprisingly, materials which are characterised as not being 
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antifreeze active are not screened for recrystallisation inhibition and thus the structural 
features necessary for this property are not understood. It is anticipated that modem 
polymer and carbohydrate chemistry can be combined to illuminate the mechanisms 
of these processes. 
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2.1 INTRODUCTION 
The synthesis of polypeptides is usually achieved by one of three methods: 
solid phase synthesis; bio-engineering1; or the polymerisation of N-carboxy 
anhydrides2 (NCAs). The NCA route is the most convenient method to obtain high 
molecular weight homo-polypeptides. t The first reported synthesis of NCAs was by 
Leuchs3+ in 1906, while he was attempting the stepwise synthesis of polypeptides. 
0 
Ph~Oy~~ 
: . OH 
o R 
SOCI2! O 
Ph~y~~0 
l:)CI 
Scheme 1. Synthesis of NCAs by the Leuchs approach 
Phenyl chloroformate derivatives of amino acids were used in his original 
synthesis, although it has also been described with methyl and t-Bu equivalents. 
Activation ofthe carboxylic acid by thionyl chloride4, then heating to reflux triggered 
an intramolecular cyclisation rather than intermolecular condensation give the 
anhydride. Although this method is now 100 years old, it is still an attractive method 
due to the simplicity of the alkoxyamino acid starting materials. PBr3 and PC155'6 have 
also been used to activate the carboxylic acid. Apart from the toxicity and handling 
difficulties associated with thionyl chloride, the main difficulty with this method lies 
t Details of the polymerisation ofNCAs is covered in chapters 3 and 4 and reference [2] 
: NCAs are also less commonly referred to as Leuchs anhydrides, after their discoverer. 
------------···-·---~----·-------------·----·-------------
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in the high temperature required for cyclisation which is close to that at which many 
NCAs decompose thermally. 
The most common method used now for the synthesis of NCAs is the Fuchs-
Farthing method7. It was shown that simply treating an amino acid with phosgene gas 
in an inert organic solvent (such as dioxane or ethyl acetate) gave the corresponding 
NCA in high yield (>70%) with short reaction times (<3 hours) and no racemisation 
(Scheme 2). 
H2N 
CI2CO 0~ .. HN~O ~OH Cl)l(~~OH "'\ "'\H~ HCI }-o 
0 0 0 
0 0 0 
CIACI CI3C........_ )l /CCI3 A /CCI3 0 0 Cl 0 
A B c 
Scheme 2. Top. Fuchs-Farthing synthesis of glycine NCA using phosgene gas; below. (A) 
phosgene; (B) triphosgene; (C) diphosgene 
In 1987 Eckert and Forster8 showed that triphosgene (Scheme 2, B) could 
replace phosgene in many reactions. This is a solid at room temperature, so is far 
simpler and safer to handle on a laboratory scale and provides three equivalents of 
phosgene. Diphosgene9 has also been used to a lesser extant, shown in Scheme 2 C. 
Triphosgene was soon shown to be suitable for NCA synthesis 10, and is now widely 
applied 11 - 14• Another analogue of this is di-tert-butyltricarbonate 15 which offers the 
advantage of no HCl by-products but gave poor yields (25%) for less soluble amino 
acids. 
Mobashery and Johnston 16 first used N-Boc protected ammo acids as 
precursors to NCAs. By functionalising the carboxylic acid with a 1Bu-dimethyl silyl 
ester and activation with oxalyl chloride they achieved quantitative conversion to 
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NCAs (Scheme 3 A). This was later improved 17 to a one-pot synthesis by removing 
the requirement for silyl ester synthesis. Simply treating N-Boc amino acids with 
triphosgene gave the corresponding NCA in over 70% yield, in the same fashion as 
Leuch's synthesis. (See above) This reaction proceeds at room temperature and theN-
Boc group imparts greater solubility in organic solvents relative to the free amino acid 
(Scheme 3 B). 
B 
Scheme 3. Synthesis of NCAs from N-8oc amino acids. Where R2 =any protected amino acid side 
chain. Conditions (i) When R1 =A: oxalyl chloride, O"C, 5 mins; R2 = 8: RT, 3 h 8 is introduced 
by triphosgene. 
Some peptide coupling agents such as PyBop18 and P20 5 19 induce cyclisation 
of N-Boc amino acids However, DCC20 has been shown instead to form a symmetric 
anhydride. There are many more methods in the literature for NCA synthesis which 
can not be all be covered here including the Curtis conversion21 which yields 
exclusively racemic NCA mixtures and re-arrangement of a ~-lactam22 . Perhaps the 
most interesting new synthesis is that of Taillades et aP3•24 which involves nitrosating 
N-carbamoyl amino acids, producing only H20 and N2 as side products. This has led 
to speculation that NCAs could have been involved in the prebiotic formation of 
peptides on Earth25-27 . 
Most of the methods described above generate HCl as a side product, which 
can cause serious problems with NCA polymerisation2 (see Chapter 3). Typically, 
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NCA purification is achieved by repeated precipitations or by judicious choice of 
solvent mixtures to minimise the solubility of HCl. Numerous papers and patents 
describe methods to reduce the HCl content by including charcoal as an absorbene8, 
purging N2 through the solution29 and addition of alkenes30'31 as scavengers. 
In 1966 Rude and co-workers32 demonstrated that oligo-(glyco )peptides could 
be synthesised by the addition of carbohydrate-functionalised NCAs to short peptide 
sequences. 
R= 
R,......o\r (iii) 
OH 
H2N 
0 
OAc Ac~o.-.-Ca ~ 
A) 
R HN\""rO }-o 
0 
HO 
Cbz......_ \ro, 
N Bn 
H 
0 
(i), (ii) 
Br 
Scheme 4. Synthesis of GlycoNCA by Rude eta/. (i) acetobromoglucose (2 equiv), Hg(CN)2 
(excess), dry nitromethane, 3 days; (ii) H2/Pd, MeOH; (iii) phosgene (excess), dry dioxane, 60°C, 1 
h, N2. 
The synthesis is shown in Scheme 4. The glycosylation step involves the 
Koenig-Knorr reaction33 between an acetobromo sugar and a suitably protected amino 
acid. A promoter is required to activate the anomeric bromide and in this case an 
insoluble highly toxic34 mercury salt, Hg(CN)2, was used giving a reactive 
intermediate which can be attacked nucleophilically by the alcohol group of serine. 
This glycosylation promoter has been superseded by the use of less toxic Lewis acid 
promoters such as BF3 and AlCl3 which are tolerant of free carboxylic acid 
groups35·36 , thus increasing the atom efficiency of multistep syntheses. Many more 
strategies are available for the synthesis of glycosylated amino acids including 
activated cyclohexene donors37, thioglycosides38 , enzymatic39 , and recombinant gene 
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expression 40 but these require more synthetic steps and are more suited to complex 
polysaccharide formation. Synthesis of the NCA is accomplished by taking the 
partially deprotected intermediate (shown in Scheme 4) and reacting it with phosgene 
in the Fuchs-Farthing method. This is currently the only literature method for the 
synthesis ofNCAs, giving a final yield of less than 40% and as low as 15% for the ~­
D-galactose derivative32 . Biodi et a!. 41 did report a small modification when they used 
triphosgene instead of phosgene. Aoi et a!. are the only group to have published the 
successful polymerisation of glycoNCAs42, which were all derived from serine. 
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2.2 RESULTS AND DISCUSSION 
Two different routes were employed to synthesise the glycosylated and non-
glycosylated NCAs. For clarity they will be discussed separately. 
2.2.1 NoN-GLYCOSYLATED NCAs 
The protected monomers Thr(Bzl)NCA (1), Glu(Bzl)NCA (2), Lys(Boc)NCA 
(3) and Ala NCA ( 4) were synthesised by the intramolecular cyclisation of their 
parent N-Boc protected amino acids by treatment with triphosgene and NEt3 in dry 
ethyl acetate. The synthetic procedure is shown in Scheme 5. The decision to use this 
method was made primarily on availability of materials and minimising the number of 
synthetic steps. An initial investigation was undertaken to use per-trimethyl silyl 
protected L-threonine43 '44 , which can be converted directly to the NCA. This was soon 
disregarded due to the difficulties encountered in purification (distillation) and lability 
of TMS ethers/esters/amides even under mild conditions. 
(i) 
R= Q Q' ~0~ 0 - 0 y-y~ Y n 0 
2 3 4 
Scheme 5. Synthesis of NCAs from N-Boc amino acids with the R groups suitably protected. 
Conditions: (i) triphosgene (1/3 equiv); NEt3 (I equiv); dry EtOAc; under N2; RT; 16 h. 
---------· 
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A wide range of N-Boc protected amino acids with protected R groups are 
readily available, and the single step cyclisation expedites the process. The protecting 
groups also increases the solubility in organic solvents, relative to the free amino 
acids, which can exist as doubly charged zwitterions, leading to improved yields in 
some cases. This method (as with many others) is known to proceed without 
racemisation of the chiral centre. 
The choice of ethyl acetate as solvent was important in this reaction to ensure 
that the NEt3.HCl salt, which precipitates, is as sparingly soluble as possible. 
Reducing the temperature to -20°C prior to filtration aided its precipitation, but 
probably led to some precipitation of the NCA as well. During the course of the 
reaction excess HCl will be present, which can lead to cleavage of the Boc group and 
generation of the corresponding salt. These amino acid salts are insoluble in ethyl 
acetate and are either removed with the NEt3.HCl by filtration or can react with 
triphosgene by the Fuchs-Farthing45 route to give the same NCA product. 
The formation of NCAs is traditionally confirmed by their characteristic 
infrared absorption bands in the carbonyl region. The unsymmetrical anhydrides give 
two C=O stretches in the region of 1750-1850 cm· 1, which are resolved from other 
common carbonyls such as esters and carbamates. These are summarised in Table 1. 
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Table I. Infrared absorbances for NCAs synthesised<•) 
IR peaks (cm-1) 
NC1\ Yield C2=0 Cs=O 
Thr(Bzl) (1) 64% 1860 1791 
Glu(Bzl) (2) 55% 1864 1705 
Lys(Boc) (3) 65% 1862 1769 
AI (4) 68% 1861 1772 
(a) Obtained from Smg of sample prepared as a KBr disc 
Scheme 6. Numbering scheme used for characterisation of NCAs 
The 1H NMR spectra of the NCAs show a peak attributable toN-H. Due to the 
labile nature of protons bound to nitrogen atoms, this peak can vary in both chemical 
shift and in its integral relative to C-H peaks. The consequences of this are discussed 
in some more detail in Chapter 3. There is no evidence of any residual Boc methyl 
groups in the 13C NMR spectra for all the NCAs synthesised (Figure 1), indicating 
complete conversion to the NCA. 
,-------------~-------------
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* 
A 
I Ill I J 
B 
Anhydride 
11 ~ l 
150 100 ppm 50 
Figure I. 13C NMR spectra of A: N-Boc-(0-benzyi)-L-threonine, with methyl carbon of Boc 
marked*; B: 0-benzyi-L-threonine NCA. Two carbonyl peaks arising from NCA are marked. 
These monomers must be extremely pure if they are to be used in controlled 
polymerisation by the 'amine' mechanism. The standard methods for determination of 
the purity of small organic molecules are elemental analysis and/or chromatography 
of some type - normally GC or HPLC. NCAs will degrade to some exterit during 
chromatography making it difficult to determine purity by this method. Similar 
arguments hold for elemental analysis, which is not normally conducted in a manner 
where all degradation pathways can be avoided. Typically NCAs are purified by 
repeated precipitations; however we found that this method was not sufficient to 
remove the NEt3.HCl salt impurities. In order to achieve this we adopted the method 
of Poche et a/.45 The NCA solution in ethyl acetate was extracted at 0°C with an 
aqueous sodium bicarbonate solution. This method results in some loss ofNCA due to 
hydrolysis (the products of which are transferred into the aqueous layer), but does 
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generate higher purity monomers. 1H NMR of an NCA which has been extracted 
compared to one which has not shows no evidence of the NEt3.HCI peaks at 3ppm 
(Figure 2). 
A 
B 
4.50 4.00 3.50 3.00 
ppm(l1) 
Figure 2. 1H NMR spectrum of 0-Benzyi-L-threonine NCA. A: purification by precipitation; 8: 
purification by aqueous extraction then precipitation 
Visually, it is clear that the monomers are of higher purity compared to when only 
recrystallisations are used (Figure 3). 
Figu're 3. Photograph showing NCA purified by aqueous extraction then precipitation (left) and 
precipitation only.(right) 
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The purification procedures were identical for all the NCAs synthesised anq 
the products were all isolated as powdery solids. They are soluble in THF, CHCh, 
DCM, EtOAc, DMF and DMAc, although alanine NCA is not soluble in CHCh even 
with gentle heating. 
2.2.2 GLYCOSYLATED NCAS 
The acetate protected glycoNCAs BocThr(GluAc) (7a), BocThr(GalAc) (7b), 
BocSer(GluAc) (7c) and BocSer(GalAc) (7d), were synthesised by the Fuchs-
Farthing reaction of their parent glycosylated amino acid with triphosgene. It was 
found that cyclisation of the N-Boc glycosylated amino acids to the NCA did not 
occur, therefore the Boc group was cleaved selectively using TF A. Iodine-mediated 
glycosylation of the Boc amino acids was stereospecific (~). The choice of N-Boc as 
the protecting group for the amine was made using the same considerations as for the 
non-glycosylated NCA synthesis: availability, ease of removal and the possibility of 
direct cyclisation to the NCA. The literature procedure for glycoNCA synthesis 
involves highly toxic mercuric cyanide as the promoter28 which should be avoided 
wherever possible, and requires both amine and carboxylic acid groups to be protected 
meaning atom efficiency is reduced. We have utilised modern glycosylation 
techniques with more benign promoters which has resulted in increased yield. 
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(i) 
(iii) 
(ii) 
Sa- 7a R 1 = OAc, R2 = H, R3 =Me 
5b - 7b R 1 = H R2 = OAc R3 = Me 
' ' 
5c- 7c R1 = OAc R2 = H R3 = H 
' , 
5d- 7d R 1 = H, R2 = OAc, R3 = H 
(iv) 
7 a-d 
Scheme 7. Synthesis ofglycosylated NCA monomers. Conditions: (i) N-Boc amino acid (2 equiv); 
12 (1.5 equiv); K2C03 (1.5 equiv); MeCN; N2; RT; 5 h; (ii) TFA (5 equiv); DCM; 1 h O"C~ RT; 
(iii) triphosgene (113 equiv); NEt3 (1 equiv); EtOAc; N2; RT; 16 hrs; (iv) triphosgene (2/3 equiv); 
EtOAc; N2; 20h, RT 
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2.2.2.1 GLYCOSYLATION OF N-BOC PROTECTED AMINO 
ACIDS 
The most common amine protecting group over the last two decades in 
polypeptide and amino acid synthesis is the almost ubiquitous Fmoc group46 . It is 
readily removed using piperidine, and is stable to strong acids and hydrogenation 
giving rise to desirable orthogonality. When used on the solid phase, post deprotection 
purification is facile and can be monitored by depletion of its tluorophore. However, 
in solution the liberated Fmoc cations require scavenging, which would typically be 
achieved by addition of a thiol47 followed by purification. 
Reports of the glycosylation of N-Boc amino acids in the literature are less 
common. To access the N-Boc glycoamino acids which were desired for NCA 
synthesis, we tested a number of different glycosyl donors and promoters. It was 
necessary to use protected glycosyl donors, as free OH groups are not compatible with 
NCAs. Acetate protected carbohydrates were chosen for their facile handing and a 
variety of promoting systems which they are compatible. The other common 
protecting group for glycosyl donors are per-benzylated derivatives, which are more 
active48 ('armed'), but have associated handling difficulties. 
The first system tested used ~-D-glucosyl pentaacetate as the donor, under BF3 
promotion36 (Scheme 8). This is a well known system and has been used to make 
carbohydrate-derivatised vinyl monomers49. 
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OAc 
AcO~ --OO A~O~\ OAc 
BF,IDCM YYN 0 OH 
0 
Scheme 8. Method for glycosylation of N-Boc L-threonine by p-o-glucosyl pentaacetate under BF3 
promotion. 
Following the work up, frustratingly there was no evidence that the desired 
product had been synthesised. The ratio of donor to acceptor was varied from 1 :2 to 
2:1 and gave the same results. Changing the Lewis acid to AlC13, which has been used 
in the literature with Fmoc protected amino acids, again resulted in a complex mixture 
of products as judged by TLC. 
The literature revealed that the Lewis acid AlCl/0•51 has been investigated as a 
reagent for N-Boc group removal in peptide synthesis (Scheme 9). There are reports 
of BF 3 cleaving a Boc group 52 and others where the Boc group it is stable under these 
conditions53 . With trichloroacetimidates as the glycosyl donors, N-Boc amino acids 
can be glycosylated as only catalytic quantities of the promoter are used54 . 
HOY 
y~~OH 
AICI3 
Scheme 9. Suggested mechanism for Boc group cleavage by AICI3 
The primary amine formed in this reaction (Scheme 9) is far more nucleophilic 
than the secondary alcohol, and thus competes in the glycosylation mechanism. Side 
products include ~ and a N-linked glycosides, L-threonine and associated salts, along 
with the ortho-esters often found when carbohydrate peracetates are used. These 
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observations implied N-Boc ammo acids are not compatible with glycosylation 
strategies involving certain Lewis acids. 
A suitable method did, however, present itself in the form of iodine-promoted 
glycosylation, as developed by Field et a!. 55•56 Anomeric bromides are required in 
place of acetates, as iodine is strongly halophilic57, but less Lewis acidic than other 
promoters. The bromide is also more labile in general than acetates. This reduced 
Lewis acidity endows compatibility with the N-Boc group. 
(i) 
Scheme 10. Iodine mediated glycosylation of N-Boc amino acids with acetobromo sugars. (i) 
MeCN; under N2; K2C03; 5 hr~; RT._a and p indicate the product stereochemistry arising from 
nucleophilic attack of the oxonium intermediate at different angles. 
It was necessary to have a base present, in this case insoluble K2C03, to 
remove any HI and HBr which is evolved. The reaction was found to be complete 
within 5 hours by TLC measurements. 
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Table 2- Results from the glycosylation of N-Boc amino acids under 12 promotion. Yields quoted 
relative to glycosyl donor, following purification. 
Anomeric chemical shift 
Rl R2 RJ Yield Iu Jt-2 (Hz) nc alp 
5(a) OAc H Me 64% 5.75 8.17 92.4 ~only 
5(b) H OAc Me 55% 5.73 8.26 92.9 ~only 
5(c) OAc H H 62% 5.75 8.13 92.0 ~only 
5(d) H OAc H 54% 5.73 8.21 90.0 ~only 
The isolated yields were reasonably high in all cases following column 
chromatography. For both threonine and serine derivatives it was observed that higher 
yields were obtained when using acetobromo glucose, than for acetobromo galactose. 
A rationale for this has not been proposed, but we imagine it is associated with 
impurities in the starting materials, rather than a significant difference in chemical 
reactivity. This is again our proposal for the reduced yields for serine glycosylation 
relative to threonine, as it would be expected that the less sterically hindered primary 
alcohol of serine would be more reactive than the secondary alcohol present on 
threonine, which is in disagreement with our observed results. 
Our criteria for the glycosylation strategy stated that a single stereo isomer (or 
at least a large excess) be present. Acetate-protected glucose and galactose are 
expected only to lead to the ~ anomer (Scheme 1 0) due to neighbouring group 
participation. In the absence of a crystal structure, NMR is the best method to 
determine which anomer is present. 13C NMR showed only a single peak in the region 
80 - 100 ppm (where both possible configurations would be found typically) 
indicating a single anomeric stereoisomer (Figure 4 ). Evaluation of the ]-couplings 
from the 1 H NMR spectra can provide useful information about the stereochemistry 
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also. A ~- substitutent on a galacto- or gluco-configured sugar would result in the 
anomeric proton being axial, and hence trans to the axial H2, demonstrated in Figure 
5. The coupling constant for this trans situation is larger (cftrans alkenes) than for the 
cis configuration, when the substitutent is a. The measured values were between 8.13 
and 8.26 Hz. Values below 4Hz would be typical for a, and those above 7Hz for~-
C-1 p 
.l I 
150 ppm 100 50 
Figure 4. 13C Spectra of BocThr(GiuAc), Sa. Anomeric carbon= C-1 
Absolute assignment of the stereochemistry was accomplished by using the 
NOE effect. NOESY pulse sequences allow the through-space interactions between 
protons to be observed. For both the carbohydrates used here the interaction between 
the H3 and the H 1 protons gives the necessary information. When the substitutent is ~' 
the H1 proton will be axial and thus have an expected interaction with the H3 and H5• 
If the substitutent is a, then these would not been seen. This is shown more clearly in 
Figure 5. 
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a. 
Figure 5. Predicted NOEs for p and a configurations for glucose and galactose (stereochemistry 
at H4 is shown here for glucose, but characteristic NOEs for p are the same for galactose). AA = 
amino acid residue. 
The NOESY spectra for compounds Sa, 6a, 7a and 8a show interactions 
between H1 - H3, and H1 - H5. Thus they were assigned as being ~ (Figure 6 shows 
the NOESY spectrum ofBocThr(GluAc)). 
Compounds, 5(a), 6(a), 7(a) and 8(a) were isolated as white, slightly 
hygroscopic powders. They were soluble in CHCh, DCM, THF, EtOAc, EhO, DMF, 
DMAc, EtOH, MeOH, CH3CN and acetone. 
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5.50 5.00 4.50 4.00 
Figure 6. NOESY spectrum for BocThr(GiuAc). Correlation between H1 with H5 and H3 can be 
seen. 
------·------- ·-----···-·--------·------·- ---·-·---
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CYCLISATION OF Boc(GLYCO) AMINO ACIDS TO 
NCAs 
Following the successful synthesis of a range of glycosylated N-Boc amino 
acids, the next step was to cyclise these into their respective NCAs using the same 
methodology as was shown to be successful for the non-glycosylated amino acids in 
the first section. Unfortunately, we found that no cyclisation occurred under these 
conditions. Different solvents were tried; (EtOAc, THF and CHCb) without success. 
We postulate that an intramolecular hydrogen bond between the acetate protecting 
groups of the carbohydrates and the N-H could be responsible. There are two possible 
H-bonding sites on the carbohydrate, at the 2 and 6 positions, as shown in Figure 7. 
OAc 
OAc 
0-SAc 0-2Ac 
Figure 7. Proposed modes of intra-molecular H-bonding present in BocThr(GiuAc) 
To form the NCA, the carbonyl on the Boc group must attack 
nucleophilically58 the carboxylic acid (activated by triphosgene). This would not be 
possible due to the H-bond 'locking' in the ring-opened conformation. Infrared 
analysis supported the presence of this H-bond. BocThr(Bzl) which has no H-bond 
donors or acceptors on its R group has an N-H stretch at 3372 cm- 1, compared to 
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BocThr(GluAc) which is at 3439 crn-1• This shift to higher frequency corresponds to a 
lengthening ofthe N-H bond. 
NMR analysis revealed that the starting material was recovered following the 
attempted synthesis. No cyclisation was possible for all the intermediates (Sa)- (Sd). 
It was thus decided that cleavage of the Boc group would have to be undertaken. 
2.2.2.3 1BOC GROUP CLEAVAGE 
~s discussed above, it was necessary to remove the N-Boc protecting group so 
that the Fuchs-Farthing (phosgenation) method could be applied. Lewis acids, which 
were shown to cleave partially the Boc group during glycosylation, were the first 
reagents tested. They offer the advantage that the glycosidic bond should not be too 
labile to them (or they would not be used in glycosylation reactions). It was found that 
they were not very efficient and only gave low yields of the cleavage products. 
Br0nsted acids were considered instead. The strong mineral acids HCl and HBr are 
convenient reagents, in that they can be easily removed during the work up, and offer 
high reactivity. Unfortunately they tend to induce anornerisation and cleave the 
glycosidic bond. Considering this we chose to use TF A as it is known not to affect the 
glycosidic bond when it is used in moderately low concentrations and short reaction 
tirnes59 . Indeed, in our hands a 5-fold excess for 90 minutes was shown to be 
sufficient to give quantitative cleavage of the Boc group. 
- 84-
Chapter 2 
~--- ---~---,_,--~--------,--.,_,_ 
Table 3- Results of selective cleavage of N-Boc group by TFA 
Anomeric chemical shift 
Rl Rl Rl Yield IH J1-2 (Hz) nc alp 
6(c) OAc H Me >95% 5.79 8.07 93.3 p 
7(c) H OAc Me >95% 5.76 8.09 93.8 p 
8(c) OAc H H >95% 5.90 8.58 92.9 p 
9(c) H OAc H >95% 6.04 8.35 93.1 p 
* 
B 
2.00 1.50 
ppm 
Figure 8. 1H NMR spectra of: (A) BocThr(GiuAc); (B) Thr(GiuAc). Treatment with TFA/DCM 
removes Boc Me protons(*). P-Methyl from threonine residue shifts to lower field- arrow. 
Figure 8 shows an expanded 1H NMR spectrum of a Boc protected (A) and 
deprotected amino acid (B). There is no evidence of residual Boc methyl groups. The 
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13C spectrum shows no residual (CH3) 3C signal at 28 ppm (Figure 9). The carbonyl 
stretch of the Boc group in the IR spectrum can also be seen to be absent. However it 
is not clearly resolved from the acetate groups so was not used to quantify the degree 
of cleavage. 
The absence of anomerisation is essential during any of the reaction steps. 
This is to ensure that any structure-property relationships which are later derived from 
the materials can be attributable to the precise structure present. A significant amount 
of a second anomer (in all these cases a would be the impurity) would cast doubt on 
any results. Evaluation of the H1 - H2 coupling constants gives values above 8 Hz, 
implying a trans configuration and therefore ~· The proton NMR spectra also show 
the expected ratio between the anomeric proton and methyl of threonine (or CH2 of 
serine). The carbon NMR spectra (Figure 9) show only a single peak in the anomeric 
region, at the same chemical shift as that assigned as ~-C 1 in the Boc protected amino 
acid. 
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* 
I I 
B 
200 150 100 50 0 ppm 
Figure 9. 13C NMR Spectra for (A) BocThr(GiuAc); (B) Thr(GiuAc). * = (£H3) 3C Boc 
Purification of these ammo acids was achieved by exchanging the TF A 
counterion for acetic acid. It was not possible to isolate the TF A salt as solids due to 
the difficulty of removing the excess TF A, even following prolonged high vacuum 
treatment. There was no trace of the TF A in the 13C NMR spectrum following 
extraction of an aqueous solution containing CH3C02H with hexane (expect 
CF3C02H at ~120 ppm.). No side products were found as N-Boc group cleavage 
results in the evolution of isobutene and C02 which are both gaseous, allowing for 
facile workup. The compounds 5(b ), 6(b ), 7(b) and 8(b) were isolated as very 
hydroscopic white solids soluble in H20, CHCb, DCM, EtOAc, DMF, DMAc, EtOH, 
MeOH and CH3COOH. 
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2.2.2.4 GLYCOSYLATED NCA SYNTHESIS 
The Fuchs-Farthing methodology was adopted here. The amino acids were 
treated with triphosgene in ethyl acetate allowing for purification by aqueous 
extraction, as demonstrated with the non-glycosylated NCAs. Initially we wanted to 
conduct the reaction at room temperature to limit any decomposition which may be 
caused by the evolved HCl, but found that raised temperatures (60°C) were required 
to obtain reasonable conversion due to precipitation of the amino acid.HCl salts. This 
was overcome by using a 2:1 ratio of amino acid to triphosgene (triphosgene being 3 
equivalents of phosgene), rather than a large excess, and adding the non basic HCl 
scavenger a-pinene. Terpenes such as this which contain an alkene group have been 
shown to be excellent reagents for this purpose in the synthesis of NCAs on a large 
scale.30•31 The solution typically became clear within 90 minutes of addition of a-
pinene, but if not, any remaining solids (amino acids HCl salts) were simply removed 
by filtration following cooling in a freezer. Repeated re-precipitations were 
undertaken from EtOAc to hexane to remove any residual a-pinene, or its product of 
reaction with HCI. 
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Table 4. Results for the synthesis of glycoNCAs from parent amino acids.<•> 
Anomeric chemical Shift 
R1 Rl RJ Yield(%) 1H J1-2 (Hz) uc alp 
S(c) OAc H Me 47 (73) 5.72 8.14 92.8 ~ 
6(c) H OAc Me 44 (86) 5.68 8.18 93.3 ~ 
7(c) OAc H H 43 (70) 5.75 8.00 96.1 ~ 
8(c) H OAc H 44 (82) 6.04 7.5 95.6 ~ 
<•>Total Yield. Yield this step in parenthesises 
Under these reaction conditions, no anomerisation was observed. Table 4 
shows the H 1-H2 coupling constants for all the NCAs, giving values mostly above 
8Hz characteristic of ~ (trans) configuration. This stereochemical assignment was 
confirmed by NOESY. The 13C NMR spectrum (Figure 1 0) showed only a single peak 
attributable to an anomeric carbon, confirming that only one stereoisomer was 
present. 
----·-------·-------·----
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A 
B 
* l l 
150 100 50 ppm 
Figure 10. 13C NMR spectra (A) Thr(GiuAc); (B) Thr(GiuAc)NCA. A single anomeric peak -90 
ppm, and characteristic £=0 at 157 ppm ofNCA (*),can be seen. 
The proton NMR spectrum also displays an N-H peak attributable to the NCA 
(Figure 11 ), and as is expected of these it is somewhat broadened relative to other 
peaks, and does not show any coupling to protons on adjacent carbon atoms by 
COSY. Infrared analysis on these materials was not as helpful as for the non-
glycosylated NCAs. The characteristic carbonyl stretches were obscured by the broad, 
strong absorptions attributable to the acetate protecting groups. Figure 12 shows the 
tentative assignments. High resolution mass spectrometry was employed to confirm 
the presence ofNCA. 
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N-H H-1 
I I 
6.00 ppm 5.50 5.00 
Figure 11. 1H NMR spectrum of Thr(GiuAc)NCA showing the N-H of the NCA and the single p 
anomeric peak (H-1) 
2200 2000 1800 
'iVavenumbers (cm-1) 
1600 1400 
Figure 12- Infrared analysis (Smg/KBr disc) of the conversion ofglycoamino acid (red) to the 
corresponding NCA (blue). Arrows indicate the carbonyl stretches. Example shown is for 
Thr(GiuAc). Peaks, cm-1: 1860, 1788, 1750 
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The chloride content as judged by ion chromatography was below 0.01% by 
mass, confirming the removal of HCl related impurities. 
The NCAs were soluble in CHC1 3, DCM, THF, EtOAc, DMF, DMAc and 
DMSO. 
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2.3 CONCLUSIONS 
The synthesis of a diverse range of NCAs starting from their N-Boc protected 
amino acids in a single step has been demonstrated according to literature procedures. 
The extreme purification procedure was shown to be an excellent method to obtain 
NCAs free of acidic impurities, as judged by NMR and ion chromatography. The 
NCAs with functional side groups were blocked with easily cleavable protecting 
groups. The use of Boc L-alanine for the first time gave alanine NCA in improved 
yields owing to the improved solubility gained from the Boc group. This methodology 
was unfortunately shown to be incompatible with N-Boc amino acids bearing 
peracetate protected carbohydrate moieties. Infrared spectroscopy suggested that an 
intramolecular hydrogen bond between acetate and amide locked the conformation in 
a manner which prevented cyclisation from occurring. This problem was 
circumvented by selective cleavage of the N-Boc groups with TF A, followed by 
treatment with triphosgene to synthesise the glycoNCAs in improved yields over the 
literature method, without the need for toxic mercury salts. 
We anticipate that exchanging the easy-to-handle acetosugars for the more 
reactive benzylated derivatives would allow the direct conversion of Boc amino acid 
to NCA in a single step, as there would be no hydrogen bonding sites. 
--· ------·-----·-·-----
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2o4 EXPERIMENTAL 
N-Boc (0-benzyl) L-threonine (>99%), N-Boc L-glutamic acid y-benzyl ester, 
N-a,t di-Boc L-lysine dicyclohexylammonium salt (>98%), N-Boc L-threonine 
(>98%), N-Boc L-serine (>98%) were purchased from Fluka. L-Alanine (99%), 
acetobromo-a-D-glucose (>95%), acetobromo-a-D-galactose (>95%), iodine 
(>99.8%), potassium carbonate (>99%), trifloroacetic acid (>98%), sulphuric acid 
(95-98%) and sodium carbonate (>99.5%) were purchased from Aldrich. Triphosgene 
(>96%) and triethylamine (>98%) were purchased from Lancaster synthesis. THF, 
MeCN and DCM (>99.5%) were purchased from Fischer Scientific and dried by 
passage through two alumina columns using an Innovative Technology Inc. solvent 
purification system and stored under N2. THF was further dried over 
sodiurnlbenzophenone complex with at least 3 freeze-thaw cycles, until the purple 
colouration persisted. Anhydrous ethyl acetate (>99.8%, <0.005% H20) was 
purchased from Aldrich. Hexane (Fischer Scientific >99%) was dried over 3A 
molecular sieves. 3A molecular sieves (Aldrich) were activated in an oven at 200°C 
before use. All other chemicals were used as received. Glass backed silica (Biotage) 
was used for TLC with 5wt% phosphomolybdic acid in ethanol, developed at 80°C as 
the visualising agent. Column chromatography was undertaken on a Biotage SPl flash 
chromatography unit using UV detectors at 200 and 236nm. Gradients were 
calculated using the supplied software from TLC place measurements. 
NMR-spectra were recorded with a Varian-Inova 500 spectrometer, operating 
at 500MHz eH) or at 125 MHz (13C); results of HSQC and COSY correlation studies 
have been used in order to assign the observed signals to the hydrogen and carbon 
atoms of the compound. Alternatively 1H and 13C spectra were acquired with a Bruker 
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Avance-400 spectrometer operating at 400MHz and IOOMHz respectively. NOESY 
was used to assign the configuration of carbohydrate moieties where appropriate. 
Mass spectra were obtained with a Micromass Platform spectrometer and with a 
Micromass LCT spectrometer, ionisation modes ES+ or ES-. Infrared spectroscopy 
was conducted on a Nicolet Nexus FT-IR as a KBr disc. Liquid samples were 
analysed by direct injection of the reaction medium into a liquid cell with KBr 
windows. Elemental analyses were conducted on an Exeter analytical E-440 elemental 
analyser. Digital photographs were taken using a Kodak DX6340 with a resolution of 
3.1 megapixels. Images were cropped using Adobe Photoshop version 6.0. 
0-Benzyl L-threonine N-carboxy anhydride- Thr(Bzl)NCA 
To a stirred solution of N-Boc-(0-benzyl)-L-threonine (2.1g, 6.6mmol) in 40 
mL ethyl acetate under an atmosphere of nitrogen was added triphosgene (0.65g, 
2.2mmol) in one portion and stirred to dissolution. Triethylamine (0.92ml, 6.6mmol) 
was added dropwise via syringe. The reaction was stirred at 30°C under a flow of 
nitrogen for 16 hours. After this time the reaction flask was placed into a freezer at -
20°C for 30 minutes. The hydrochloride salt of triethylamine was removed by 
filtration through a glass sinter. 
The reaction mixture was immediately extracted with ice cold H20, followed 
by ice cold aqueous NaHC03 solution(5% w/w). The organic layer was dried over 
MgS04 in a refrigerator at <4°C. The organic layer was decanted from MgS04 and 
concentrated to 1/51h of its original volume on a rotary evaporator under reduced 
pressure, with the water bath below 30°C. The concentrate was added to hexane and 
the precipitate recrystallised three times from ethyl acetate/hexane at -20°C. The white 
- 95-
Chapter 2 
solid was obtained by centrifugation following each crystallisation, and finally dried 
under high vacuum. Yield 1.5g; 68%. 
1H NMR (500MHz, CDCh) &ppm; 1.25 (3H, d, J6,5 = 6.35Hz, H6), 3.85 (IH, 
q, Js,6 = 6.35Hz, H\ 4.12 (1 H, d, J3,s = 4.31 Hz, H3), 4.36 (1 H, d, J7a,7b == 11.50Hz, 
H7a), 4.52 (IH, d, J7b-7a = 11.50Hz, H7b), 6.96 (IH, s(broad), H2), 7.18-7.28 (5H, m, 
H9). 
13C NMR (125.7MHz, 1H-decoupled, CDCh) &ppm; 15.9 (C6), 62.9 (C\ 71.3 
(C\ 73.0 (C5), 127.8, 128.0, 128.5 (C9), 136.9 (C8), 152.9 (C\ 167.8 (C4). 
IR (KBr disc) cm-1: 3300 (N-H), 1860 (C=O amide), 1791 (C=O anhydride). 
MS (ES+) m/z = 285.3 (20%) [M+Nat, 299.3 (100%) [M+Na+MeCNt, 
493.3 (30%) [2M+Na( 
~0~ 8 5 3 
HN O 
2 L__ 0 4 c{/1 
y-Benzyl L-glutamic aci~ N-carboxy anhydride- Glu(Bzi)NCA 
The same method was used as for Thr(Bzl)NCA using BocGlu(y-Bzl) (2.0g, 
5.95 mmol), triphosgene (0.58g, 1.98mmol) and Triethylamine (0.83mL, 5.95mmol). 
Yield 0.98g; 63%. 
1H NMR (500MHz, CDCh) &ppm; 2.12 (IH, m, H5a), 2.26 (IH, m, H5b), 2.59 
(2H, t, J6_5 = 6.9Hz, H6), 4.38 (IH, t, J3_5 = 6.1Hz, H3), 5.13 (2H, s, H8), 6.76 (IH, 
s(broad), H2), 7.33-7.39 (5H, m, H10). 
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13C NMR (125.7MHz, 1H-decoupled, CDCh) Oppm; 26.8 (C5), 29.7 (C6), 56.9 
(C\ 67.1 (C8), 128.3 + 128.5 + 128.7 (C 10), 135.1 (C9), 151.9 (C 1), 169.4 (C4), 172.3 
(C\ 
IR cm- 1 (KBr disc): 1864 (C=O amide), 1785 (C=O anhydride), 1705 (C=O 
ester). 
MS (ES+) m/z = 286.0 (100%) [M+Na( 
Melting Point 83-84 °C. 
N (a,i-di butoxy carbonyl) L-Lysine- (Boc2LysOH) 
Boc2LysOH.DCHA (5g, 9.49mmol) was suspended in 50mL of ethyl acetate 
at 0°C. 0.1 M H2S04(aq) was added dropwise with stirring until all solids were 
dissolved. The reaction mixture was immediately transferred into a separating funnel 
and washed 3 times with brine. Following concentration and drying on a high vacuum 
line a white solid was obtained. Isolated yield 2.93g (89%). 
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1H (500MHz, CDC13) Oppm; 1.42 (18H, s, H9), 1.65 (2H, d, J4-5 = 9.7Hz, H4), 
1.82 (2H, d, J 3_4 = 12.56Hz, H3), 2.00 (2H, d, J 5_4 = 11.18Hz, H5), 3.09 (2H, t, J 6•5 = 
5.49Hz, H6), 4.12 (IH, t, J2.3 = 7.04Hz, H2). 
13C NMR (125.7MHz, 1H-decoupled, CDCh) Oppm; 24.9 (C3), 28.6 (C9), 29.3 
(Cs), 32.9 (C4), 40.5 (C6), 54.5 (C2), 79.5 (Cs), 156.0 (C7), 177.0 (CJ). 
IR cm- 1 (KBr disc): 3369 (N-H), 2942 (C-H), 1705 (C=O Boc). 
MS (ES+) m/z = 369.2 (100%) [M+Nat 
6 
4 
~)lN 2 
9 7 H 
OH 
1 
0 
(N-t-butoxy carbonyl) L-lysine N-carboxy anhydride - BocLysNCA 
To a stirred solution Boc2LysOH (2.7g, 7.42mmol) in 35mL of ethyl acetate 
under N2, was added triphosgene (0.73g, 2.47mmol) in one portion and stirred to 
dissolution. Triethylamine (1.03ml, 7.41mmol) was added dropwise via syringe. The 
reaction was stirred at 25°C under a flow of nitrogen for 16hours. After this time the 
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reaction flask was placed into a freezer at -20°C for 30 minutes. The hydrochloride 
salt oftriethyl amine was removed by filtration through a glass sinter. 
The reaction mixture was immediately extracted with ice cold H20, followed 
by ice cold aqueous NaHC03 (5% w/w). The organic layer was dried over MgS04 in 
a refrigerator at <4°C. The organic layer was decanted from MgS04 and concentrated 
to Y2 of its original volume on a rotary evaporator under reduced pressure, with the 
water bath below 30°C. The concentrate precipitated into hexane at -20°C. This was 
recrystalised from warm (-35°C) ethyl acetate into hexane at -20°C three times. The 
white solid was obtained by centrifugation following each crystallisation, and finally 
dried under vacuum to give a white solid. Isolated yield l.32g. 65% yield. 
1H NMR (500MHz, CDCi)) Dppm; 1.36 (l3H, 9xH 12, 2xH6, 2xH\ 1.67 (2H, 
m, H\ 2.89 (2H, q, J 1 = 6.5Hz, J2 = 12.4Hz, H8), 4.42 (1H, t, J3_5 = 6.17Hz, H\ 6.80 
(lH, s, H2) 9.08 (lH, s, H9). 
13C NMR (125.7MHz, 1H-decoupled, CDCb) Dppm; 22 (C6), 28.2 (CI2), 28.8 
(Cs), 29.8 (C7), 40.2 (Cs), 57.1 (C3), 77.3 (C11), 152.0 (CIO), 155.0 (C1), 172.4 C4). 
IR cm-1: (KBr disc): 1862 (C=O amide), 1769 (C=O anhydride), 1705 (C=O 
ester). 
MS (ES+) m/z = 567.2 (100%) [2M+Na( 
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7 
0 
N" -(Butoxy carbonyl)-3-0-(2, 3, 4, 6-tetra-0-acetyl-P-D-glucopyranosyi)-L-
threonine - BocThr(GiuAc)- 5(a) 
N-Boc-L-threonine (3.0g, 13.6mmol), potassium carbonate (1.41 g, 1 0.2mmol) 
and acetobromoglucose (2. 79g, 6.8mmol) were dissolved in 40 ml of dry acetonitrile 
under an N2 atmosphere with stirring for 5 minutes to ensure dissolution. Iodine 
(2.59g, 1 0.2mmol) was then added in a single portion against a flow of N2• The vessel 
was sealed and allowed to stir at ambient temperature with the exclusion of light for 5 
hours. 
To the still-stirring solution, saturated sodium thiosulphate (aqueous) was 
added until the deep red colouration had gone, to leave a slightly yellow solution. The 
insoluble components (residual potassium carbonate) were removed by filtration and 
the filtrate concentrated to 14 of its original volume under reduced pressure on a 
rotorary evaporator. 40 mL of dichloromethane were then added, and the solution 
extracted with sodium bicarbonate (aqueous 5% w/v, 50 mL) followed by brine (2 x 
50mL), and the organic layer dried over magnesium sulphate. Separation by column 
chromatography (Hexane/THF 10: 1 -7 2:8) yielded the title product as a white solid. 
Isolated yield 2.05g; 55%. 
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1H NMR (500MHz, CDCl3) Dppm; 1.25 (3H, d, J16-? = 6.39Hz, H16), 2.0I -
2.06 (12H, m, H1s), 3.82 (IH, ddd, Js-6a = 2.20Hz, Js-6b = 4.96Hz, Js-4 = I0.07Hz, H\ 
4.09 (I H, dd, J6a-s = 2.I9Hz, J6a-6b = I2.36Hz, H6a), 4.23 (I H, dd, J7-9 = 6.36Hz, h-s = 
9.7Hz, H\ 4.30 (IH, dd, J6b-5 = 5.02Hz, J6b-6a = 12.44Hz, H6b), 4.33 (IH, m, H8), 
5.IO (IH, t, J= 9.70Hz, H\ 5.I5 (IH, dd, J 2_1 = 8.18Hz, J2_3 = 9.60Hz, H2), 5.26 (lH, 
t, J= 9.47Hz, H\ 5.30 (IH, d, J 8_7 = 9.6Hz, H8), 5.75 (lH, d, J 1_2 = 8.17Hz, H\ 
13C NMR (125.7MHz, 1H-decoupled, CDCh) Dppm; I9.9 (C 16), 28.2 (C 13), 20.5 
and 20.7 (C 1s), 58.9 (C\ 61.3 (C6), 67.5 (C8), 67.8 (C\ 70.0 (C2), 72.5 (C\ 72.9 
(C5), 80.1 (C12), 92.4 (C 1), I56.0 (C 11 ), I69.4-I67.0 (4xC14), I70.9 (C9). 
IR (KBr disc) cm- 1: 3447, broad, (N-H), 2980 (C-H), 1757 (C=O Ac), I7I8 
(C=O Boc). 
MS (ES+) m/z= 572.2 [M+Nat 100%. 
Elemental: (Found%); C 50.I6; H 6.38; N 2.35; (Expected%); C, 50.27; H, 
6.42; N, 2.55. 
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IV'" -(Butoxy-carbonyl)-3-0-(2, 3, 4, 6-tetra-0-acetyi-P-D-galactopyranosyl)-L-
threonine - BocThr(GaiAc)- S(b) 
The same procedure was followed as for the glucose derivative using N-Boc-L-
threonine (3.0g, 13.6mmol), potassium carbonate (1.41g, 10.2mmol) 
acetobromogalactose (2.79g, 6.8mmol) and iodine (2.59g, 1 0.2mmol). Separation by 
column chromatography (hexane/THF 10:1 7 2:8) yielded the title product as a white 
solid. Isolated yield 2.20g; 59%. 
1H NMR (500MHz, CDCh) Dppm; 1.26 (3H, d, Jt6-7 = 6.38Hz, H16), 1.99 -
2.06 (12H, m, H1\ 4.04 (lH, td, Js-4 = 0.74Hz, Js-6a = Js-6b= 6.47Hz, H5), 4.07 (lH, 
dd, J6b-5 = 6.14Hz, J6b-6a = 1 0.89Hz, H6b), 4.20 (1 H, dd, J6a-5 = 6.40Hz, J6a-6b = 
10.86Hz, H6a), 4.22 (lH, d, J 8_7 = 9.2Hz, H8), 4.35 (lH, m, H\ 5.08 (lH, dd, J3-4 = 
3.41 Hz, J 3_2 = 1 0.44Hz, H\ 5.33 (1 H, dd, J 2_1 = 8.26Hz, J2_3 = 1 0.44Hz, H\ 5.42 
(lH, dd, J4_3 = 3.41Hz, J4_5 = 0.94Hz, H\ 5.73 (lH, d, J1-2 = 8.26Hz, H1). 
13C NMR (125.7MHz, 1H-decoupled, CDCb) Dppm; 19.9 (C 16), 20.5-20.7 
(4xC 15), 28.2 (C1\ 59.0 (C\ 60.8 (C6), 62.3 (C8), 67.2 (C4), 67.9 (C2), 71.4 (C\ 
72.3, (C\ 80.1 (C1\ 92.9 (C1), 156.0 (C 11 ), 169.9-170.1 (4x C1\ 170.6 (C9). 
IR (KBr disc) cm-1: 3447, broad, (N-H), 2981 (C-H), 1757 (C=O Ac), 1718 
(C=O Boc). 
MS (ES+) m/z = 572.2 [M+Nat 100%. 
Elemental: (Found%); C, 50.48; H, 6.54; N, 2.36; (Expected%); C, 50.27; H, 
6.42; N, 2.55. 
A~C 6 4 5 0 
AcO 
1 0~7 16 3 2 OAc 
11 9 OH 1~/ )V~It~o 8 a 
13 0 
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.N'--(Butoxy carbonyl)-3-0-(2, 3, 4, 6-tetra-0-acetyi-P-D-glucopyranosyl)-L-Serine 
- BocSer(GiuAc)- S(c) 
The same procedure was followed as for the threonine glucose derivative 
usmg N-Boc-L-serine (3.01g, 14.6mmol), potassium carbonate (1.52g, 11mmol), 
acetobromoglucose (3.01g, 7.32mmol) and iodine (2.79g, 11mmol). Purified by 
column chromatography (hexane/THF 10:1 7 2:8). Isolated yield 2.19g; 56%. 
1H NMR (500MHz, CDCh) Oppm; 1.43 (9H, s, H13), 1.99-2.07 (12H, m, H15), 
3.83 (1H, ddd, Js-6a = 2.15Hz, Js-6b = 4.65Hz, Js-4 = 9.95Hz, H5), 4.02 (1H, m, H7a), 
4.10 (1 H, dd, J6a-5 = 2.20Hz, J6a-6b = 12.48Hz, H6a), 4.28 ( 1 H, dd, J6b-5 = 4.81 Hz, J6b-6a 
= 12.45Hz, H6b), 4.35 (lH, m, H7b), 5.11 (lH, t, J = 9.90Hz, H\ 5.14 (lH, dd, J2-t = 
8.15Hz, J2_3 = 9.47Hz, H2), 5.26 (lH, t, J= 9.38Hz, H3), 5.40 (1H, dd, Js-7a = 2.79Hz, 
Js-7b = 6.67Hz, H8), 5.75 (lH, d, J 1_2 = 8.13Hz, H1). 
13C NMR (125.7MHz, 1H-decoupled, CDC13) Oppm; 20.5- 20.7 (4xC 15), 28.0 
(C 13), 56.2 (C\ 61.0 (C6), 62.3 (C8), 67.6 (C4), 70.0 (C2), 71.1 (C 12), 72.4 (C\ 72.8 
(C5), 92.4 (C1), 155.1 (C 11), 169.2- 170.0 (4x C 14), 170.8 (C9). 
IR (KBr disc) cm- 1: 3447, broad, (N-H), 2979 (C-H), 1753 (C=O Ac), 1717 
(C=O Boc). 
MS (ES+) rn/z = 558.2 (100%) [M+Nat, 
Elemental: (Found%); C, 49.52; H, 6.25; N, 2.10; (Expected%); C, 49.34; H, 
6.21; N, 2.62 
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~-(Butoxy carbonyl)-3-0-(2, 3, 4, 6-tetra-0-acetyl-P-D-galactopyranosyl)-L-
Serine -BocSer(GaiAc)- S(d) 
The same procedure was followed as for the threonine galactose derivative 
using N-Boc-L-serine (3.06g, 14.9mmol), potassium carbonate (1.54g, 1l.Ommol) and 
acetobromoglucose (3.07g, 7.5mmol) and iodine (2.77g, 11.0mmol). Purified by 
column chromatography (hexane/THF 10:1 ~ 2:8). Isolated yield 2.29g; 57%. 
1H NMR (500MHz, CDC13) 8ppm; 1.43 (9H, s, H13), 1.99-2.06 (12H, m, H15), 
5.08 (IH, dd, 13-4 = 3.45Hz, 13-2 = 10.45Hz, H\ 5.31 (IH, dd, 1 2_1 = 8.28Hz, 1 2_3 = 
10.43Hz, H2), 5.46 (1H, dd, 14-s = 1.08Hz, 14_3 = 3.35Hz, H4), 5.73 (IH, d, 11_2 = 
8.21Hz, H1). 
13C NMR (125.7MHz, 1H-decoupled, CDC13) Dppm; 20.4-20.7 (4xC 15), 29.2 
(C 13), 57.7 (C\ 61.0 (C6), 62.0 (C8), 66.7 (C\ 67.5 (C\ 70.8 (C\ 72.1 (C4), 80.3 
(C 12), 89.8 (C 1), 155.0 (C 11 ), 169.2-170.5 (4xC 14 and C9). 
IR (KBr disc) cm- 1: 3411 (N-H), 2976 (C-H), 1760 (C=O Ac), 1714 (C=O 
Boc). 
MS (ES+) m/z = 558.2 (85%) [M+Nat, 599.2 (100%) [M+Na+CH3CN( 
Elemental: (Found %); C, 49.12 ; H, 6.30; N, 2.30; (Expected%); C, 49.34; 
H, 6.21; N, 2.62. 
A~C 6 4 5 0 
AcO 
1 01 3 2 OAc 
11 9 OH 
1 !.--/ ~,0'Jt~o 8 0 
13 0 
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3-0-(2, 3, 4, 6-tetra-0-acetyi-P-D-glucopyranosyi)-L-threonine acetic acid salt -
Thr(GiuAc)- 6(a) 
BocThr(GluAc) (lg, 1.82 mmol) was dissolved in 10 mL of DCM under N2. 
TFA (0.7 ml, 9.11 mmol) was then added dropwise and allowed to stir at ambient 
temperature for · 90 minutes. The solution was then concentrated under reduced 
pressure on a rotorary evaporator to give a thick syrup. The syrup was taken up in 20 
mL of 10% w/v acetic acid(aq) solution and extracted 3 times with 20 mL portions of 
n-hexane. The title product was isolated as a white solid by freeze-drying. No further 
purification was required. Yield 0.91 g; >95%. 
1H NMR (500MHz, CDCh) Oppm; 1.49· (3H, d, Jls-7 = 6.08Hz, H15), 1.99 -
2.14 (12H, m, H 11 + H 13), 4.06 (1H, d(b), J= 9.95Hz, H\ 4.15-4.22 (2H, m, H8 + 
H6b), 4.25 (lH, dd, J6a-6b = 12.37Hz, J6a-s = 2.74Hz, H6a), 4.35 (lH, q, J?-s = J?-15 = 
6.14Hz, H\ 5.12 (2H, t, J = 9.24Hz, H2 + H\ 5.35 (1H, t, J = 9.41Hz, H\ 6.00 
(lH, d,J1-2 = 8.12Hz, H1). 
13C NMR (125.7MHz, 1H-decoupled, CDCh) Oppm; 19.9-20.6 (C 11 + C 13), 21.2 
(C15), 59.4 (C8), 61.1 (C6), 65.9 (C\ 67.6 (C4), 69.8 (C2), 72.3 (C\ 72.5 (C\ 93.2 
(C1), 166.9(C9), 169.4-170.1 (C 12), 170.7(C14). 
MS: (ES+) m/z = 449.9 [Mt (100%). 
AcO ~~:~ r. A~~o~7 16 l 3 2 OAc 9 OH 12 '.r' CH CO H HzN 8 
11 r 3 2 10 0 13 14 
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3-0-(2, 3, 4, 6-tetra-0-acetyl-P-D-galatopyranosyi)-L-threonine acetic acid salt-
Thr(GaiAc)- 6(b) 
The same procedure as for Thr(GluAc) was followed using BocThr(GalAc) 
(0.9g, 1.64mmol) and TFA (0.63ml, 8.2mmol). Yield 0.83g; >95%. 
1H NMR (500MHz, CDCI3) Dppm; 1.41 (1H, d, lts-7 = 5.88, H15), 1.95- 2.06 
(ISH, m, H 11 + H 13), 3.97 (lH, m, H8), 4.08 (lH, dd, Js-6a = 6.62Hz, Js-6b = 7.88Hz) 
4.13 (1H, dd,J6a-6b = 10.84Hz,J6a-5 = 5.92Hz, H6a), 4.19 (1H, dd, J6b-6a = 10.31Hz, J6b-
5 = 5.91Hz, H6b), 4.39 (lH, q, J 7.t5 = J1-s = 6.27Hz, H\ 5.22 (lH, dd, J3.2 = 10.44Hz, 
J3.4 = 3.04Hz, H\ 5.31 (lH, dd, J2-t = 8.25Hz, Jz-3 = 10.10Hz, H2), 5.45 (1H, d,J4-3 = 
2.89Hz, H\ 5.96 (lH, d, J 1•2 = 8.07Hz, H1). 
13C NMR (125.7MHz, 1H-decoupled, CDCb) Dppm; 19.5 - 20.9 (4xC 11 , C 13 , 
C15), 59.2 (C8), 60.6 (C6), 61.9 (C5), 65.8 (C\ 66.6 (C4), 67.5 (C2), 70.3 (C\ 71.6 
(C\ 93.7 (C1), 166.6 (C9), 179.8- 171.0 (4xC 12), 175.6 (C 14). 
MS (ES+) m/z = 449.9 [Mt (100%). 
AcObAc 
4 5 0 
AcO 
1 0~7 16 l 3 2 OAc 9 OH 12 'I' CH CO H HzN 8 
11 r 3 2 10 0 13 14 
--- -----·----------·-----·----------·---~---
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3-0-(2, 3, 4, 6-tetra-0-acetyl-P-D-glucopyranosyi)-L-serine acetic acid salt-
Ser(GiuAc)- 6(c) 
The same procedure as for Thr(GluAc) was followed using BocSer(GalAc) 
(lg, 2.02mmol), TFA (0.78ml, 10.1mmol). Yield 0.93g; >95%. 
1H NMR (500MHz, CDCh) 8ppm; 1.98-2.18 (15H, m, H11 , H13), 3.86 (lH, dd, 
ha-7b = 3.63Hz, J1a-s = 4.43Hz, H7a), 4.02-4.14 (4H, m, H6a, H6b, H7b, H5), 4.22 (lH, t, 
J 8_7 = 4.50Hz, H8), 5.21 (1 H, dd, J4-s = 7.45Hz, J4-3 = 3.50Hz, H4) 5.29 (1 H, t, J3-4 = 
J3_2 = 5.00Hz, H\ 5.33 (lH, td, Jz_3 = 2.00Hz, Jz_ 1 = 8.5Hz, H2), 5.90 (lH, d, J1-2 = 
8.58Hz, H1). 
13C NMR (125.7MHz, 1H-decoupled, CDCh) Dppm; 18.4- 21.4 (4xC 11 , C13), 
58.9 (C\ 59.1 (C6), 60.3 (C8), 66.2 (C8), 67.4 (C4), 69.8 (C2), 71.0 (C\ 72.2 (C5), 
98.9 (C1), 166.6- 171 (C9, 4xC 12, C14). 
MS (ES+) m/z = 435.9 [Mt (100%). 
AcO~ 7 
l Ac 3 2QAc Oh 9 OH 12'_r CH CO H H2N 8 
11 r 3 2 10 0 13 14 
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3-0-(2, 3, 4, 6-tetra-0-acetyl-P-D-galactopyranosyl)-L-serine acetic acid salt -
Ser(GalAc)- 6(d) 
The same procedure as for Thr(GluAc) was followed using BocSer(GalAc) 
(1.2g, 2.42mmol), TFA (0.94ml, 12.1 mmol). Yield 1.08g; >95%. 
1H NMR (500MHz, CDCh) &ppm;; 2.05-2.15 (12H, m, H11 ), 4.14 (IH, ddd, 
Js-6a = 3.00Hz, Js-6b= 3.60Hz, Js-4 = 7.06Hz, H\ 4.39 (IH, t, 14-5 = J4.3 = 6.5 H\ 4.69 
(1H, dd, J7a-7b = 2.50Hz, J1a-s = 7.5Hz, H7a), 4.80 (IH, m, H6a), 4.91 (IH, t, J = 
4.50Hz, H2), 5.05 (IH, dd, J3•4 = 3.5Hz, J3•2 = 4.5Hz, H\ 5.46 (1H, m, H6b), 6.04 
(1H, d, J1-2 = 8.35Hz, H1). 
13C NMR (125.7MHz, 1H-decoupled, CDCh) &ppm; 20.5-21.2 (4xC 11 ), 59.0 
(C\ 59.3 (C6), 60.2 (C8), 65.2 (C8), 69.1 (C2), 71.0 (C3), 72.3 (C4), 72.6 (C\ 99.1 
(C 1), 168.2-170.6 (C9, 4xC 12), 174.8 (C 14). 
MS (ES+): m/z = 435.l[M+] 100%. 
Aco~OAc 
4 
AcO 0 7 
0 3 2 OAc \r 9 SOH A CH3C02H HzN 
12 13 ?I 13 14 0 
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Synthesis of L-threonine ((2, 3, 4, 6-tetraacetyl)-P-D-glucopyranose)) N-carboxy 
anhydride- Thr(GluAc)NCA 7(a) 
Thr(GluAc) (lOOmg, 0.20 mmol) was taken up in 5 mL of EtOAc under N2. 
Triphosgene (39mg, 0.13 mmol) was added in a single portion, against the flow of N2 
followed by a-pinene (0.37mL, 2.34 mmol) and allowed to stir at ambient 
temperature for 20 hours then concentrated to Y2 of its original volume on a rotary 
evaporator under reduced pressure, with the water bath below 30°C. The concentrate 
was precipitated into hexane at -20°C. The resulting solid was collected then re-
precipitated from ethyl acetate into hexane at -20°C three times. The white solid was 
obtained by centrifugation, and finally dried under vacuum. Yield 68mg; 73%. 
1H NMR (500MHz, CDCb) Oppm; 1.54 (3H, d, J14-7 = 6.24Hz, H14), 1.98 -
2.10 (12H, m, H 12), 3.87 (lH, dd, J5_4= 10.09Hz, J5_6 = 2.33Hz, H\ 4.00 (1H, d, Js_7 = 
4.85Hz, H8), 4.09 (1H, dd, J6a-6b = 12.30Hz, J6a-5 = 1.14Hz, H6a), 4.28 (lH, dd, J6b-6a 
= 12.58Hz, J 6b-s = 4.52Hz, H6b), 4.76 (lH, m, H\ 5.12 (2H, m, H2 + H\ 5.26 (1H, t, 
J= 9.41Hz, H\ 5.72 (lH, d, J 1_2 = 8.14Hz, H1), 6.30 (lH, s, H\ 
13C NMR (125.7MHz, 1H-decoupled, CDCb) Oppm; 20.5 - 21.0 (4 X C12 + 
C1\ 59.9 (C8), 61.3 (C6), 67.6 (C4), 69.9 (C2), 72.2 (C\ 72.9 (C5), 75.0 (C\ 92.8 
cc'), 157.7 (C 10) 168.8 cc"), 169.3-170.5 (4 x C13). 
High Resolution MS (ES+) m/z = 476.1396 [M+Nat; Expected 476.1399. 
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Synthesis of L-threonine ((2,3,4,6 tetraacetyl) P-D galactopyranose)) N-carboxy 
anhydride- Thr(GaiAc)NCA -7(b) 
The same procedure was used as for Thr(GluAc)NCA using Thr(GalAc) 
(92mg, O.I8mmol), triphosgene (36mg, O.I2mmol) and a-pinene (0.34mL, 
2.I5mmol). Yield 73mg; 86%. 
1H NMR (500MHz, CDCh) Oppm; I.55 (3H, d, JI4-7 = 6.32Hz, H14), I.96- 2.I9 
(12H, m, H12), 4.00 (IH, d, J8.7 = 4.83Hz, H8), 4.80 (IH, m, H\ 5.II (IH, dd, J3•2 = 
I0.45Hz, J3.4 = 3.38Hz, H\ 5.29 (IH, dd, J2-J = I 0.40Hz, J 2•1 = 8.22Hz, H\ 5.43 
(IH, d,J4•3 = 2.69 Hz, H4), 5.68 (IH, d,J1•2 = 8.18Hz, H1), 6.I6 (IH, s, H9). 
13C NMR (125.7MHz, 1H-decoupled, CDCh) Oppm; 20.5- 2I.O (4 X C12 , C14), 
60.2 (C8), 6l.I (C6), 66.8 (C4), 67.9 (C2), 70.5 (C3), 72.2 (C\ 75.4 (C\ 93.3 (C 1), 
I57.9 (C 10), I68.0 (C 11 ), I69.8- I70.4 (4 X C13). 
High Resolution MS (ES+) m/z = 498.I230 [M+Nat; Expected 498.I218. 
AcO~c 
4 
6 
5 0 
AcO 
1 o~7 14 3 2 OAc 8 ~r' 9 HN ~ 
12 ~0 
0 10 
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Synthesis of L-serine ((2, 3, 4, 6 tetraacetyl) P-D glucopyranose)) N-carboxy 
anhydride- Ser(GiuAc)NCA- 7(c) 
The same procedure was used as for Thr(GluAc)NCA using Ser(GluAc) 
(IOOmg, 0.22mmol), triphosgene (43mg, 0.14mmol) and a-pinene (0.4lmL, 
2.57mmol). Yield 65.lmg; 70%. 
1H NMR (500MHz, CDCh) 8ppm; 1.99-2.19 (12H, m, HI 3), 3.70 (IH, dd, ha-
7b = 3.50Hz, ha-s= 4.00Hz, H78), 4.06-4.19 (4H, m, H68, H6b, H7ba, H8), 4.21 (IH, t, h 
4 = 4.50Hz, H\ 4.77 (IH, m, H5), 5.11 (IH, dd, hs = 7.50Hz, 14-3 = 3.00Hz, H\ 5.25 
(IH, td, h 3 = 2.00Hz, hi = 7.7Hz, H2), 5.75 (IH, d, JI-2 8.00Hz, HI), 6.07 (IH, s, 
H9). 
IJC NMR (125.7MHz, IH-decoupled, CDCb) Dppm; 20.7- 21.8 (4xCI 2), 58.9 
(C\ 59.1 (C6), 60.1 (C8), 66.2, 67.4 (C4), 69.8 (C2), 71.0 (C\ 72.2 (C\ 98.6 (CI), 
154.l(CI0), 165.3(CII), 168.7-171.0 (4xC 13). 
High Resolution MS (ES+) m/z = 484.1066 [M+Nat; Expected 484.1062. 
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Synthesis of L-serine ((2, 3, 4, 6 tetraacetyl) P-D galactopyranose)) N-carboxy 
anhydride- Ser(GalAc)NCA- 7(d) 
The same procedure was used as for Thr(GluAc)NCA using Ser(GalAc) 
(200mg, 0.43mmol), triphosgene (87mg, 0.28mmol) and a-pinene (0.82mL, 
5 .14mmol). Yield 150 mg; 82%. 
1H NMR (500MHz, CDCh) Dppm; 2.02- 2.14 (H13), 4.00 (IH, ddd, Js-6a = 
3.00Hz, Js-6b = 3.60Hz, Js-4 = 7.06Hz, H\ 4.35- 4.48 (4H, m, H4, H63, H6b H8), 5.07 
(IH, dd, J2-J = 3.50Hz, J1-2 = 4.50Hz, H2 ), 5.45 (lH, dd, J3-2 2.00Hz, J3-4 = 3.50Hz, 
H3), 6.04 (IH, d, J1,2 =6Hz, H1), 6.71 (1H, s, H9). 
13C NMR (125.7MHz, 1H-decoupled, CDCI3) Dppm; 20.5 - 21.2 (4xC 13), 59.0 
(C\ 59.3 (C6), 60.4 (C8), 69.2 (C\ 71.0 (C3), 72.2 (C4), 72.6 (C5), 99.1 (C 1), 155.8 
(C 10), 164.7 (C 11 ), 167.2-170.1 (4xC 13). 
High Resolution MS (ES+) rnlz = 484.1061 [M+Nat; Expected 484.1062 
4 5 0 
AcO~Ac 
~ AcO 3 2 OA~ Oi 8 
~/ 9 HN.~~1 
12 \.-o 
II 10 
0 
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CHAPTER3 
L-THREONINE N-CARBOXY ANHYDRIDE: 
CONTROLLED POL YMERISA TION AND 
CHARACTERISATION 
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3.1 INTRODUCTION 
In the presence of an appropriate initiator, NCAs polymerise without 
racemisation to give high molecular weight polypeptides without the need for time 
consuming solid phase synthetic methods1, although N-protected NCAs have also 
been used in stepwise peptide synthesis2-5. Leuchs first investigated their 
polymerisation in the early 201h century after observing that, in the presence of 
differing amounts of water, NCAs either hydrolyse or polymerise6. The materials 
produced tended to be insoluble and were difficult to characterise with the equipment 
available and the lack of acceptance of the idea of polymeric structures. Higher 
molecular weight polypeptides were successfully synthesised and characterised, by 
using alcohols and primary amines as initiators instead of water by workers at 
Courtaulds UK7. The homopolymers formed from NCAs allowed the identification of 
the famous secondary structures motifs formed by peptides8•9, namely the a-helix and 
~-sheet 10 to be performed. 
NCA polymerisation has historically been initiated by one of two methods 11 • 
Strongly nucleophilic species such as primary amines initiate by nucleophilic attack, 
and ring opening of the NCA. C02 is evolved, regenerating a primary amine end 
group which can continue propagation. This is referred to as the 'amine' mechanism, 
shown in Scheme 1. 
Oigio'poly peptides 
Scheme 1. NCA polymerisation by the amine mechanism using n-hexylamine as the initiator. 
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As the initiator is incorporated into the polymer chain, the feed ratio dictates 
the degree of polymerisation, in the absence of any other initiation reactions. Blout 
and Karlson 12 showed that, when a tertiary amine is used, the molecular weights 
obtained were substantially greater than with primary amines or alcohols. Bamford et 
a/13 proposed the process now known as the activated monomer (AM) mechanism to 
explain this (Scheme 2). Addition of base results in the formation of NCA anions by 
abstraction of the N-H. This can then attack nucleophilically another monomer, as 
with the amine mechanism. However the end group can also react with other NH2 
groups resulting in chains condensing together, thus inflating the observed molecular 
weight. Table 1 displays the molecular weights of poly(y-benzyl-glutamate) (PBLG) 
obtained using different initiators. n-Hexylamine initiates by the amine mechanism 
and thus gives the lowest molecular weights, while the increasingly basic species 
inflate the molecular weight due to the AM mechanism. 
Table 1. Molecular weights obtained by polymerisation of BLG NCA in dioxane at equaiiMJ:IIJ 
ratios. 14 
Initiator 
n-Hexylamine 
Diethylamine 
T riethy !amine 
Sodium hydroxide 
Sodium methoxide 
Sodium borohydride 
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Mol. Wt. x 10-3/ Da 
15 
83 
280 
31 
29.5 
32.5 
!\Lacy! NCA 
Scheme 2. NCA polymerisation by the activated monomer mechanism 
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ED 
BH 
Kinetic investigations into both of these mechanisms were conducted by 
measuring the evolution of C02 conductmetrically. Different groups reported 
conflicting findings, attributing the complex kinetics to initial and intermediate 
secondary structure formations, the presence of impurities and two competing 
mechanisms 14"17• A common feature ofNCA polymerisation through the last 50 years 
has been the lack of control of the molecular parameters of the final polymer 18, which 
have been associated with numerous side reactions involving degradation products§ of 
the NCA, and the assumption that during polymerisation the mechanism switches 
§ Isocyanates have been reported, which can end-cap the amine. Hydantoic acid end groups caused by 
hydrolysis also terminate the chain. NCAs also degrade to their constituent amino acids in the presence 
of any unprotected functionality, which further complicate the process. 
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between the AM and amine route. The first successful procedure to overcome this was 
described by Deming in 1997 who exploited the previous observations 19 that various 
transition metal complexes polymerised NCAs although in an uncontrolled manner, 
and without isolation of the active species. By tuning the ligand20 and metal it has 
since been shown that the best initiators are based on zero valent nickel and cobalt 
complexes21 '22 . Briefly the polymerisation mechanism involves23 •24 (Scheme 3) 
oxidative addition of the NCA across the C5-0 bond, and expulsion of CO. This 
generates a metallocycle which can expand to accommodate another NCA with 
accompanying evolution of C02 . Proton migration releases one end of the polypeptide 
and re-forms the active metallocycle. A wide range of NCAs can be polymerised 
(including stereoselective polymerisation of racemic mixtures25) by this system 
resulting in predictable molecular weights and low polydispersity indices. Block 
copolymers containing up to 5 different blocks have been synthesised26, and the 
method has been combined with other living polymerisations (anionic and atom 
transfer radical polymerisation (ATRP)) to give hybrid materials containing vinyl 
derived and polypeptide blocks27·28 . Other promising organometallic initiators based 
on complex's between aluminium and Schiff bases have been reported29•30• 
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0 
Scheme 3. Mechanism of polymerisation of NCAs by Deming type initiators. 
Schlaad et al. 31 have proposed an alternative method involving ammonium 
chloride-terminated macroinitators. Polymerisation can proceed by the amine 
mechanism, but with reduced reactivity due to the equilibrium between the dormant 
ammonium and active amine species. This reduction in reactivity gives an associated 
increase in control and high molecular weight polypeptide blocks can be synthesised. 
Results using PEG-NH3Cl however are less encouraging, producing only short 
polypeptide blocks (DP < 20) even with large excess of monomer and extended (over 
7 days) reaction times32 . 
Aoi et ae3 have used ammonium salts to produce poly(sarcosine), and even 
claim that controlled polymerisation occurs in the presence of OH groups in the form 
of chitosan. No other groups have reported this behaviour, indeed the presence of any 
other nucleophiles has always resulted in poorly defined materials. A key feature of 
the ammonium mediated methods is that high purity monomers were used. These 
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were obtained by the aqueous extraction method of Poche et a/. 34 . (See chapter 2) 
High purity NCA monomers have also been used by Hadjichristidis et al. 35 for 
controlled polymerisation. The NCAs in this method are never exposed to air during 
their synthesis and polymerisation. In combination with high vacuum techniques and 
rigorously dry solvents and initiators they showed that perfectly controlled 
polymerisation could be achieved to high DP (>700) while retaining the living end-
groups. This has effectively settled the issue regarding whether NCA polymerisation 
continuously switches between the amine and activated monomer mechanisms and 
has indicated that poor control and side reactions were caused by impurities. 
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RESULTS AND DISCUSSION 
POLYMERISATION OF NCAs PURIFIED BY STANDARD 
TECHNIQUES 
Thr(Bzl)NCA (as described in chapter 2) was purified by the standard 
technique of repeated precipitations from THF into hexane. To test the utility of this 
monomer, which to our knowledge has not previously been polymerised, two 
initiating systems were used. The polymerisations were conducted under a nitrogen 
atmosphere using standard glassware. 
1) Triethylamine, which is a strong base and poor nucleophile, initiates 
by the activated monomer mechanism, (Table 2). 
2) n-Hexylamine, which is a weak base but strong nucleophile, initiates 
by the amine mechanism, (Table 3). 
The results ofthese experiments are tabulated below. 
--------------------------------
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Table 2. Polymerisation ofThr(Bzi)NCA by NEt3 
RunN° [M]:[I] Mu,SEC (kDa) DP PDI Modality 
1 (a) 50 11.4 60 1.34 Mono 
ia) 75 8.5 45 1.65 Mono 
3(a) 100 25.9 136 1.90 Bi 
4(a) 130 25.2 132 1.27 Mono 
5(a) 200 30.1 158 1.86 Bi 
6(a) 370 3,4 18 2.44 Tri 
7(a) 520 3.7 20 1.7 Mono 
8(b) 100 NIA 
9(c) 100 NIA 
lO(d) 100 2.9 15 1.01(e) Mono 
Conditions: monomer concentration -10% (wt) under dry N2• Solvent: (a) DCM; (b) DMF; (c) 
acetonitrile; (d) THF. (e) POI value abnormally low, due to very weak signal in light scattering. 
Appears to be broader in RI. 
Table 3. Polymerisation ofThr(Bzi)NCA by n-hexylamine. 
RunN° [M]: (I] Mu,SEC (kDa) DP PDI Modality 
30 2.3 12 2.02 Mono 
2 50 3.9 20 1.86 Bi 
3 100 24.5 128 1.90 Bi 
4 100 4.3 22 1.52 Mono 
5 200 <1.0 
6 500 <1.0 
Conditions: Monomer concentration -tO% (wt) under dry N2 in DCM 
It is generally accepted that basic initiators produce higher molecular weight 
polypeptides than nucleophilic initiators. The results in Tables 1 and 2 clearly 
demonstrate this. Using NEt3, DPs over 150 were obtained (Table 2, entry 5) 
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__________________ , 
compared to the best result of 128 (Table 3, entry 3) by n-hexylamine. There are many 
reports of basic initiating systems giving rise to polymers with Mn' s of> I 00 kDa 12•34 
particularly in the case of y-benzyl-L-glutamate (BLG) NCA, which is substantially 
greater than what is reported here. Less that 50% of the experiments conducted 
resulted in polymer formation. 
With NEt3 as the initiator, multimodal distributions and high molecular weight 
distributions were observed. There was a general trend of increasing molecular weight 
with increasing feed ratio as would be expected. When the feed ratio was increased 
above 200, then only low molecular weight species were formed. At these ratios, only 
a very small amount of initiating species is present, thus a lower concentration of 
terminating impurities are needed to prevent polymerisation. DCM was found to be a 
suitable solvent for the polymerisation of Thr(Bzl)NCA as it is for many other NCA 
monomers. Its lack of functionality prevents any unwanted interactions. The only 
limitation was that the reaction could not be heated above 38°C, which may have 
driven the polymerisation forward. DMF is probably the most commonly used solvent 
for NCA polymerisation36 owing to its polarity, and ability to dissolve a wide range of 
peptides. •• In our hands no significant polymerisation was detected when DMF was 
used as the solvent. Vayboury et al. 37 have shown that DMF can act as an end capping 
reagent, rendering the chain ends dead as shown in Scheme 4. DMF is also very 
difficult to dry, requiring fractional distillation. 
R 
Scheme 4- End capping of a growing polypeptide by reaction with DMF 
•• DMF is also commonly used in solution phase peptide synthesis. 
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Acetonitrile is another polar solvent, but has not been used extensively for 
NCA polymerisation as it is also very hygroscopic, which may explain why no 
polymerisation was observed when it was used, (Table 1, entry 9). With THF as the 
solvent, polymerisation was observed, as would be expected as its structural relative 
1,4 dioxane is a commonly used solvent for NCA polymerisation and it can be easily 
dried over sodium. When n-hexylamine was used as the initiator, only DCM was used 
as the solvent and similar patterns were observed. Multimodal distributions indicate 
that chain termination, unequal rates of propagation or multiple initiation events are 
occurring. 
In the early stages (0-1 0 hours) of the polymerisation the solutions in DCM 
became turbid which sometimes resulted in precipitation of oligomers and amino acid 
salts. This highlights the most frustrating impurity associated with NCAs, which is 
residual HCl from the synthetic procedure using triphosgene. The chloride ion in 
sufficiently high concentration can initiate polymerisation by the nucleophilic 'amine' 
mechanism 1, accounting for some of the multimodal distributions. More importantly 
the propagating amine end groups can be terminated by addition of a proton from 
HCI. At low DPs, the oligomers with a charged end group are less soluble in organic 
solvents causing precipitation. NCA decomposition products including hydantoic 
acids, ioscyanates and amino acid are all capable of interfering with the 
polymerisation. 
In summary, it is clear that Thr(Bzl)NCA, which has been purified by re-
precipitations, cannot be used to obtain polymers of defined molecular weight and 
architecture due to impurities derived from the presence of HCI. Furthermore, the 
failure of half of the experiments to initiate limits the application to more complex 
NCAs which may not be available in significant quantities. 
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3.2.2 POLYMERISATION OF ULTRA-PURE NCAs 
To remove acidic impurities from the NCA monomer, extraction with a basic 
aqueous solution was conducted as an additional purification step. This extreme 
measure (NCAs decompose in the presence of water) leads to high purity monomers. 
The removal of acidic impurities should prevent deactivation of the amine initiators 
by an acid-base reaction. To ensure that the reaction medium remains free of 
impurities high vacuum techniques were used38 . Chemicals were transferred by 
syringe or flask-to-flask distillation and handled under vacuum or in an inert 
atmosphere. THF was used as the solvent unless otherwise stated. The results of this 
are summarised in Table 4. 
Table 4. Polymerisation ofThr(Bzl)NCA by n-hexylamine 
RunN° [M]:[I] Mn,SEC (k.Da) Mn,Theo (k.Da) Conv (%) PDI 
25 5.1 4.5 95 1.32 
2 50 4.4 5.4 57 1.25 
3 50 9.6 8.6 90 1.36 
4 75 10.2 12.2 85 1.25 
6 100 18.9 17.6 90 1.16 
5 100 21.1 19.1 95 1.12 
8 150 20.4 21.5 75 1.11 
7 150 30.9 27.5 95 1.4 
Conditions: Monomer concentration 10% (wt); THF distilled from Na/benzophenone; 
under vacuum(< O.lmbar); 35"C; 4 days. 
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Figure 1- THF SEC trace of poly(benzyl-L-threonine), M" = 21600. 
In all cases the polymerisation of the high purity Thr(Bzl)NCA was 
successfully initiated by addition of n-hexylamine. A single peak attributable to the 
polymer was observed in the SEC chromatograms with no low molecular weight 
material (other than unreacted monomer) present, (Figure 1 ). Increasing the feed ratio 
from 30: 1 to 250:1 gave corresponding increases in the molecular weight of polymers 
formed, while the polydispersity indices remained below 1.4. The polymerisation data 
are summarised in Figure 2. Unlike when the lower purity monomers were used, there 
is no turbidity at any stage in the reaction. 
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Figure 2. (Lower): Correlation between experimental and theoretical Mn determined by the feed 
ratio; (Upper): PDI of corresponding materials. 
Utilisation of the aqueous extraction method obviously improved the level of 
control over the polymerisation of Thr(Bzl)NCA compared to monomers purified by 
the traditional routes. It was necessary to combine the increased purity with high 
vacuum techniques, as this is the only method which gives absolute control over the 
internal environment of the reaction vessel. It was thus possible to produce polymers 
with a high molecular weight (> 30,000 Da) without the need for a basic initiator, 
while still controlling the DP by stoichiometry. A monomodal distribution was 
obtained in the SEC traces and MALDI-tof, (Figures 3 and 4) suggesting that there 
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was a single polymerisation mechanism in operation without premature termination 
reactions, as opposed to the situation with the low purity NCAs which gave rise to 
multimodal distributions. 
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Figure 3. MADLI-TOF spectrum of low molecular weight poly(benzyi-L-threonine). Repeat unit 
= 191 Da 
MALDI-Tof was used determine whether initiator was incorporated into all of 
the polymeric chains. This would indicate if the amine mechanism was operating 
exclusively. The higher molecular weight polymers did not 'fly' very well and gave 
poor results, so a low molecular weight polymer was used instead with a DP of 15, 
(Ca. 3 kDa). 
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Figure 4. (Top) Expanded portion of MALDI-TOF spectrum of poly(benzyi-L-threonine). 
(Bottom) Predicted spectrum for poly(benzyi-L-threonine) incorporating CH3(CH3) 5NH residue 
from initiator. 
Figure 4 shows that the predicted spectrum matches exactly with that found, 
thus confirming that hexylamine was incorporated into each ofthe chains, and that the 
only repeat unit present has a mass of 191 Da: ie, a single (0-benzyl)-L-threonine 
unit. 1 H NMR also confirmed the presence of the end group but no attempt was made 
to asses the molecular weight as the peaks were both small and slightly obscured, 
which would introduce significant error. 
···--·----··-------
- 133 -
Chapter 3 
3.2.3 POLYMER CHARACTERISATION 
To determine the molecular weight and molecular weight distributions of the 
synthesised polymers, size exclusion chromatography (SEC) in combination with 
right angle laser light scattering (RALLS) was used. Extensive discussion of light 
scattering theory ofthis is not appropriate here, but is summarised below39 . 
When light interacts with a molecule it is scattered. This scattered light has the 
same wavelength as the incident beam and is known as the Rayleigh scattering. Pure 
solvent also scatters light, so it is the excess light scattering caused by the solute 
which is measured. This excess light scattering is proportional to both the 
concentration of solute and its Mw. Polymeric materials scatter a sufficiently large 
excess, allowing them to be analysed by this method. 
C is the concentration ofthe solution 
A2 is the second virial coefficient 
K is an optical constant 
Pe is the particle scattering function, (angular dependence of scattering intensity) 
Re is the exce.ss Rayleigh ratio 
The excess Rayleigh ratio is calculated from the amount of light scattered 
relative to a reference of the pure solvent and an instrument calibration using a known 
standard. Pe is calculated online. To calculate Mw all that is needed is an accurate 
measure of the Rayleigh ratio (from the RALLS detector) and an accurate value of 
concentration. Concentration can be determined either by using volumetrically 
measured solutions of the polymer each time ensuring that no residual monomer 
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remains, or by an online method. This is achieved simply by using an online refractive 
index detector. Assuming a material has a constant refractive index increment ( dn/dc) 
at all molecular weights (which is a reasonable assumption above a certain Mw) the 
concentration can easily be calculated. The value of dn/dc is normally obtained from 
tables of known values (such as can be found in the Polymer Handbook40). This value 
is specific to the solvent and temperature. No values are published for poly (0-benzyl-
L-threonine) in any solvent thus we had to calculate dn/dc. 
The integrated RI peak area is described by the following equation: 
}{Jr(cal) c/11 
RJ(area) = •- • ~nj • C (2) 
'lo clc 
The change in Riarea with concentration is thus: 
I1RJ area 
~c 
RJ Cal c/11 
--•-•V.. (3) 
clc mJ 
'lo 
RicaJ, llo, and V1nj are all known parameters so dn/dc is simply related to the slope of 
the plot of RI response against concentration. 
The polymer used for this must be free of monomer, so that the concentration 
of polymer is known exactly. This was achieved by repeated precipitation into diethyl 
ether and water, then analysis by NMR to ensure no monomer persisted. 
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Figure 5. Change of refractive index integral with concentration of poly(benzyi-L-threonine) in 
THF. Measured online on SEC instrument 
A good linear fit was obtained (Figure 5) between the Rl response and 
concentration. Ideally, the extrapolated line of best fit should pass though the origin. 
This is not the case, probably due to impurities in the THF, particularly water 
absorbed from the atmosphere. When calculating the value of the slope the data 
obtained from the best fit regression were used, without forcing through the origin. 
Table 5. Results of dn/dc determination of poly(benzyi-L-threonine) in THF 
Polymer Slope (mV.mL2/g) dn/dc (mL/g) 
Poly-(Bzl)-L-threonine 11787 0.1111 
An important observation to be made here is that the molecular weights 
calculated by RALLS using this value of dn/dc differed significantly from those 
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obtained by conventional calibration, using narrow polystyrene standards. The 
relationship is shown in Figure 6. The Mn calculated by RALLS is always larger than 
that from conventional calibration. The implication is that the hydrodynamic volume 
of poly-(benzyl)-L-threonine is smaller than that of polystyrene at similar molecular 
weights. This behaviour is consistent with the expectation that this polymer will form 
compact secondary structures rather than the random coil which is expected of 
polystyrene. The linear relationship between the two calculation methods is useful 
however when one needs to consider smaller polymers. As described above, the 
intensity of the light scattering signal is proportional to the molecular weight, meaning 
that low molecular weight polymers give less reliable data, if any significant signal at 
all. An approximation can be made to the true molecular weight from the 
conventional methods which only require an RI signal which is (relatively) insensitive 
to molecular weight. 
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3.2.4 POL YMERISATION KINETICS 
In a controlled polymerisation process, there should be no irreversible chain 
terminations reactions hence the number of active chain ends is constant during the 
course of reaction. If this criterion is fulfilled then the system should follow first order 
kinetics with respect to the chain ends. 
The first order rate equation gives the following result: 
Plotting ln(M1/M0) vs time will give a linear fit if the process follows first 
order kinetics . That is to say, the rate varies only with monomer concentration as the 
other reactants have constant concentration. A non linear fit suggests that other 
processes such as termination or chain transfer are occurring. 
3.2.4.1 ONLINE NMR MONITORING OF NCA 
CONCENTRATION 
The most convenient method for following vinyl polymerisations is by online 
1H NMR41 . A tube can be sealed with a Young's tap or similar, and the reaction 
monitored by the disappearance of the vinyl protons between 5-6 ppm typically. This 
is particularly good for radical processes which can reach high conversion quickly (2-
5 hrs), thus not using up expensive spectrometer time. In NCA polymerisation, the 
only proton peak which is specific to monomer conversion is theN-H. However, N-H 
peaks can be non-quantitative due to rapid exchange and hydrogen bonding 
interactions. To test the validity of NMR for online monitoring of Thr(Bzl)NCA a 
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series of proton spectra were collected with the concentration varied from 100 mg.mL-
1 (typical polymerisation conditions) to 5 mg.mL-1in CDC13• The spectra are shown in 
Figure 7. 
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Figure 7. 1H NMR spectra ofThr(Bzl) NCA in CDCh taken at 25"C. Concentration (mg.mL-1) A) 
100; B) 71; C) 57; D) 36; E) 17; F) 11; G) 6. 
When the NCA concentration is 100 mg.mL- 1 the N-H peak is not resolved 
from the aromatic peaks of the benzyl protecting group (Figure 7, A), and as the 
concentration is reduced to 5 mg.mL-1 the peak has shifted approximately 2 ppm 
upfield. (Figure 7, G) A further complication is that the N-H peaks were not always 
well defined or quantitative. When the integral is compared to that of the ~-methyl 
group, the N-H is found to vary from 0.6 to 0.98 protons, (Figure 8). To monitor 
successfully a polymerisation by NMR the observed peaks must be quantitative. To 
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this end, it was decided that NMR was not suitable for this polymerisation system. 
The variation in the integration of the N-H peaks was not due to H20 contamination 
as dry CDCI3 was used under a dry N2 atmosphere when acquiring the spectra. 
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Figure 8. The chemical shift in ppm of the N-H peak (red circles) and the integrated area relative 
to the 3 P-methyl protons (blue triangles) against NCA concentration. 
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3.2.4.2 OFFLINE INFRARED SPECTROSCOPIC MONITORING OF 
NCA POLYMJERISATION 
Due to the demonstrated unreliability of NMR in analysis of amide protons, as 
discussed above, an alternative method was required to investigate the depletion of 
monomer during polymerisation. Infrared spectroscopy has been successfully used to 
monitor the polymerisation of vinyl monomers by anionic and free radical 
techniques42 . The obvious caveat associated with this method is that it involves 
sampling or the use of a flow cell. Most polymerisation reactions are carried out under 
inert atmospheres, and in the case of anionic and ring opening polymerisation, in the 
complete absence of water to avoid chain termination and monomer degradation. It is 
impossible to rule out the introduction of contamination when withdrawing samples 
for analysis, and this must always be considered. In situ fibre optic probes, where 
available, have largely overcome this problem43 • 
NCAs contain two distinct carbonyl groups which can be resolved from each 
other in the infrared region of 1750- 1880 cm- 1• The IR spectrum of Thr(Bzl) NCA is 
shown in Figure 9. The amide carbonyl disappears as C02 is expelled during the 
polymerisation, and the ester carbonyl shifts to lower wavenumber ( ~ 1650 cm- 1) when 
it is incorporated as an amide bond. Both can therefore potentially be monitored to 
determine monomer concentration. 
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Figure 9. Depletion of anhydride stretches of Thr(Bzi)NCA with decreasing concentration. A is 
the amide carbonyl (blue) and B is the ester carbonyl (red). 
It was again necessary to asses the reliability of this method using a series of 
control solutions of known concentration. Both the carbonyl peaks areas were 
measured, and plotted against concentration in Figure 10. As can be seen, there is a 
linear relationship between concentration and absorbance for both the carbonyl peaks. 
The wavenumber at which the signal is seen, is also unaffected by concentration. 
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Figure 10. Dependence of the intensity ofiR absorption of the carbonyl groups in Thr(Bzl) NCA 
with concentration 
The absorption at 1790 cm- 1 is significantly larger thus making it more 
suitable for following reactions, particularly at high conversion when the monomer 
concentration will be low. Unfortunately this strong absorption was found to be too 
strong in some cases, and the absorption was beyond the range of theIR spectrometer, 
meaning that the weaker, but still quantitative band at 1860 cm-1 was used. 
Upon considering this evidence, it was decided that the IR method would be 
used for the kinetic investigations rather than NMR, despite the serious concerns over 
the introduction of impurities with each sample drawn. All efforts were made to 
reduce this, as described below and in the experimental. 
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3.2.4.3 RESULTS AND DISCUSSION 
A series of polymerisation reactions were monitored by the depletion of the 
amide carbonyl stretch with conversion. Samples were drawn from a Schlenk tube 
fitted with a septum, by gas-tight syringe. The needle was flame dried before use, and 
the syringe body stored in a desiccator, under vacuum until required. (Figure 11) 
Figure II. Photograph of Schlenk tube fitted with a septum for withdrawing samples for IR 
analysis. 
Conversion was measured relative to the t=O sample. This was drawn before 
any initiator was added, and the monomer conversion at all further times were 
calculated using the following equation: 
% conversion = "'Xo x I 00 {6) 
The same baseline was defined for all samples based on the t=O sample. It was 
not necessary to calculate an absolute value for [M]1 as only the ratio of [M]1 : [M]o is 
required: 
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tn [M;(MJI = kt + c (7) 
Absorbance (A) is proportional to concentration [M]1 k =proportionality constant. 
A oc [M l (8) 
A= k[M l 
Considering the ratio [M]1/[M]0 , and substituting. 
Thus only the total absorbance (in this case the integral) needs to be measured 
In X = kt + C (10) 
The first order plots arising from this are shown below: 
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Figure 12. Polymerisation ofThr(Bzl)NCA monitored by offline IR. IMJ:III =50; 10% (wt) in 
THF; 35"C; N2 atmosphere 
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Figure 13. Polymerisation ofThr(Bzi)NCA monitored by offline JR. IMI:III = 60; 10% (wt) in 
THF; 35"C; N2 atmosphere. 
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Figure 14. Polymerisation ofThr(Bzi)NCA monitored by offline IR.IMI:III = 75; 10% (wt) in 
THF; 35"C; N2 atmosphere. 
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Figure 15. Polymerisation ofThr(Bzi)NCA monitored by offline IR.IMI:II) = 80; 10% (wt) in 
THF; 35"C; N2 atmosphere. 
Table 6. Summary of results of kinetic investigation of polymerisation of Thr(Bzl) NCA 
Experiment Cone. NCA (M) [M):[I] Observed rate constant (min-1) 
1 (Fig II) 0.384 50 0.00201 
2 (Fig I2) 0.377 60 0.00108 
3 (Fig I4) 0.391 75 0.00093 
4 (Fig IS) 0.327 80 0.00180 
For each experiment shown in Table 6 a linear relationship between ln(A0/At) 
and time was observed indicating that the number of active chain ends remained 
constant. No attempt was made to extrapolate the true rate constants for this system. 
To obtain these the total volume of solvent added would need to be measured 
accurately. The solvent was distilled into the Schlenk tube, and the total volume was 
not calculated, (although they were all tentatively the same volume having been filled 
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to the same predetermined mark). The ratio of the initiator to monomer in each case 
was known, allowing for the first order plots to be constructed. 
Each of the kinetic plots shown begins at t > 1 000 min. This is due to the 
observation of two different rate constants displayed in Figure 16. A long inhibition 
period can not be attributed to impurities as anything which inhibited the 
polymerisation (by interaction with amine end group) would do so irreversibly, and 
quantitative initiation would not be observed. This inhibition period has been 
observed previously in other kinetic investigations of NCA polymerisation14 . The 
most likely reason is that, at low conversions, the less soluble ~-sheet structures form. 
This reduces the rate initially until the chain ends become mobile enough to reach 
maximum reactivity. 
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Figure 16. First order kinetic plot of polymerisation of Thr(bzi)NCA from t = 0 mins. IMI:III = 
50; 10 % (wt) in THF; 35°C; N2 atmosphere. 
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The intercept of the two linear regions, shown in Figure 16, corresponds to 
25% conversion which is equivalent to a DP of 12.5 (as the target DP was 50). This 
agrees with previous observations that above 12 units homo poly (amino acids) 
become more soluble36 accounting for the observed increase in the reaction rate. 
3.2.5 EVOLUTION OF MN WITH CONVERSION 
A further criterion for a controlled polymerisation is that Mn evolves linearly 
with conversion. To determine this, it was necessary to remove samples from the 
reaction mixture again and analyse by SEC. The RI detector was used to determine 
the concentration of polymer and monomer at a given time. The molecular weights 
were determined by conventional calibration and are shown below. 
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Figure 17. Evolution of M. with conversion for polymerisation of Thr(Bzi)NCA. 10 % (wt); 
[M[:[I) = 100; n-hexylamine initiation; 35"C. 
~ 
Figure 17 illustrates the excellent correlation between Mn and conversion, 
even up to 85% conversion (last sampled data point). The line of best fit does not pass 
through zero because conventional calibration was used. As discussed in the previous 
section, poly-(benzyl)-L-threonine does not have similar elution behaviour to 
polystyrene. Normally, this is overcome by the use of light scattering, but is not 
applicable here: in the early stages of the polymerisation the molecular weight is too 
low to obtain a sufficiently strong signal from the RALLS detector. Earlier 
experiments indicated a linear relationship between the two calibrations, so the results 
from the conventional method are proportional, if not absolute. The molecular weight 
of the final polymer by RALLS (18.4 kDa) agreed with that predicted by the feed 
- 151 -
Chapter 3 
ratio (19.1 kDa). The polydispersity index increased with conversion, which is the 
opposite of what is expected for other controlled polymerisations, where higher PDI' s 
are found at the initial stages. This was simply due to inherent problems of sampling 
from the reaction, resulting in some contamination being introduced, and the erosion 
of the rubber septa. 
3.2.6 RE-INITIATION OF POLY-(BENZYL)-L-THREONINE 
The kinetic and molecular weight data indicated that this polymerisation 
system was indeed controlled under the conditions used. As such the end groups· of 
the polymer should still be well defined and of equal reactivity: that is to say, they 
retain their primary amine functionality, and can be thought of as being 'living'44 • 
This is assessed by the ability to reinitiate polymerisation by the addition of further 
monomer to give chain extension. The presence of any residual low molecular weight 
polymer would indicate that some chain termination reactions have occurred. A 
sample was drawn from the initial polymerisation once it was completed, then a 
further aliquot of NCA added to the reaction vessel. SEC was used to judge if chain 
extension had occurred. 
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Figure 18. SEC refractive index traces showing chain extension by sequential monomer addition. 
Blue: Mn = 3330. Red: Mn = 5500. Conditions, 151 block: 10% (wt); lnitiaiJMJ:[I) =20; n-
hexylamine initiation; 35°C, 42 hrs. 2"d monomer addition: [M):[I) = 30; 35°C; 48 hrs. 
As can be seen in figure 18, chain extension occurred following addition of 
further monomer. The final polymer had a PDI of 1.16, as calculated by RALLS. This 
is probably an underestimate due to it being at the limit of the RALLS sensitivity. 
Conventional calibration gives a PDI of 1.3 which is more realistic. The important 
feature is that it is monomodal without any evidence of low molecular weight polymer 
contamination, (this is hard to judge as the two traces overlap, however if any of the 
initial polymer did remain a non symmetric distribution would have been obtained). 
This clearly indicates that under the reaction conditions described the end groups of 
the polymer can be considered to be living. 
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3.3 CONCLUSIONS 
The effect of impurities on the polymerisation of Thr(Bzl) NCA resulting from 
the preparation procedure has been investigated. NCAs which were only purified by 
repeated crystallisations often failed to initiate even with strongly basic initiators. 
When initiation did occur, materials which were multimodal, with low molecular 
weight contaminants and low levels of conversion were obtained. This was shown to 
be solvent independent. By changing the purification procedure to include an aqueous 
wash to remove acidic impurities, and conducting the polymerisatiori under high 
vacuum conditions as is typically used for anionic ring opening polymerisation it was 
shown that high conversions and well defined materials with DPs up to 200 were 
obtainable. A key feature was the use of anhydrous THF as the solvent in place of the 
more commonly used DMF, which is difficult to handle and requires specially-made 
apparatus if controlled polymerisation is to be observed. Kinetic analysis by offline 
infrared spectroscopy demonstrated that the polymerisation followed first order 
kinetics, following an initial inhibition period associated with secondary structure 
formation, and that the molecular weight evolved linearly with conversion. Finally, 
the livingness of the end groups was demonstrated by a chain extension experiment. 
This evidence demonstrates that controlled polymerisation of an NCA is 
possible without the need for either difficult to handle organometallic initiators or 
extreme purification and polymerisation conditions in conjunction with harsh polar 
solvents. It should be noted that this method does not produce materials with as 
narrow PDis as the other two, nor has it yet been applied to the synthesis of controlled 
architectures, but it does provide a way of making predictably sized poly( amino acid), 
which is accessible to all chemists. 
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3o4 EXPERIMENTAL 
GENERAL 
All NCAs were synthesised as described in Chapter 2. They were used 
immediately following synthesis and purification, not being stored for longer than 3 
hours and below -10°C. n-Hexylamine (>99.5%, H20<0.2%) was purchased from 
Fluka. THF and DCM (<99.5%) were purchased from Fischer Scientific and dried by 
passage through two alumina columns using an Innovative Technology Inc. solvent 
purification system and stored under N2. THF was further dried over 
sodium/benzophenone complex with at least 3 freeze-thaw cycles, until the purple 
colouration persisted. Dimethyl acetamide (anhydrous <0.005% H20) was purchased 
from Aldrich. Further purification was achieved by drying over 3A molecular sieves 
for 24 hours. Hexane (Fischer Scientific >99%) was dried over 3A molecular sieves. 
3A molecular sieves (Aldrich) were activated in an oven at 200°C before use. All 
other chemicals were used as received. NMR-spectra were recorded with a Varian-
Inova 500 spectrometer, operating at 500MHz (1H) or at 125 MHz (13C); results of 
HSQC and COSY correlation studies have been used in order to assign the observed 
signals to the hydrogen and carbon atoms of the compound. Alternatively 1H and 13C 
spectra were acquired with a Brucker Advance-400 operating at 400MHz and 
IOOMHz respectively. MALDI-TOF spectra were collected on an Applied Biosystems 
Voyager DE. Gel permeation chromatography was undertaken using THF as the 
eluent. lOO~L of solution (agitated overnight to ensure complete dissolution) was 
injected at a flow rate of 1.00 mL.min- 1 by a Viscoteck SEC autochanger module. A 
Viscoteck TDA 301 unit with triple detection (right angle laser scattering at 670nm, 
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differential refractometer and viscometer) was used. dn/dc Values were calculated 
online for each polymer. Analyses were undertaken using OmniSEC 4.0 software. 
Infrared spectroscopy was conducted on a Nicolet Nexus FT-IR as a KBr disc. Liquid 
samples were analysed by direct injection of the reaction medium into a liquid cell 
with KBr windows. Omnic 5.1a (Nicolet) was used to analyse the data obtained. 
Poly(O-benzyi-L-threonine)- (PBLThr) 
Thr(Bzl)NCA (0.20 g, 0.85 mmol) was dissolved in 3 mL of dry DCM, and 
injected into a Schlenk tube fitted with a Young's tap and 9mm rubber septa already 
under vacuum. The DCM was removed under vacuum and the NCA allowed to dry 
under vacuum for a further 2 hours. THF (3mL)was vacuum distilled into the vessel 
to give an approximately 10 % (wt) solution. The tube was then immersed in an oil 
bath thermostated at 35°C, and stirred to dissolution. n-Hexyl amine (0.08mL, 0.2 M) 
was added via syringe into the tube and allowed to stir for 4 days. 
Following this time a 100111 sample was withdrawn for SEC analysis, and the 
remainder of the reaction was poured into a 1 0-fold excess of diethyl ether with 
stirring, and the white powder was collected by filtration. Further purification was 
achieved by re -dissolving in THF and precipitating into a 10-fold excess of water. 
Yield 0.11 g, 70%. 
1H NMR (CDCh) Dppm; 0.93 (3H, H\ 3.77 (IH, H\ 4.1-4.8 (3H, H3 + H6a + 
H6b), 7.09 -7.25 (5H, H8) 
13C NMR Dppm; 17 (C5), 57 (C\ 71 (C6), 75 (C\ 127.2 and 128.2 (C8), 138.3 
(C\ 169 (C2) 
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IR (KBr disc) cm- 1: 3290 (N-H), 2973 (C-H), 1637, (C=O) 
H N'tt 
5 
n 
Chain extension ofPoly(O-benzyl-L-threonine) 
The initial polymer was grown in the same manner as described above (0.2 g, 
0.85 mmol). After 3 days a 100 ~-tL sample was drawn for SEC analysis. 
Thr(Bzl)NCA (0.1g, 4.26 mmol) prepared as described in Chapter 2 was added to 
another Schlenk tube as a DCM solution and concentrated to dryness on a high 
vacuum line for 2 hours. Approximately I mL of THF was then distilled into the 
flask, and it backfilled with dry N2. Using a flame dried syringe this monomer was 
injected in a. single portion to the polymerisation vessel and stirred at 35°C for a 
further 4 days. 100 f.!L was drawn for SEC analysis and the remainder precipitated 
into a large excess of diethyl ether to yield a white powder, collected by filtration. 
Yield 0.15 g, 60%. 
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SYNTHESIS AND CHARACTERISATION OF 
WELL DEFINED BLOCK CO POLYPEPTIDES 
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4.1 INTRODUCTION 
The first synthesis of block copolymers was described by Swarc et a/1 in 1956 
and they utilised anionic polymerisation of vinyl monomers. Under rigorously dry 
conditions, the anionic end groups remained active ('living'), such that addition of 
further monomer resulted in chain extension. This has since been applied to a wide 
variety of viny I and cyclic monomers to create materials of defined architecture2. As 
was discussed in Chapter 3, NCA polymerisation has traditionally been blighted by 
the lack of control of the reaction, resulting in multimodal distributions and 
incomplete monomer conversion3 . Selective precipitation or column chromatography 
was required to remove homopolymer contaminants4 and in order to synthesis 
polymers of defined architecture, it was necessary to fractionate the mixture to obtain 
a narrow distribution of chain lengths. This is in stark contrast to radical vinyl 
polymerisations which, in the last 10 years have received much attention with regard 
to controlled polymerisation methods including RAFT5 (reversible addition 
fragmentation and transfer), ATRP6 (atom transfer radical polymerisation) and NMP7 
(nitroxide mediated polymerisation). The first successful method for synthesising 
block copolypeptides without isolation and purification of the homopolymer, was by 
Deming in 19978tt using zero-valent transition metal initiators, particularly those 
based on nickel and cobalt9• These have been applied to a wide range 10•11 of NCAs. 
Another transition metal system based upon aluminium-schiff base complexes 12 has 
been used to produce block copolymers of methyl glutamate and leucine NCAs by 
sequential monomer addition 13 . Unfortunately the only evidence for the diblock's 
architecture was based upon 13C NMR and no GPC data were provided, casting 
tt See chapter 3 for discussion of this method 
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doubts over whether the material was truly two individual blocks, or composed of 
some alternating regions. An intriguing report has been made, claiming that poly(L-
glutamtic) acid has been used to make block copolymers with (y-benzyl)-L-glutamate 
NCA 14• This result seems remarkable, as NCAs are not tolerant of carboxylic acid 
functionalities. Quantitative yields were also reported, but again no GPC data were 
supplied. Mention here should be made of the work of Schlaad and coworkers15, who 
showed that ammonium chloride terminated polystyrene macroinitiators could 
polymerise NCAs to give hybrid block copolymers with extremely narrow molecular 
weight distributions. This has been applied to a range of macroinitiators including 
poly(styrene) 16, PEG 17 and poly(oxazoline)18, but has not yet been used for the 
synthesis of poly(vinyl)-block-poly(peptide )-block-poly(peptide )s yet. This may be 
due to the observation of inflated molecular weights at high conversion, attributed to 
incomplete initiation15. The residual macroinitator was removed by selective 
precipitation, which would not be possible when used with block copolypeptide 
macro initiators as both blocks would have similar solubility. Simply using an amino 
terminated macroinitiator also allows the growth of a single peptide block in a 
reasonably controlled manner19-23 , but again no diblock peptides have been 
synthesised in this manner. There is evidence that the amine end groups remain active 
upon reducing the polymerisation temperature to 0°C preventing unwanted side 
reactions, which may allow for controlled polymerisation24 • The final method of note 
is that described in 2004 by Hadjichristidis et a/. 25 By applying rigorous high vacuum 
techniques to purify all the monomers, initiators and solvents it was possible to 
prevent any chain termination reactions, resulting in polymers with living amine end 
groups which can reinitiate polymerisation upon addition of further monomer. This 
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has been applied to the preparation of a series of well defined di- and tri-block co-
polypeptides26·27 and even star-branched polypeptides28 . 
4.2 RESULTS AND DISCUSSION 
Chapter 3 described how Thr(Bzl) NCA could be polymerised in a controlled 
fashion, including the observation that the addition of a second aliquot of monomer 
resulted in chain extension. To determine ifthis polymerisation system was applicable 
to other NCAs we chose to extend this to include (y-benzyl)-L-glutamic acid (BLG) 
and (£-Boc)-L-lysine (LysBoc) NCA, which have been used previously in the 
literature, and when the protecting groups are removed give either anionic or cationic 
side-group functionality. 
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4.2.1 HOMOPOLYMERISATION OF NCAS 
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Scheme I. Polymerisation of NCAs by n-hexylamine followed by protecting group removal. 
Conditions. (i) THF or DMAc; 35"C; 3 days; (ii) R 1 =AlB, HBr (2.5 equiv)rfFA; R1 = C, Pd/C 
(10%) HC02H/DMF; N2, 16 hrs. 
F 
n-Hexylamine was chosen as the initiator as it had shown in Chapter 3 that it 
-gave well-defined materials when used in conjunction with high purity monomers and 
high vacuum conditions. BLG NCA was polymerised in THF at 40°C. The obtained 
molecular weights agreed well with those predicted by monomer : initiator ratios. 
LysBoc NCA displayed lower solubility in THF than the other NCAs used, requiring 
elevated temperatures > 50°C to maintain a homogeneous reaction mixture. Upon 
changing the solvent to DMAc a homogenous mixture was observed at all 
temperatures and the resulting polypeptides were sufficiently soluble in THF for SEC 
analysis. For polymers obtained from both monomers PDI values below 1.4 were 
- 166-
Chapter 4 
~--------··-
found. The values obtained by SEC for PLysBoc were elevated compared to the 
predicted values. 
Table 1. Polymerisation of BLG NCA by n-hexylamine. 
RunN° [M]: [I] Mu,SEC (kDa) Mn,Theo (kDa) Conv (%) POI 
1 
2 
3 
4 
50 3.8 5.0 45 1.27 
75 15.2 16.7 >95 1.21 
100 19.0 22.3 >95 1.23 
150 35.5 33.4 >95 1.30 
Conditions: Monomer concentration 10% (wt); THF; under vacuum(< 0.1mbar); 35°C; 
4 days. 
Table 2. Polymerisation of LysBocNCA by n-hexylamine 
RunN° [M]: [I] Mn,SEC (kDa) Mn,Theo (kDa) Conv (%) POI 
2 
3 
50 13.5 9.1 80 1.37 
75 17.1 16.0 >95 1.27 
100 31.1 23.1 >95 1.34 
Conditions: Monomer concentration 10% (wt); THF; under vacuum(< 0.1mbar); 35°C; 
4 days. 
SEC analysis was conducted as in Chapter 3, using RALLS to calculate 
molecular weight. The dn/dc values were calculated in exactly same manner by 
varying the concentration of pure polymer and recording the change in RI response. 
The plots of R1 response verses concentration are shown below: 
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Figure 1. Change in refractive index integral with concentration for poly(y-benzyl-L-glutamate), 
determined in THF; 30"C 
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Figure 2. Change in refractive index integral with concentration for poly(l:-N-Boc-L-Lysine), 
determined in THF; 30"C 
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Table 3. Summary of the calculated values for dn/dc 
dn/dc (mL/g) 
Polymer Slope (m V .mL 2 /g) Experimental(a) Literature(6l29 
Poly ( 0-Bzl-L-glutamate) I 0527 0.1023 0.124 
Poly (N-Boc-L-lysine) 5179.5 0.0503 (c) 
(a) THF; (b) dioxane; (C) no data available 
The experimental value for dn/dc of PBLG in THF agreed well with the 
literature value in the similar solvent dioxane. (Table 3) No value for PLysBoc has 
previously been reported, to the best of our knowledge. 1H NMR analysis confirmed 
that the protecting groups had not been displaced during polymerisation or workup. 
Conversion was estimated by SEC. 1 H NMR was not used to estimate the molecular 
weight due to overlap of the relevant peaks with the polymeric backbone. PBLG has 
been analysed by SEC previously showing that its · secondary structure (a-helix) 
would not give erroneous molecular weights30• Homo-polymerisation of L-Alanine 
NCA was attempted in both THF and DMAc, but only gave rise to insoluble materials 
and was not pursued further. The results shown here appear to suggest that the 
reaction conditions employed lead to well defined materials, as long as all the 
reactants display good solubility characteristics. 
---------·~--~-·------------
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4.2.1.1 SIDE CHAIN DEPROTECTION 
The high reactivity of NCAs to nucleophilic functionality necessitated that 
protecting groups were used in their synthesis and polymerisation. The protecting 
groups were chosen on the basis of their facile cleavage31 and work-up, to give water 
soluble polymers which were required for the work in Chapter 6. 
Cleavage of the benzyl ester and Boc, protecting groups was achieved by 
using 2 equivalents of HBr in trifluoroacetic acid. PBLG is more commonly 
deprotected by the use of KOH (or similar) in THF. We found that this gave rise to 
precipitation of the polymer, resulting in non-quantitative cleavage, even in the more 
polar solvent DMF. TF A on the other hand, is an excellent solvent for pep tides, and in 
conjunction with HBr led to deprotection in less than one hour, reducing the 
possibility of racemisation or chain scission. The Boc group of PLysBoc was also 
removed quantitatively using these conditions. Following dialysis against ultra-pure 
water and freeze drying, the polymers were analysed by 1H and 13C NMR. 
Quantitative removal of the benzyl ester protecting group from PBLG was judged by 
the absence of both aromatic and benzylic peaks in the 1H and 13C NMR spectra in 
Figure 3 and 4 respectively. 
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Figure 3. 1H NMR spectra: A: poly(y-benzyi-L-glutamate) aromatic region; B: poly(L-glutamic 
acid) without any evidence of aromatic peaks. Residual solvent peak (!:!OD) 
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Figure 4. 13C NMR Spectrum: (A): Poly(y-benzyi-L-glutamate) with key resonances indicated. 
(B): Poly(L-glutamic acid) showing no protecting group residues. 
1H NMR interpretation for PLysBoc was made difficult by the 1Bu peaks (from 
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Boc group) which were broad and obscured some of the CH2 groups of the 
lysine residue preventing resolution of the individual peaks. Following deprotection 
the CH2 groups of PLys were resolved from each other, without the presence of the 
large Boc group, (Figure 5). 13C NMR analysis of PLysBoc (Figure 6) showed a peak 
at 150 ppm relating to the carbonyl functionality of the Boc group, resolved from that 
of the amide carbonyl (170 ppm). Following treatment with HBr/TF A the Boc 
carbonyl peak disappeared, while the amide remained. 
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lO !0 wn •o JO 1 a 
Figure 5. 1H NMR spectrum Top: PLysBoc. Large, broad peak -1.2 ppm of Boc can be seen. 
Bottom: PLys. CH2 peaks are resolved without Boc Me obstructing. *=residual solvent peak, A: 
CHChB: HOD 
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Figure 6. 13C Spectra: A: Poly(i;-Boc-L-lysine) showing the carbonyl peak of Boc group. B: poly(l-
lysine) without the Boc protecting group 
PLG and PLys gave monomodal distributions in the aqueous SEC profile, 
proving that the conditions were mild enough to prevent any chain scission. 
A different strategy was required to remove the protecting groups from PBThr. 
Benzyl ethers can be cleaved by the HBr/TF A reagent as used above, by bromination 
ofthe aromatic ring followed by hydrolysis ofthe ether32 . Extended reaction times are 
required (>24 hours) to achieved full deprotection which would likely lead to 
cleavage of some of the amide bonds and racemisation33 . Hydrogenation is the more 
common method for benzyl group removal34 , owing to the high conversions, 
selectivity and mild conditions. We chose to use catalytic transfer hydrogenation35, 
where Hz is generated in situ. This has obvious safety and handling benefits. Many 
reagents are available to generate the Hz including cyclohexene36, sodium 
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hypophosphite37 and alcohols38• To avoid decomposition of the peptide backbone we 
required a system which was both high yielding and selective, without the need for 
elevated temperatures. This was achieved by the use of formic acid with palladium on 
carbon (10%)39 . Formic acid is a far better solvent for peptides than cyclohexene, 
allowing a large excess of the H2 donor to be present (30%). Following reaction 
overnight, the isolated polymer generated from this was found to be insoluble in 
boiling water. Initially this was attributed to a failed or incomplete deprotection 
reaction. Changing the catalyst system to Pd(Ac)2 and Pd(CaC03) also gave the same 
results. A search of the literature gave conflicting information regarding the solubility 
of poly(L-threonine). CD studies have been successfully conducted in aqueous 
solution40, but other reports suggest this could be due to the presence of some D-
isomers in the chain increasing the random coil character which is more soluble than 
the ~-sheets41 • NMR analysis of the resulting polymer was enabled by dissolution in 
D20 with the addition of TFA-d (20%). The proton spectrum in Figure 7 shows 
clearly that the benzyl groups were removed quantitatively by the absence of aromatic 
resonances at around 7 ppm and benzylic at 5 ppm. No 13C spectra were obtained as 
only very small concentrations of the polymer were dissolved. It was not possible to 
determine if any chain scission has occurred as SEC was not possible. We expect this 
not to be the case because: (i) literature suggests that these conditions do not degrade 
short peptide sequences. (ii) shorter peptide sequences or amino acid degradation 
products would have been water soluble, but this was not seen. 
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(i), (ii), (iv) 
~ ) 1 (iii) (*) (*) 
(i) (ii) 
(*) 
80 70 60 5 0 PJ1I11 4.0 30 20 10 
Figure 7. 1H NMR spectrum showing PBThr (top) and PThr (bottom). Key resonances are 
indicated. * Indicates residual DMF. 
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4.2.2 BLOCK COPOLYMER SYNTHESIS 
Encouraged by the successful polymerisation of BLG and LysBoc NCAs and 
the demonstrated 'living' character of the PBThr end groups we attempted to 
synthesise diblock copolypeptides by the sequential monomer addition method25 . 
(i) (ii) 
R= 
0 
Y. 0'-./"fc} 'tf~r~ N ~ H 
5 0 H R m 
n 
Scheme 2. Synthesis of block copolymers by sequential addition of NCAs to poly(O-benzyl-L-
threonine) macroinitiator. Conditions: (i) JM) = 10% (wt); DMAc; vacuum (<O.lmbar); 3 days; 
40°C, (ii) BLG orLysBoc NCA; 4 days; 40°C. 
As THF was a suitable solvent for polymerisation of both Thr(Bzl) and BLG 
NCA it was the first solvent investigated. PBThr was synthesised and a sample 
removed for SEC analysis, confirming that no monomer remained, and then an aliquot 
of the second monomer was added. This resulted in the solution becoming turbid 
followed by precipitation. THF SEC analysis, shown in Figure 8, of the soluble 
fractions showed residual homopolymer, plus a small amount of high molecular 
weight polymer assumed to be the di-block. 
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--PBThr plus BLG NCA 
--PBThr 
0 5 10 15 
Retention volume 
Figure 8. SEC trace for chain extension of PBL Thr by BLG NCA in THF. Macroinitiator Mn = 
11 kDa, PDI = 1.25 
Initiation was clearly not quantitative and there is a large amount of excess 
monomer remaining. This suggests that the block copolymers display lower solubility 
in THF than the two constituent homopolymers. It is not uncommon for polypeptides 
to aggregate in non polar solvents, so the reaction solvent was changed to N,N-
dimethyl acetamide (DMAc). This was chosen instead of the more commonly used 
DMF in response to poor results that had been obtained for the homopolymerisation 
of ThrBzl NCA, which was discussed in Chapter 3. DMAc does not have a labile 
proton, and is thus less prone to decomposition, but this still can occur to some 
degree. It was dried over 3A molecular sieves42 without distillation, as elevated 
temperatures would promote decomposition giving dimethyl amine, a good NCA 
initiator. 
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Using DMAc, the first block to be grown (PBThr) proceeded to high 
conversion and gave predictable molecular weights and reasonably narrow 
distributions ( <1.4), showing it was a suitable solvent for this process. Following 
addition of BLG NCA, the reaction mixture remained homogenous. The same 
observation was true when LysBoc NCA was added as the second monomer. SEC in 
DMF showed an increase in molecular weight following the addition of both types of 
monomer. Figure 9 shows a SEC trace for each NCA type. In both the examples 
shown there is no residual macroinitiator, and the resulting block copolymer has a 
symmetrical distribution. Calculation of the molecular weight of the second block was 
not possible by RALLS, as the block copolymers will not necessarily have a constant 
value of dnldc. Conventional calibration is also unsuitable owing to the significant 
structural differences between the polypeptides and polystyrene or PEG standards. To 
circumvent this, the first block was analysed by SEC in THF to determine the 
molecular weight. 1 H NMR (Figures 1 0 and 11) could then be used to determine the 
relative length of the second block to the first, and thus calculate the number of repeat 
units and overall M0 • These results are summarised in Table 4. 
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---PL1br47 
--PL 1br47 -Block PBLG28 
15 
Retention Volume (ml) 
--PB1br23 
PBThr23 PBocLys25/ 
/ 
15 
Retention volume (ml) 
Figure 9. SEC (DMF) traces showing chain extension of PBThr by sequential addition of BLG 
NCA (top) and LysBoc NCA (bottom). 
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Table 4. Chain extension of PBThr by addition of BLG NCA (top) and LysBoc NCA (bottom) in 
DMAc 
1st Block 2" Block (BLG) Copolymer 
Run No DP SEC (aj PDI [M]:[I] DPNMR Mn (lij PDisEc NsEc,MNMR 
Pl56 47 1.32 45 28 15500 1.60 47,28 
Pl57 26 1.32 40 22 10200 1.47 26,22 
P158 50 1.33 25 20 14500 1.71 50,20 
P197 16 1.45 20 16 6800 1.54 16,16 
1st Block 2" Block Copolymer 
(LysBoc) 
Run No DPsEC (aj PDI [M]: [I] DPNMR Mn (lij PDisEc NsEc,MNMR 
P160 16 1.20 23 19 7300 1.47 16,19 
P163 46 1.38 20 18 12800 1.54 46,18 
P195 20 1.38 25 22 8870 1.60 20,22 
P196 20 1.41 50 46 14300 1.60 20,46 
(a) Determined in THF by RALLS, dn/dc = 0.11 mL. g·1; (b) calculated from sum of I'' 
block by SEC and 2"d by NMR 
Increasing the ratio of [monomer]: [macro initiator] gave a corresponding 
increase in DP for the second block. In all cases there was an increase in the 
polydispersity index following re-initiation, indicating some loss of control. All the 
distributions were monomodal, proving the absence of any competing initiation or 
termination processes. The broadening of the PDI can be attributed to the inherent 
difficulties of adding a further highly reactive species to the reaction. Typically, with 
anionic polymerisation, the second monomer ( eg styrene, butadiene )43 would be 
distilled in, ensuring the purity of monomers and maintaining the high vacuum 
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environment. The use of syringes and septa in our case will have resulted in a non-
pristine environment, allowing some decomposition of the NCA to occur, and 
accounting for the reduced DP of the second block relative to the feed ratio. 
(v+ I)) 
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8.0 r~ 60 
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Figure 10. 1H NMR spectrum ofpoly(BThr 47 -block-BLG27). Solvent DCIV(/TFA-d(S%) 
·----·--·--------
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Figure 11. 1H NMR spectrum of poly(BThr16-block-LysBoc19). Solvent CDCh/MeOH-d4 (5%) 
The homopolymerisation of alanine NCA failed due to its insolubility at low 
DPs, so we reasoned that polymerisation may be possible by using a solubilising 
macroinitiator, such as PEG-NH244 . The same result was obtained as with the 
homopolymer, with precipitation occurring with 5 hours of monomer addition. No 
attempts were made to characterise this material. 
An important observation was made during the NMR analysis of the block 
copolymers. In the common NMR solvent CDCh, gelation was observed during their 
preparation. To obtain liquid samples suitable for analysis we found that addition of 
approximately 5-10% TFA-d was required for poly(BThr-block-BLG) and in the case 
of poly.(BThr-block-LysBoc), 5-10% MeOH-d4 . Both of these are known to disrupt 
H-bonding in peptides. TF A was preferable as it does not have any overlapping 
signals in the region of 0- 7.5 ppm in the 1H NMR, which are of interest. The acid 
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sensitive Boc group can not be used with TF A, hence the choice of MeOH. The 
gelation behaviour is investigated further in Chapter 5. 
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4.3 CONCLUSIONS 
Following on from the results of Chapter 3, we first showed that BLG and 
LysBoc NCAs can be polymerised in a controlled fashion without the need for 
transition metal catalysts or meticulous high. vacuum techniques. The resulting well 
defined homo-polymers were quantitatively deprotected without any chain scission 
occurring. This resulted in a diverse set of polypeptides bearing either a neutral, 
cationic or anionic side group. All the polymers were characterised by NMR and SEC, 
with the exception of poly(L-threonine) which was insoluble in most solvents. Having 
polymerised these monomers we then made use of the 'living' end groups ofPBThr to 
initiate a second monomer of BLG or LysBoc NCA. For this to be possible, the first 
block grown must reach high conversion (>95%) to ensure that each block is 
homogenous. Using this sequential method, control over the composition of both 
blocks was obtained. The diblock copolymers were not as well defined as the homo 
polymers, with polydispersity indices around 1.5. They were however monomodal, 
indicating structural if not chain length homogeneity within the polymers. This is the 
first example of poly(benzyl-L-threonine) being combined into a block copolymer, 
and one of only a handful of reports of the controlled synthesis of block-co-
polypeptides by NCA polymerisation. By removing the requirement for transition 
metal catalysis, the work up is facile and there are no concerns over the biological 
significances of residual metal species. This relatively simple methodology should be 
compatible with a wide range of NCA monomers. 
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4.4 EXPERIMENTAL 
4.4.1 GENERAL 
All NCAs Were synthesised as described in Chapter 2. They were used 
immediately following synthesis and purification, not being stored for longer than 3 
hours and below -10°C. n-Hexylamine (>99.5%, H20<0.2%) was purchased from 
Fluka. THF and DCM (<99.5%) were purchased from Fischer Scientific and dried by 
passage through two alumina columns using an Innovative Technology Inc. solvent 
purification system and stored under N2 • THF was further dried over 
sodiurn!benzophenone complex with at least 3 freeze-thaw cycles, until the purple 
colouration persisted. Dimethyl acetamide (anhydrous <0.005% H20) was purchased 
from Aldrich. Further purification was achieved by drying over 3A molecular sieves 
for 24 hours. Hexane (Fischer Scientific >99%) was dried over 3A molecular sieves. 
3A molecular sieves (Aldrich) were activated in an oven at 200°C before use. All 
other chemicals were used as received. NMR spectroscopy (1H, and COSY) was 
determined at 400MHz or (13C) at 100MHz using a Brucker Avance-400. 
Alternatively this was conducted eH and COSY) at 500MHz and (13C) 125MhHz on 
a Varian Inova-500 spectrometer. Alternatively Varian Inova-500 COSY and HSQC 
correlation studies were used to assign the observed signals to the carbon and 
hydrogen atoms of the compounds. MALDI-TOF spectra were collected on an 
Applied Biosystems Voyager DE. Gel permeation chromatography was undertaken 
using THF as the eluent. 1 00~-tL of solution (agitated overnight to ensure complete 
dissolution) was injected at a flow rate of 1.00 mL.min- 1 by a Viscoteck SEC 
autochanger module. A Viscoteck TDA 301 unit with triple detection (right angle 
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laser scattering at 670nm, differential refractometer and viscometer) was used. dn/dc 
Values were calculated online for each polymer. Analyses were undertaken using 
OrnniSEC 4.0 software. Infrared spectroscopy was conducted on a Nicolet Nexus FT-
IR as a KBr disc. Liquid samples were analysed by direct injection of the reaction 
medium into a liquid cell with KBr windows. Omnic 5.la (Nicolet) was used to 
analyse the data obtained. 
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4.4.2 POLYMER SYNTHESIS 
Poly(y-benzyi-L-glutamate) (PBLG) 
BLG NCA (0.20 g, 0.75 mmol) was dissolved into 3 mL of dry DCM, and 
injected into a Schlenk tube fitted with a Young's tap and a 9mm rubber septum 
already under vacuum. The DCM was removed under vacuum and the NCA allowed 
to dry under vacuum for a further 2 hours. THF (3mL) was vacuum distilled into the 
vessel to give an approximately 10% (wt). The tube was then immersed in an oil bath 
thermostated at 35°C, and stirred to dissolution. n-Hexylamine (0.08mL, 0.2 M 
solution) was added via syringe into the tube and allowed to stir for 4 days. 
Following this time a 1 00~-tl sample was withdrawn for SEC analysis, and the 
remainder of the reaction was poured into a 10 fold excess of diethyl ether with 
stirring, and the white powder collected by filtration. Further purification was 
achieved by re -dissolving in THF and precipitating into a 10 fold excess of water. 
Yield 0.13 g, 75%. 
1H NMR (CDCh) Dppm; 7.19- 7.29 (5H, H\ 5.04 (2H, H\ 3.94 (IH, H\ 
2.60 (2H, H\ 2.28 (2H, H4) 
13C NMR Dppm; 175 (C2), 172 (C6), 136 (C8), 128.0 and 128.4 (C9), 66 (C\ 57 
(C3), 31 (C\ 25 (C4), 
IR (KBr disc) cm-1: 3296 (N-H), 2955 (C-H), 1734 (Aromatic C-C), 1651 
(Amide C=O) 
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p. 
0 
Poly(t-N-butoxy carbonyi-L-lysine) (PLysBoc) 
The same procedure was used as with the polymerisation of BLG NCA with 
DMAc as the solvent in place ofTHF. LysBoc NCA (0.2g, 7.35mmol); n-hexylamine 
(0.08mL, 0.2M solution). Yield 0.114g, 68%. 
1H NMR (CDCh) Dppm; 1.37 (13H, H11 + H5 + H6), 1.86 (2H, H4), 3.02 (2H, 
H\ 5.14 (1H, H\ 8.21 (lH, H8), 
13C NMR 8ppm; 21.5 (C\ 28.5 (C 11 ), 29.7 (C4), 30.1 (C6), 40.5 (C\ 65.8 
(C\ 78.7 (C 10), 156.1 (C9), 170.7 (C2), 
C=O) 
IR (KBr disc) cm-1: 3292 (N-H), 2960 (C-H), 1695 CBoc C=O), 1651 (Amide 
........._;11 
Jol'--.. 
0 9!=0 
8 HN 
Poly(L-glutamic acid) sodium salt (PLG) 
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PBLG (250 mg, I.I6 mmol repeating unit) was dissolved in I mL of 
trifluroacetic acid. HBr (33% in acetic acid) (0.54 mL, 2.9 mmoi) was added dropwise 
under N2 and stirred at room temperature for I hour. The solution was then 
precipitated into a 30 fold excess of diethyl ether. The solid was washed (2 x IO mL) 
with diethyl ether, then dissolved in 2 mL of 0.5M aqueous NaOH solution and 
dialysed against distilled water. The polymer was obtained as a white solid by freeze 
drying. Yield I45 mg, 72%. 
1H NMR (CDCl3) Dppm; 0.65 (H8), 1.07, 1.29, 3.06 (H\ 1.72 (1H, H4a), 1.83 
(IH, H4b), 2.07 (2H, H5), 4.I1 (IH, H3) 
13C NMR Dppm; 28.2 (C4), 33.7 (C5), 53.6 (C\ 173.6 (C2), I81.6 (C6) 
80 Na® 
0 
0 
n 
Poly(L-Iysine) HBr salt (PLLys) 
PLysBoc (I60 mg, 0.66 mmol repeating unit) was dissolved in 1 mL of 
trifluroacetic acid. HBr (33% in acetic acid) (0.54 mL, 2.9 mmol) was added dropwise 
under N2 and stirred at room temperature for 1 hour. The solution was then 
precipitated into a 30 fold excess of diethyl ether. The obtained solid was washed (2 x 
10 mL) with diethyl ether, then dissolved in distilled water and dialysed against 
distilled water. The polymer was obtained as a white solid by freeze drying. Yield I20 
mg, 82%. 
1H NMR (CDCh) Dppm; 1.20- 2.82 (6H, H4 + H5 + H6), 2.8I (IH,H\ 4.11 
(IH, H3) 
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13C NMR Dppm; 22.3 (C\ 26.5 (C6), 30.7 (C\ 39.3(C\ 53.5 (C\ 173.7 (C2) 
Poly(L-threonine) (PThr) 
PBThr (0.2g, 1.05 mmol repeat unit) was dissolved in 2 mL of DMF, and 
HC02H was added dropwise until the solution became slightly turbid (0.8mL) under 
N2. Pd/C (I 0%) (0.2 g) was added in a single portion under N2, and the reaction 
stirred at room temperature overnight. The reaction was diluted with DMF (3 mL) 
then centrifuged to remove Pd/C. The resulting cloudy solution was precipitated into 
I 00 mL of cold EtzO and the grey solid obtained by filtration. Yield 0.04 g, 33%. 
13C NMR (D20/TFA-d) Dppm. Peaks too weak due to low solubility. See text 
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5.1 INTRODUCTION 
Molecular self-assembly has recently been drawing huge amounts of attention 
in the development of supramolecular structures and materials1: those held together by 
non/covalent interactions such as Vander Waals and H-bonding. The inspiration for 
these structures is taken from nature which utilises self-assembly of molecular scale 
objects to give macroscopic assemblies. Most synthetic polymeric materials can not 
form permanent 3-dimensional objects due to their irregular, random coil 
conformations. However, there are some cases where polymers do form rigid 
structures in solution2•3• Poly(y-benzyl-L-glutamate), PBLG, for instance forms a 
stable a-helix in many organic solvents4. Above a critical concentration gelation is 
observed5. This behaviour has been attributed to phase separation as chain-chain 
entanglements can not form6. Microscopic phase separation increases the 
concentration of PBLG locally, and liquid crystalline alignment occurs. Formation of 
a network of fibres stabilised by dipolar n- n interactions physically immobilises the 
solvent matrix. This has led to significant interest in rod-coil block copolymers. The 
rigid rod segments can align together to give highly ordered solid state structures7 
shown in Figure I. n-Conjugated polymers and oligomers, which have found 
applications in OLEDs8 and as molecular wires9, form rigid rods in the solid7 and 
solution state 10• These stacking interactions have been exploited as assembling motifs 
when incorporated as a block-co-polymer segment with a solublising unit such as 
PEG. PEG 110-block-oligo(phenylene vinylene)s-block-PEG1 1o polymers assemble into 
long cylindrical micelles where the phenylene-vinylene rods stack within a corona of 
PEG 11 . Reducing the length of the phenylene-vinylene to three units, with a 
sufficiently long PEG chain results in gel formation, stabilised by lamellar packing of 
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the OPV units12 when each PEG unit is fully hydrated with 4.6 molecules of water. 
Other conjugated polymers including poly(thiophene) block copolymers also display 
this behaviour13 . 
Figure J. Schematic illustration of rod:.coil iblock copolymer packing directed by rod-rod 
alignment. 14 
The onset of gelation in dilute sol'utions of these polymers is ,of particular 
interest as ~templates for nanostructured materials 15 or even for the restoration of 
artworks by immobiEsing organic solvents'16• The undedying mechanism for gel 
-
formation is attributed to formation of a networked ·scaffold17 (Figure 2) which can 
immobilise the solvent, even at low concentrations of the gellant. Helation can also be 
induced in star shaped polymers where one block is incompatible With the solvent 18 
(in !linear diblock copolymers 'one may expect micelles or similar19) or by addition of 
charged end groups to give 'en&·to'"end interactions20 . 
Nature provides much of the inspiration for self assembled materials, the most 
famous being the DNA double helix21 • In addition to this motif P-sheets and a-helices 
formedl by polypeptides22, which can then self organise ~into elegant tertiary and 
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quaternary23 structures including enzymes and carbohydrate binding lectins24 , are 
similarly employed. Gelation systems based upon peptide sequences, and their rigid 
secondary structures, have been utilised extensively25·26 . A particular driver is to 
understand the formation of amyloid fibrils which are associated with Alzheimer's 
and Parkinson's diseases27 . Tirrel et a!. 28 showed that ABA triblock structures of a 
flexible poly-electrolyte flanking a leucine zipper29 core could reversibly self 
assemble by association of the 'zipper' regions. The elastin derived peptide sequence 
VPGVG has also been shown to be able to aggregate when incorporated into a 
polymer30, but gelation has not been reported to date. 
Figure 2. SEM of dried down gel fibres formed by self assembly of a low molecular weight 
organogelator31 • 
The self assembly properties of P-sheet peptide sequences32-34 , especially those 
which have been inserted between two PEG blocks, have been the focus of intense 
research. Poly(L-alanine) oligomers with PEG flanking groups form self assembled 
structures in the solid state, in which poly(L-alanine) rich regions are produced by the 
formation of antiparallel P-sheets35 . Klok and co-workers have used amphiphilic P-
strand forming peptides conjugated to PEG36, and shown that they assemble into 
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antiparallel ~-sheets, which can then assemble into fibres37 by lamella stacking in both 
the melt and solution state. By using a peptide which forms intra-chain antiparallel ~-
sheets, stacking only occurs in one direction giving molecularly thick ribbon 
structures38 . 
Deming and co-workers have utilised controlled polymerisation of N-carboxy 
anhydrid~s39 (as opposed to solid phase synthesis or bio-engineering) to produce 
polypeptides with defined structural motifs. By incorporating poly(L-valine) and 
poly(L-leucine), which give ~-sheet and a-helical conformations respectively, with a 
poly-electrolyte block, hydrogels could be formed at concentrations below 1 % (wt).40 
Interestingly this work showed that a-helices are also suitable packing motifs for 
gelation, as shown in Figure 3. 
Figure 3. Assembly of poly(L-Ieucine)-block-poly(L-Iysine) by anti parallel arrangement of 
helicies, insulated by water soluble, polyelectrolye blocks. 
More recently Manners et a!. showed that poly(y-benzyl-L-glutamic acid) 
(PBLG), copolymers containing a random coil41 or dendritic block42 self assemble in a 
similar fashion, with antiparallel alignment of a-helices. The mechanism is essentially 
the same as that presented above, as the PBLG is insoluble in the solvent, toluene. 
The supramolecular ribbons can be viewed by AFM, and result in an entangled 
network, providing rigidity and hence organogelation. Increasing the size of the 
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assembling block gave a corresponding decrease m the mtmmum gelation 
concentration, attributable to more efficient packing. tt 
H PBLG has also been used extensively as the rod unit in rod-coil polymers described earlier. These 
systems did not give gelation unless mentioned, so were outside of the scope of this introduction. 
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5.2 RESULTS AND DISCUSSION 
During the analysis of the block copolypeptides described in Chapter 4, it was 
observed that thermo-reversible gelation occurred in the common NMR solvents 
CDCh and CD2Ch. This was surprising, as the constituent homopolypeptides were 
soluble in these solvents, without any observed gelation at concentrations above 200 
mg.mL-1• To assess the gelation abilities of the block-co-polypeptides we first 
screened a range of solvents for solubility. Heating or sonication was required in most 
cases. The results of this are shown in Table 1, below. 
Table I. Solubility test for P(BLThr47-BLG281 at I wt% 
Solvent Soluble* 
THF X 
Dioxane X 
DMF 
DMAc 
CHCh 
DCM 
TCE 
Benzyl Alcohol 
TFA 
* Judged by formation of optically transparent solutions 
The diblock polymer was soluble in all the three chlorinated solvents which 
were tested, along with benzyl alcohol. TF A, DMAc and DMF which are all known as 
excellent solvents for peptides also readily dissolved the block-co-polymer. 
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Surprisingly, THF and dioxane could not dissolve the polymer even with heating and 
sonication. Homopolymers of the individual blocks are very soluble (>200mg.mL- 1) 
in both of these solvents at room temperature. 
To evaluate the gel forming properties, simple inversion tests were used. 
Briefly a sample of block co-polymer was transferred to a vial with solvent and 
sonicated for 30 minutes then left to stand for 1 hour. The vial was then inverted and 
allowed to stand for I hour. If no flow was observed it was defined as being a gel. 
Table 2 shows the results of the inversion tests which began with solutions of 
concentrations of 8 wt % which were then diluted until the minimum gelation 
concentration was found. This was only undertaken for DCM and CHCh. Gelation 
was also observed in tetrachloroethane. 
Table 2. Composition of block-co-polypeptides, and their minimum gelation concentration as 
determined b~ inversion tests 
Min. Gel Cone. (wt %f1 
Entry PBThr(a) PBLG(Ii) PLysBoc(li) DCM CHCh 
P156 47 28 4 4 
P157 26 22 4 4 
P158 50 25 4 3 
P197 16 16 
Pl60 16 19 
P163 46 18 5 5 
Pl95 20 22 3 
P196 20 46 4 6 
(a) Determined by RALS SEC in THF. (b) Calculated by 1 H NMR relative to PBTIIr block. (c) 
Minimum gelation concentration: tested in I wt% increments. (-) indicates no gelation was 
observed at up to 8 wt % concentration. 
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Figure 4 shows photographs of PBThr4rPBLG28 at 4 wt% concentration. All 
the gels are clear and able to support their own weight for extended periods (observed 
to last for over 1 week). 
TCE 4 wt% CHCb 4 wt% DCM4wt% 
Figure 4. Photographs of PBThr47PBLG 28 at 4 wt% concentration in different chlorinated 
solvents. Samples have been inverted for I hour previously 
When the concentration of the polymers was reduced below their critical 
concentration a viscous liquid instead formed and upon lowering the concentration 
further a free flowing liquid was obtained; (Figure 5). 
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6% 5% 4% 
Figure~· PB"J:'hr23PLysBoc18 in CHCh at various concentrations, showing transition from gel (far 
left) to viscous liquid (middle)Jo fr~e nowing liquid (right) 
The different copolymers containing a PBLG block gelated DCM and CHCh 
similarly , with the exception of the best gelator PBThr5oPBLG25 which could gelate 
CHCb down to 3 wt% concentration as oppose~ to 4 wt % for the others. Polymers 
containing a .PLysBa<; segment gelated DCM .at lower concentrations than in CHCl3. 
The di-blocks with the shortest PBThr block (DP = 16) failed to gelate either CHCh 
or DCM. In comparison the diblock with the longest PBThr (DP = 50) segment was 
the strongest gelator. This suggests that the PBL Thr block plays a key role. 
Polymeric gelators typically have amphiphilic character, allowing for a self 
assembly process whereby solvent is excluded from the insoluble region, or regions 
where chains ~an associa~e by e!e<;tro~tati<;\ hydrogen bonding ·or entanglme.m. For 
inst_(lnce polypeptides have been used to make hydrogels where one segment has a 
rigid hydrophobic structure, and the other is a polyelectrolyte40. The homopolymers 
from which our block copolymers are derived from are all soluble in the solvents in 
which gelation has been induced: TCE, .CHCh and DCM, making the gelation 
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behaviour completely unexpected. Mixtures of the two homopolymers in solution do 
not result in gelation; neither do solutions of the individual homopolymers. It has been 
commented43 that block copolypeptides containing an L-glycine block form gels in 
DMF, due to the highly insoluble nature of the polyglycine, which is in contrast to the 
soluble nature of both the blocks in our system. 
All the gelation systems we investigated displayed irreversible loss of 
structure by addition of hydrogen bond breaking co-solvents: methanol for PLysBoc 
and TF A for PBLG containing copolymers. This process made it possible for NMR 
analyses to be conducted in chlorinated solvents. The gels were also observed to be 
thermo-reversible. At 4 wt %, PBThr4rPBLG28 was stable to heating to 35°C, but 
when the temperature was increased to 40°C, the gel broke down to give a free 
flowing liquid. Upon standing and allowing to cool to ambient temperature a clear gel 
reformed. This process was repeated 5 times, with gelation occurring following each 
heating period. 
The first step taken in explaining the above behaviours was to visualise the 
structures which support the gel. 
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5.3 ORGANOGEL STRUCTURE AND MORPHOLOGY 
For gelation to .occur in the dilute concentration range, it was apparent that a 
network of some sort must be forming, stabilising the solution. In the case of a 4 wt% 
solution in CHCh of a I 0 kDa each chain is gelating over 6000 molecules of solvent! 
To our surprise the dried down gels, shown in Figure 6, had a network structure which 
was clearly visible by optical micrqscopy. 
A B 
c D 
Figure 6. Optical micrographs of dried gel samples cast onto glass from O.lmg,mL DCM solution. 
Width of images= 250 Jlm. A= PBThr26.PBLG22, B = PBThr50-PBLG 25, C = ,PBThr2o~PLysB_oc22, 
D = PBThr46-PLysBoc1s· 
-----·---------·------- --------·------·--------
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The size and morphology of these networks varied from one polymer to 
another. The sizes of the fibres are in the region of 1-3 microns as measured from 
these photographs, though the values are not really reliable, as this is at the diffraction 
limit of optical microscopy. The copolymers which failed to induce gelation in any 
solvent also produced these networked structures when dried down. In Figure 6 a 
range of morphologies are shown. A and B show extended, dendritic features. C and 
D appear to have smaller fibres resulting in a porous appearance. 
To circumvent the diffraction limit problem, environmental scanning electron 
microscopy (ESEM) was employed. The images obtained in the presence of H20 
vapour had very poor resolution, and the underlying structures were not clearly 
visible. We found that coating with gold and using standard SEM mode gave superior 
results (Figure 7). 
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Figure 7. (E)SEM micrographs ofPBThrwPBLG22 • Top in ESEM mode with H20 vapour. 
Bottom high-vacuum SEM mode following gold coating 
As in the optical images, a fibrous network is clearly present. It appears there 
are entanglement points where many fibres meet together, which are essential to retain 
the network rigidity. Although all the samples displayed a network structure, the 
morphology of these varied. PBThr26-PBLG22 shown in Figure 7 displays a highly 
branched, almost dendritic morphology. Significantly, increasing the size of the 
PBThr block to give PBThr50PBLG25 resulted in a different morphology, in Figure 8. 
Figure 8. PBThr50-PBLG 25 
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The structure comprises similar networked fibres. Surprisingly, along the 
fibres pores were visible. Shortening both blocks to PBThrwPBLG 16 (which did not 
give gelation) encouraged the porous morphology giving an appearance akin to the 
highly porous polyHIPE44 cross linked-materials shown in Figure 9. 
Figure 9. SEM showing porous structure .obtained from PBThr16PLysBoc 16 
This morphology was not expected. Gel forming polymers tend to form long 
fibrous assemblies which entangle. In Figure 10, at higher magnification the ·structure 
still appears to be. porous, rather than layered assemblies of fibres. 
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Figure 10. High magnification ESEM .of PBThr16PLysBoc16 
This structural phenomena was not unique to this one polymer. More examples are 
shown below (Figure 11 ). 
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A 8 
c 
Figure II. Examples of porous structures from drying down polymers. A = PBThr46PLysBoc 18, B 
= PBThr20-PLysBoc46, C = PBThr 16PBLG 16 
Both morphologies also appear for polymers containing PBocLys. PBThr2o-
PLysBoc22 in Figure 12.A appears to be porous, but closer examination (B), shows 
that it is overlaying fibres that give this appearance. The morphological features and 
average fibre sizes are summarised in Table 3. 
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A B 
Figure 12. PBThr20- PLysBoc22• Picture A can be misinterpreted as having a porous morphology, 
but higher magnification resolves overlaying dendritic fibres. 
Table 3. Summary of morphological characteristic of dried down gel samples determined by 
SEM. 
Polymer Ratio A:B(a) Fibre width (p.m)(b) Morphology 
PBThr41PBLG2s 1.68 1.31 Dendritic network 
PBThr26PBLG22 1.18 1.45 Dendritic network 
PBThrsoPBLG2s 2 1.10 Network of porous fibres 
PBThr16PBLG16 0.61 Porous 
PBThr16PLysBoc19 0.84 0.58 Highly porous 
PBThr46PLysBoc1s 2.55 0.67 Porous. Large aggregates 
PBThr2oPLysBoc22 0.91 0.62 Dendritic network 
PBThr2oPLysBoc46 0.43 0.37 Highly porous 
(a) DPon./DP2nd Block (b) Average of 10 points from SEM images 
Table 3 shows a relationship between the ratio of PBThr to the helical block 
and the average width of the fibres formed. The length ratio of one block to the other 
does not seem to influence the mean fibre width. The morphology appears to be 
independent of fibre size and the ratio of helix to sheet. Similar features were obtained 
from a series of castings of each sample, though the effect of concentration and 
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casting procedure was not investigated. Thus, this should be regarded as only an 
observation of the morphology rather than a critical study into the relationship 
between it and the composition of the constituent polymers. 
The dried down gels were also examined by atomic force microscopy, AFM. 
This is not normally used for investigating structures so large, which requires a large 
area to be scanned increasing the chances of any features being damaged or affected 
by the AFM tip. It was however possible to visualise the points where individual 
fibres intersect. One ofthese is shown in Figure 13. 
7.4 
0 
0 Microns 
0 Microns 7.4 
Figure 13. AFM Height image of dried down PBThr47-PBLG 28• Left shows an entanglement point 
for three fibres. Right shows two different fibres side by side, with the appearance of some 
twisted character. Horizontal lines represent cross sections shown in Figure 14. 
The width of these fibres is between 1.3 and 1.6 J.lm, in agreement with the 
values obtained by SEM, reported in Table 3. The fibres appear to have some twisted 
character to them. Using the image in Figure 13, right, it is possible to examine the 
height of individual fibres. Figure 14 shows three cross sections taken across both the 
fibres at three points. The two fibres have different sizes, but surprisingly, each 
individual fibre appears to have a constant height profile along its long axis. 
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Figure 14. Height profiles of cross sections through fibre of PBThr48-PBLG 28 taken from Figure 
13 (right) 
The larger fibre has a height roughly twice (300 nril) that of the smaller fibre 
( 150 nm). This agrees well with the SEM observations that not all the fibres are of 
equal size. Individual fibres showed consistent heights over tens of microns but a 
range of heights can be seen between different fibres. A possible explanation is that 
the larger features could be assembled from smaller ones. By reducing the 
concentration of the solutions which were cast from 0.1 mg.mL-1 to approximately 
0.02 mg.mL·' it was possible to decrease the amount of entanglements and view the 
morphology of individual fibres. To our surprise the fibres formed micron-scale right 
handed helical aggregates. These structures are typically found on far smaller length 
scales and are composed of chiral building blocks. The helical fibres are over 20 
microns in length which we believe to have not been seen previously on this scale. 
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Figure 15. AFM height image ofPBThr48PBLG28• Example of the twisted helical structures 
formed from dilute solution casting, 0.02mg.m r•. 
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From the evidence presented here, it would seem that the large structures 
which were visible in the optical and ESEM micrographs are constructed of smaller 
features. To explain these phenomena the structure of the block copolymers must be 
fully understood, particularly their secondary structures which are responsible for 
many self assembly processes. 
5.3.1 BLOCK COPOLYPEPTIDE SECONDARY STRUCTURE 
Infrared spectroscopy has been used for over 50 years to probe the structure of 
peptides owing to the subtle differences arising from the hydrogen bonding 
interactions in random coils, a-helices and P-sheets. PBLG has been investigated 
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extensively in reference to its well defined a-helical conformation in organic solvents. 
In general a-helices are more soluble than ~-sheets, demonstrated well in the case of 
poly-L-alanine which can form both structures45 . The most commonly investigated 
region of the infrared spectrum in this respect is the so-called amide I region (Table 
4). 
Table 4. Characteristic wavenumbers (cm-1) of infrared bands associated with secondary 
structure motifs of homo-polypeptides 
Band a-Helix ~-Sheet Disordered 
Amide A 3293 (II) 3283 c:-) 
Amide I 1650 (II) 1630C:-) 1656 
1685 (II) 
Amide II 1546 C:-) 1530 (II) 1535 
Amide V 615 C:-) 700 c:-) 650 
(II) Indicates a parallel, and G-) a perpendicular stretch. 
The amide I regions of the homopolymers in DCM are shown in Figure 16. 
The amide I peak at 1652 cm-1 for PBLG and PLysBoc is characteristic of their 
expected a-helices. PBThr also has a peak in a similar region at 1647 cm-1• It is 
unlikely that a homopolymer containing L-threonine would form a helix, as this amino 
acid is predicted46 to be helix breaking and ~-sheets promoting. A peak in this region 
could also be interpreted as being a random coil. Upon changing to the solid state 
there is no difference in the spectrum for PBLG which retains its helical structure, and 
displays the same peak at 1653 cm- 1• PBThr conversely shows a shift to lower 
wavenumber relative to what is seen in solution. The amide I peak is found at 1630 
cm- 1, which is characteristic of a ~-sheet. 
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1652 cm-1 1647 cm-1 
1653 Cin-1 1630 Clll-1 
1700 1600 1700 1600 
Figure 16. Infrared spectra of homopolymers. Left: (in DCM) green= PLysBoc; blue= PBLG; 
red= PBThr. Right: (solid state) blue= PBLG; red= PBThr. 
It IS now possible to explore the structure of the block copolymers and 
compare them to their parent homopolymers. This was undertaken at dilute 
concentrations, well below that at which gelation occurs for each sample. Figure 17 
shows the amide I region for PBThr26PBLG22 in DCM. The peak at 1653 cm- 1 is 
identical to that observed in the homo PBLG and can be assigned as its a-helical 
amide stretch. A second peak at lower wavenumber is also present (1627 cm- 1) 
indicative of a ~-sheet. It was not possible to analyse the amide II region (which gives 
information about ~-sheets) due to aromatic vibrations from the protecting groups. 
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1653 cm-1 1627 cm-1 
Wavenumber (cm-1) 
Figure 17. Infrared spectrum of PBThr2~BLG22, obtained in DCM. 
The same peaks were present in all the block co-polymers, including those 
containing PLysBoc. Of the three amino acids used here only L-threonine has any 
tendency to form sheets. Accordingly the peak at 1627 cm-1 is assigned as PBThr in 
the ~-sheet conformation, which is significantly different from the random coil seen in 
solution for the homopolymer, but in agreement with its solid state conformation. 
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1652 cm- 1 
1627 cm-1 
1670 1610 
Figure 18. IR spectra of PBThr20PLysBoc46 in benzyl alcohol (red) and methanol (blue). 
As mentioned earlier, it is normally required for a polymeric gelation system 
to contain at least one block which is incompatible with the solvent. The parent 
homopolymers used here clearly do not obey this rule. The IR results show a change 
in secondary structure of the PBThr block when going from homopolymer (random 
coil) to block-copolymer (p-sheet) giving a peak equivalent to what is seen in the 
solid state. The conclusion which can be drawn from this is that, when the PBThr is 
incorporated with a helix-forming block, it assumes a more rigid P-sheet 
conformation, which is far less soluble than the coil adopted by the homopolymer. 
Stabilisation of P-sheet peptides by conjugation to PEG has been observed47 . This 
provides the requisite feature of amphiphilicity thus explaining the onset of gelation, 
if not the origin of this structural reorganisation. Upon changing the solvent from 
DCM to benzyl alcohol, or addition of methanol, systems in which no gelation was 
seen, there was little change in the IR spectra (Figure 18) suggesting that both 
secondary structures remained though a quantitative analysis of the sheet and helix 
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content was not possible. Addition of methanol to PBLG or PLysBoc 
homopolypeptides did not produce any changes in the amide I peak. (Data not shown) 
5.3.2 MECHANISM OF SELF-ASSEMBLY 
Considering the evidence shown so far, it is apparent that a self-assembly 
process is occurring, resulting in the long fibres which support the gel solution, as 
opposed to micellisation which may be expected for amphiphilic block copolymers. 
The process must also involve hydrogen bonding, as shown by the gel-disrupting 
effect of methanol and TF A. To probe the 3 dimensional structures of the gels, wide 
angle X-ray scattering (WAXS) was utilised. Samples of the dried-down gels revealed 
diffraction patterns, indicating that ordered structures are present. An example is 
shown in Figure 19. 
0 5 10 15 20 25 
28 
Figure 19. WAXS pattern for PBThr46PiysBoc18• 
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a e esu ts rom T bl 5 R I f WAXS' mvestie:atton o fd . d d ne own eels 
Sample 20 d spacing Assignment 
PBThrso-PBLG2s 19.5 4.55 A Anti-parallel ~-sheet 
5.12 16.0 A Inter-sheet spacing 
PBThr46PLysBocts 19.5 4.55 A Anti-parallel ~-sheet 
5.12 16.9 A Inter-sheet spacing 
PBThr5o-PBLG25 showed a peak at 20 = 19.5°, which corresponds to a d-
spacing of 4.55 A. This has been observed as the interchain separation for the 
anti parallel ~-sheet of poly(L-alanylglycine) in the orthorhombic unit cell48 . Identical 
patterns were seen in the PLysBoc-containing polymer, showing that the secondary 
· structure of the PBThr is maintained by two different helical co-blocks. A further 
reflection was seen corresponding to a d spacing of 15 A. In the nano-scale assembly 
of a PEG-block-~-strand peptide-block-PEG ad spacing of 12.7 A was attributed to a 
lamella type ordering36. A similar mechanism can be proposed for this system, but 
with a larger separation between lamella due to the sterically large benzyl protected 
side chains. This would result in the growth of a ribbon in the direction of the lamella 
stacking. A schematic representation of this is shown in Figure 20. 
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Figure 20. Proposed mode of self assembly for the case of PBThr1~PBLG 16• Top:. antiparallel 
arrangement of sheet segments with an interchain spacing of 4.6 A as determined by WAXS. 
Below: lamella ordering of sheets, separated by 15 A. 
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There are other examples of similar structures in the literature, but they all 
contain a random coil polymeric block, such as PEG as the 'insulating' outer layer. In 
this case a rigid rod protrudes from stacked lamella, which has not been previously 
described. The schematic shown in Figure 20 suggests that the PBLG rods are 
aligned in an ordered, parallel fashion . However, the most favourable alignment of 
PBLG (due to the dipole moment) is antiparallel, which may also contribute to the 
increased separation between lamellae. SAXS investigations did not reveal any further 
information, probably reflecting the relatively wide distribution of chain lengths. This 
does not affect the W AXS profile as it can only see inter-chain spacing. A SAXS 
reflection would be necessary to confirm unambiguously this structure. 
This mechanism does not explain why such large, micron sized features are 
seen. There is clearly at least one higher level of assembly. Twisting induced by the 
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chiral nature of the constituent units is normally used to explain why fibres (and gels) 
are formed, as opposed to uncontrolled aggregation, and precipitation49 . Indeed, 
helical superstructures were seen which raises the possibility that a series of 
hierarchically ordered structures may be contributing to the fibre formation, which 
have been previously described and are shown in Figure 21. 
rod-like monomer 
monomer ribbon fibril 
Figure 21. Assembly of rod-like monomeric units into hierarchally order structures49• 
If this model was used to describe the system presented here, then the rod-like 
monomer would be the sheet-assembled unit shown in figure 20. Twist would be 
induced by the chiral nature of the amino acids, giving a self assembled tape. 
Associated to give the large ribbons, fibrils and fibres would then follow giving the 
macro-scale features which have been observed. It should be noted that this is only a 
speculated mechanism and more data is required to designate the process occurring, 
but it does help explain the large, micron sized twists. If this mechanism is correct, 
then the different morphologies seen in the ESEM micrographs will be caused by the 
entanglement of the fibres and the different morphologies perhaps representative of 
the drying down process. 
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5.4 CONCLUSIONS 
Here we have described for the first time the self assembly of rod-sheet block 
copolypeptides into (sub)micron sized fibres. The assembly is driven by alignment of 
~-sheets into lamellae, which can then stack to give a long axis. Uniquely, these 
structures have helical rods protruding from the ribbons, in comparison to the known 
sheet-coil polymers which have a random coil insulating layer. These ribbons then 
assemble to give higher order structures resulting in the large fibres which have been 
observed by microscopy. These fibres vary in width and length within a sample, 
probably reflecting the non-monodisperse nature of the constituent diblock 
copolypeptides. It was possible to view the helical assemblies which form the fibres 
by SEM. Analysis of the secondary structures of the homopolymers by infrared 
spectroscopy showed that, upon conjugation to a helical block, poly(benzyl-L-
threonine) assumes its solid state ~-sheet structure, as opposed to the random coil seen 
in solution. This then acts as a structure-directing rigid unit, allowing the molecule to 
assemble in a lamella fashion, with an insulating layer of helical poly(peptide ). In 
order to confirm unambiguously the structures postulated here, SAXS data are 
required. A mono-disperse polypeptide may be required for this, which could be 
obtained by solid phase methods, as the peptides involved are all relatively short. As 
a consequence of this fibrous network formation, solutions of the block 
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copolypeptides form thermoreversible gels, which are disrupted upon addition of 
hydrogen bond-breaking solvents including methanol and TF A. The effect of 
molecular weight and composition was investigated. This system may prove to be a 
useful model for polypeptide gelation systems due to the highly soluble nature of both 
blocks, facilitating the synthesis. 
5.5 EXPERIMENTAL 
DCM (>99%), CHCh (>99%) and benzyl alcohol (>98%) were purchased 
from Fischer Scientific UK. Methanol (HPLC grade) and trifluoroacetic acid (>98%) 
were purchased from Aldrich. Polymers were synthesised by the ring opening 
polymerisation of the appropriate NCA, as described in Chapter 4. Infrared spectra 
were collected using a 1 iquid cell with KBr windows, path length = 0.1 mm or as a 
KBr disc (5 wt %) on a Nicolet Nexus FT-IR. Optical, AFM and (E)SEM microscopy 
samples were prepared by dropping 50 !JL of a 0.1 mg.mL- 1 solution of the polymer 
onto an appropriate surface and drying in the air overnight. AFM samples were 
prepared on freshly cleaved mica. ESEM samples were prepared on borosilicate glass 
slides, and coated with gold by vapour deposition where necessary. (E)SEM analyses 
were conducted on a Phillips FEI XL30 operating between 20-25 kV. AFM imaging 
was carried out in tapping mode on a Multimode Nanoscope IV (Digital Instruments, 
Santa Barbara, CA, USA), using etched silicon probes (Budget Sensors, BS-T AP300), 
with a spring constant, k = 40 N/m (Windsor Scientific, Slough, Berkshire, UK). 
Samples for W AXS and SAXS were prepared by taking a 6 wt% gelated solution of 
the polymer in DCM, and drying under a stream of nitrogen overnight. W AXS data 
were obtained on a Bruker D8, operating at 40kV using a copper-alpha source with a 
wavelength of 1.54 A. SAXS data were collected on a Bruker Nanostar fitted with 
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Kratky SAXS camera operating at 40kV using a copper-alpha source with a 
wavelength of 1.54 A. Digital photographs were taken using a Kodak DX 6340 at 3.1 
megapixels. Molecular graphics images were created using Cambridgesoft, Chern 
3D. 
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CHAPTER6 
INHIBITION OF ICE CRYSTAL 
RECRYST ALLISATION BY POLYMERIC 
ADDIT:O:VES 
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6.1 INTRODUCTION 
Since antifreeze glycoproteins were discovered in the blood serum of 
Antarctic fish 1 they have attracted interest as additives in cryopreservation2•3, 
cryomedicine4, cell membrane diffusion moderators5 and even in frozen foods6.7. 
Their three main effects are: non-colligative freezing point depression; dynamic ice 
shaping; and recrystallisation inhibition. The first two effects are closely related to the 
precise structure of the AFGP in solution and the carbohydrate moiety. A thorough 
investigation by Nishimura et a/8 concluded that the amino acid sequence and the 
presence of an N-acylated carbohydrate was essential to maintain the antifreeze 
activity, and related this to the secondary structures present as judged by CD 
spectroscopy. However, they did not consider recrystallisation inhibition properties as 
a marker of antifreeze activity. Consequently there has not been a complete study on 
the structural features required for this property. Briefly, recrystallisation inhibition is 
the effect of AFGPs (and related compounds) whereby the rate of growth of ice 
crystals, at subzero temperatures, is retarded or stopped. Without the AFGPs the 
larger ice crystals grow at the expense of smaller ones, resulting in a larger mean 
crystal size, shown in Figure 1. 
Figure I. Micrographs of ice wafers with (left) and without (right) AFGP. The photo on the left 
clearly shows smaller ice crystals. Scales are identical in both images. (5001Jm width) 
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The most extensive work in this area has been conducted by the group of 
Robert Ben. Their first generation AFGP mimics showed some RI activity despite 
significant structural changes from native AFGP9- 11 • Firstly, the disaccharide linked to 
threonine was replaced with a monosaccharide, galactose, linked to a lysine residue, 
and the two alanines were substituted by glycine (Figure 2). 
H~<O: HO OH HO~~ 
OH O AcNHo\ 
H'o: HO 
HO 
0 
HN 
B A t~ 0 ~~~~~L 4 55 ~JNi 
0 H 0 
n = 3-9 
Figure 2. Tripeptide repeat units of A) native AFGP; B) first generation RI inhibitor of Ben et 
a f. 
These derivatives were only weekly active, approximately 80 X less so than 
AFGP 8, which is the least active of all the native AFGPs. Interestingly, they only 
showed weak dynamic ice shaping and thermal hysteresis effects, showing that it is 
possible to isolate the individual properties from one another. By exchanging the 
native 0-glycosidic bond for a C- linkage, the stability of the materials to enzymatic 
and chemical degradation is improved 12• The importance of the distance between the 
carbohydrate moiety and the peptide backbone was also probed by a second 
generation of RI inhibitors 13 (Figure 3). The shortest distance, of 2 CH2 groups, gave 
the strongest RI activity, while 3 and 4 CH2 groups produced a sharp decrease similar 
to the G 1 peptides described above. 
__________________________ , ___ _ 
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HO 
~JNi 
0 H 0 
n=4 
Figure 3. Second generation RI peptides with variable separation between backbone and 
carbohydrate 
Perhaps the most remarkable, and only other example of an RI inhibitor is the 
structurally simple poly( vinyl alcohol), PV A. It does not possess either the 
polypeptide backbone or the carbohydrate moiety which conventional thought would 
suggest is essential for RI activity. In fact, PVA with a molecular weight of -80 000 
Da was as effective an RI inhibitor as AFGP 8 at equal molar concentrations 14, (This 
represents a 30x increase in mass concentration). Later studies15·16 showed that PV A 
inhibited the same crystal faces, { 1 0 1}, as the native AFGPs resulting in the 
appearance of pyramidal faces, previously only associated with AFGPs17. A very 
weak, but definite, thermal hysteresis of 0.037 K was also present. Capping of the 
hydroxyl groups reduced the RI and thermal hysteresis activity, as was seen with 
native AFGP. The most remarkable feature is PYA's lack of a rigid secondary 
structure, which is thought to be essential if a sufficiently hydrohobic face is to be 
presented following adsorption onto the ice crystal. Another class of poly-ol has 
recently been reported to influence the growth of ice. Poly( tartar amides) 18, Figure 4, 
which contain the rigid amide bonds found in peptides and multiple -OH 
functionalities, were shown to inhibit the growth of hexagonal ice by W AXS, and to 
alter the freezing process by DSC compared to water alone. No thermal hysteresis or 
quantitative RI assays were undertaken, preventing comparison to the afore-
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mentioned systems. PEG-block-poly((hydroxyethyl)ethylene) can also influence the 
growth of hexagonal ice, and displays recrystallisation inhibition 19• 
R= 
Figure 4. Poly(tartar amides) used as AFGP mimics. Mw- 7000 g.mor1 
AFPs should also be mentioned briefly. Antifreeze pep tides that display strong 
RI behaviour have been found in both nature and designed20 . They all contain an ice 
binding hydrophilic face and a hydrophobic face which makes it energetically 
unfavourable for the addition of further water molecules. Modifications to remove the 
a-helicity from winter flounder AFP resulted in a loss of antifreeze activity21 , 
highlighting their relationship between secondary structure and activity for AFPs. 
Also, some of the proteins which display strong RI effects, do so without a significant 
thermal hysteresis gap22 • AFPs contain various functional groups including 
carbohydrates, alcohols and amines, whereas AFGPs only contain OH (carbohydrate) 
groups. The common feature of AFPs is a well defined secondary structure, compared 
I 
to AFGP analogues which are largely unstructured. 
In summary, the structural features required for RI inhibition for both native 
AFGPs and their derivatives, and how this relates to AFPs are not yet known. 
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6.2 RESULTS AND DISCUSSION 
To investigate which structural features are essential for recrystallisation 
inhibition by polymeric materials, a series of stepwise structural simplifications of 
native AFGPs were undertaken and the activity of the resulting compounds assayed. 
The polymers used are summarised below. 
H~H~ 
HO 0 
OH AcNH 
pr~r~!N1 H 0 H 0 
rrOH Native AFGP OH 
MeO HO 
~ H Structural Simplifcations OH ( ~ }:it 
2 H,N( NH2 
OH 
M OH }:it t~ H t~ 0 
HO 
3 4 5 6 7 8 
Figure 5. Summary of the polymers which are evaluated for recrystallisation inhibition in this 
section. 1) poly(methyl-60-methacryloyl-a-D-glucopyranoside; 2) poly((p-o-galactosyloxy)ethyl 
methacrylate); 3) poly(acrylic acid); 4) poly(vinyl alcohol); 5) poly(ethylamino-methacrylate); 6) 
poly(hydroxyl-L-proline); 7) poly(L-Iysine); 8) poly(L-glutamic acid) 
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The first tests undertaken were to establish the viability of using the splat 
tese3, to assess recrystallisation inhibition. This involves generating a polycrystalline 
wafer of an aqueous solution of the polymer being examined, by dropping 10 j..tL of 
the solution onto an aluminium sheet cooled with dry ice. The samples were allowed 
to anneal at -6°C for 30 minutes, before being photographed between crossed 
polarisers. The micrographs were examined to find the single largest crystal axis in 
any direction and recorded. The average largest grain size (LGS, j..tm) was calculated 
from 3 individual assays. Phosphate buffered saline was used as the solvent in all 
cases, so this is the null result, and as it was known from the literature that PV A 
strongly inhibits ice recrystallisation 14 , it was used as the positive control 
Table 1. Mean largest grain size measurements of PBS and PV A (Mw 85-146kDa), Smg.mL-1 
LGS 1 LGS 2 LGS 3 MLGS Yz Range 
PBS 272.7 268.3 254.3 265.1 9.6 
PVA 55.0 48.7 54.4 52.7 3.5 
The deviation in the observed grain lengths were less than 10% in both cases. 
The image in Figure 6 clearly demonstrates the reduction in grain size associated with 
recrystallisation inhibition in the presence of PV A, compared to the reference solution 
of PBS. This method was thus employed as it allows for a value to be associated with 
the RI effect unlike some other methods in use 18•24 . . 
-237-
Chapter 6 
Figure 6. Optical micrographs viewed through crossed polarizers of 'splat' tested PBS (left) and 
PVA (lOOk). Scale bar= 500 Jim. PVA was 5 mg.mL-1 in PBS. Samples annealed at -6"C for 30 
minutes. 
6.2.1 INFLUENCE OF SIDE CHAIN FUNCTIONALITY ON 
Rl PROPERTIES 
Encouraged by the strong RI activity of PV A we decided to probe the 
effects of different water soluble side chains along a vinyl derived backbone. The 
following polymers were used_ 
Polymer 
Table 2. Vinyl derived polymers used, and their characteristics. 
Mw(a) Side Chain 
Poly(acrylic acid)54 5110 -C020H 
Poly(ethylamino methacrylate) 20 000 -C(O)O(CHz)2NH2 
Poly(vinyl alcohol)2625 85 -146k -OH 
Poly(vinyl alcohol)205 9000 -OH 
Poly(vinyl alcohol)so 3500 -OH 
Poly(ethylene oxide)zzs 10000 N/ A (CH2CHzO) backbone 
(a) Mw according to suppliers specifications 
---------------------------------------------------
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The polymers were chosen to allow the RI properties to be related to the 
charges on the side chains. PEO allows the influence of polymers without any H-
bonding protons to be tested, and is isomeric to PV A. The results of the splat tests for 
these polymer~ are summarised in Figure 7. 
250 
200 
-(/) e 150 
(,) 
.E 
-(/') 100 C) 
.....J 
~ 
50 
111=------6·\~.. II 
---1t- PAA 
54 
"' ------ PEG44 
------.&-- PVA2s2s 
~PVA80 
-b- PVA2os 
------t:r--- pEA M 135 
0~--~---r--~--~--~----~--~--~--,---~ 
0 2 4 6 8 
Concentration (mmoi.L-1) 
Figure 7. Mean largest grain sizes of various vinyl based polymers at different concentrations. 
Dashed line represents PBS. PEAM could not be used at higher concentrations due to gel 
formation. 
Figure 7 shows the RI behaviour of the vinyl-based polymers at different chain 
lengths and concentrations. All three PV A chain lengths which were tested displayed 
RI behaviour, with PV A2625 and PV A2os both giving MLGS around 50 microns, which 
is the limit of detection by this method§§. At equal molar concentrations the high 
molecular weight PV A gave a stronger RI effect (smaller grains). 
§§ The thickness of the wafer generated by the splat test is approximately 50 microns which due to 
orientation considerations produce the MLGS lower limit. 
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To investigate the origin of the RI behaviour the polymer mass concentration 
is normalised to Smg.mL-1• In this situation the total number of PV A repeat units 
present is constant, ruling out any non-specific effects. This is plotted in Figure 8. 
260 
240 
220 
200 
180 
-(/) 160 c 
0 140 ..__ .~ 
E 120 
-(/) 100 (!) 
_J 
~ 80 
60 
40 
20 
0 
PVA 3500 PVA 9000 PVA 85-146 kDa 
Polymer 
Figure 8. Variation in observed MLGS with chain in molecular weight of PV A, at a constant 
concentration of5 mg.mL-1• Dashed line indicates PBS. 
A strong correlation between RI activity and molecular weight is observed in 
Figure 8. By analysing the data this way, it is possible to rule out any false positive 
results that might occur due to the high concentrations of side chains, when 
comparing polymers of different molecular weight, but at equal molar concentrations. 
It is not possible to determine whether the 85-146 kDa polymer can produce a 
stronger effect at this concentration than the 9000 Da polymer as 50 microns is the 
smallest size which can be defined in this test. Figure 7 does show that the higher 
molecular weight polymer retained its activity upon on dilution whereas the 9000 Da 
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polymer began to loose it. An important issue raised from this analysis is that both 
molar and mass concentrations should be considered when defining the activity of 
polymers tested. This is especially true when comparing polymers of different 
structure, where equal molar concentrations can result in markedly different mass 
concentrations. 
The other polymers tested, P AA, PEAM and PEG all showed a small RI 
effect, in that they reduce the size of the crystals from 250 microns for PBS to around 
200 microns in all cases. This does not appear to be a true RI effect, as PEG has 
previously been analysed and has been shown to have no activity. Increasing the 
concentration of PAA to 40 mg.mL-1 (data not shown) did not give any significant 
decrease in the grain size. Importantly, upon dilution there was no large increase in 
the grain size as would be expected if they were showing RI activity. These effects 
could be attributed to the increased concentration of solutes in the case of the polymer 
electrolytes; (which were used as their salts). These observations are important to take 
into consideration when analysing other polymers, as any of them taken individually 
would give a false positive (if rather weak) effect. 
To investigate the role of solutes on RI a 1 Omg.mL-1 solution of 1-0-methyl 
glucoside was analysed. The observed MLGS was 198 Jlm, a similar value to what 
was obtained for the polyelectrolytes, suggesting that additive effects due to increased 
numbers of solutes should be considered during interpretation of any results. 
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6.2.2 HOMO-POLYPEPTIDE Rl PROPERTIES 
The polypeptide backbone of native AFGP is likely to play a role in its RI 
activity, therefore it is prudent to investigate the RI properties of polypeptides with 
the same (or closely related) side chains as were present in the vinyl polymers, 
discussed in the previous section. A small range of polymers were synthesised from 
their corresponding N-carboxyanhydrides (Chapter 4). The polymers shown in Table 
3 were used for this study. 
Table 3. Polypeptide-based polymers used and their molecular characteristics 
Poly(L-lysine )50 7200 
Poly(L-lysine )110 14400 
Poly(L-glutamic acid) 110 15950 
Poly(L-hydroxyproline )(bl 5676(bl -OH 
(a) Mw obtained from THF GPC of protected polymers; (b) Value from supplier. 
Typical micrographs obtained from each polymer are shown in Figure 9 and 
the MLGS values are summarised in Figure 10. 
-242-
Chapter 6 
Poly (glutamic acid) Poly (lysine) 
PBS 
Figure 9. Optical micrographs of frozen polymer solutions at 40 mg.mL-1• Scale bar= 500 Jtm. 
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----II-- p L G 11 o 
---- Pllys50 
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Figure 10. Rl inhibition by peptide based polymers. Dashed line indicates PBS control 
As for the vinyl polymers, a small RI effect was observed for all the polymers, 
reducing the MLGS from around 250 Jlm for PBS to 200 Jlm. The same reasoning, 
based upon polyelectrolyte concentration that was discussed in the previous section to 
explain this behaviour can be applied here. The polypeptides bearing charged side 
groups did not display any significant RI behaviour, even at concentrations of 40 
mg.mL -I. Conversely, the relatively low molecular weight poly(hydroxy~proline )44 
showed a reasonably strong RI effect. The observations confirm the previous results 
that charged side chains, as the water solublising component, do not result in any RI. 
Figure I 0 also includes the data for PV A80 which has a similar molecular weight to 
the poly(hydroxy-proline) and surprisingly the observed RI activity of the two 
polymers is very similar. Poly(hydroxy-proline) is expected to have a polyproline 
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helical25 secondary structure, but this does not give any significant increase in R1 
activity relative to the largely unstructured PV A. This is as remarkable as the PV A 
results; poly(hydroxy-proline) has a structure significantly different from that of 
native AFGP. The lack of activity for all the charged species proves that a rigid 
polypeptide backbone of defined primary structure is not an essential component for 
R1 activity, but it may play a role in the increased R1 activity of native AFGPs.*** No 
quantitative study using poly(hydroxyl-proline) has been previously described in the 
literature. 
6.2.3 VINYL DERIVED GLYCOPOLYMER Rl 
PROPERTIES 
The strong recrystallisation inhibition observed with the simple polyols 
encouraged us to investigate whether vinyl derived-glyco polymers would be 
effective. The increased density of hydroxyl groups should facilitate stronger ice 
lattice binding, while the activity of PV A shows that a carbon-based backbone 
presents a sufficiently hydrophobic surface. Two structurally different glycopolymers, 
of controlled molecular weight, synthesised by aqueous RAFT polymerisation of the 
appropriate monomer were tested, (see Experimental section for further details). 
••• It is again worth noting here that RI activity is distinct from the thermal hysteresis and dynamic ice 
shaping effects which are also associated with antifreeze proteins. The precise peptide structure and 
carbohydrate component both appear to be critical for these properties. 
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Table 4. Molecular characteristics. of glycopolymers used in this study. 
PMAMGic PGalEMA 
Mo(a) PDI Mo PDI 
PMAMGLc7o 18000(b) 1.12 PGalEMAso 12700(a) 1.3 
PMAMGlc,44 37000(a) 1.05 
PMAMGlc22o 56500(b) 1.03 
PMAMGlc4os 1 osoo<a> 1.24 
(a) Determined by aqueous GPC using RALS. (b) Determined by DMF GPC using RALS 
s 
~s l)o H?ifo HO 
HO OH 
PMAMGlc 
OH 
s 
~s l)o 
0 ) 
qloH 
HO~ 
HO HO 
OH 
PGalEMA 
Figure 1 I. Structures of the glycopolymers tested, including the end groups derived from RAFT 
polymerisation. PMAMGic = poly{methyl-60-methacryloyJ-a-D-glucopyranoside). PGaiEMA = 
poly((~-D-galactosyloxy)ethyl methacrylate) 
For these polymers, a high initial concentration corresponding to 40 mg.mL- 1 
was used to ensure that any effects were as pronounced as possible, avoiding any false 
negative results arising from weak activity. The micrographs in Figure 12 show a PBS 
control alongside PMAMGlc220 at 40mg.mL·'. The sample containing the polymer 
clearly shows a higher population of crystals, and hence a smaller grain size. There 
are also no single larger crystals in view, compared to the PBS which contains several 
significantly larger crystals. 
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PBS PMAMG1c220 
Figure 12. Optical micrograph of PBS (left) and PMAMG1c220 at 40 mg.m L-1• Scale bar 
represents 500 Jlm. 
To probe this apparent RI effect further different molecular weight 
glycopolymers were examined and the concentration reduced in a stepwise fashion. 
This helps determine if the RI effect is real, as it should show a strong dependence on 
the concentration of polymer. 
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Concentration mmoi.L-1 
Figure 13. Graph showing the change in MLGS with concentration for the glycopolymers. 
Dashed line indicates PBS control 
The data presented in Figure 13 show a strong correlation between both the 
concentration of the polymer solution and the molecular weight of the polymer with 
the observed MLGS. Both low molecular weight polymers (PMAMGlc7o and 
PGalEMA50) show similar behaviour suggesting that the stereochemistry of the 
carbohydrate may not be significant. The observed largest grain size of 138 Jlm for the 
most active glyco-polymer, PMAMGlc405 , at 0.44 mmol.L- 1 represents stronger 
activity than was observed for PVA80 (Mw = 3500) but weaker than PVAzoo (Mw = 
9000) at similar concentrations. Surprisingly, at the lower concentration of 0.11 
mmol.L- 1, PMAMGlc405 retains its (rather weak) RI activity to the same degree as 
PV A80. It should be noted that the total mass of glycopolymer is far higher than the 
mass of PV A at equal concentrations. These observations are not due to colligative 
effects, as demonstrated by the fact that at equal molar concentrations the higher 
-248-
Chapter 6 
molecular weight polymers are more active than the lower. It is, however, necessary 
to explore whether the RI is affected by the total amount of carbohydrate present in 
the solution: that is to see whether there are additive effects. This is done by 
comparing the results of the RI assays with polymers of equal mass concentration, 
rather than equal molar concentration. In this situation, the total number of repeat 
units is equal, and the effects of polymer chain length can be probed. 
150 
-(/) 
c:: 
0 
.... 
. 2 
E 140 
-(/) 
(.9 
_J 
~ 
130 
Figure 14. M LGS of PMAMGic of varying molecular weight at a constant concentration of 40 
mg.mL-1• Error bars indicate the standard deviation. 
In Figure 14, the results of the RI assay at 40 mg.mL- 1 are shown, for 4 
different molecular weights of PMAMGlc. There is a clear trend towards increasing 
activity (decreasing grain size) with an increase in the molecular weight of the 
polymer. As the total carbohydrate concentration is constant throughout this series the 
increase in activity can be directly attributed to the effect of increased chain length. 
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This result is remarkable considering the major structural differences between the 
glycopolymers and native AFGP. The activities which are observed are significantly 
lower than native AFGP. The smallest fraction, AFGP 8, is more active than these 
polymers even at concentrations as low as 1 o-3 mmol.L- 1• 
It has been shown previously that for thermal hysteresis to be present in native 
AFGP, the hydroxyl groups are an essential feature - oxidation to carboxylic acids 
results in complete loss of activity 1• Our results here show that RI activity is also 
dependent upon hydroxyl groups, rather than other water soluble motifs. An important 
consequence ofthis is that, when new glycosylated compounds are being assessed for 
RI effects the control samples should also contain an alcohol moiety, to determine if it 
is the backbone or the side chain which is contributing. Taking this into account we 
can consider the increased activity of PV A relative to our glycopolymers at various 
chain lengths. We would expect that an increased concentration of -OH groups in the 
glycopolymer would increase the strength of the ice binding relative to PV A, and 
consequently increase the RI activity. This is the opposite of what is observed. 
Previous work by Ben et al, indicates that a short distance between polypeptide 
backbone and the carbohydrate moiety in their AFGP mimics was crucial to maintain 
RI function. Increasing the separation from 2 CH2 units to 4 resulted in a complete 
loss of RI activity. The separation from backbone to -OH in PVA is zero units, 
whereas in PMAMGlc it is 3 atoms, and in PGalEMA it is 5 atoms. This is shown 
schematically in Figure 15. 
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PMAMGic PGaiEMA 
Figure 15. Schematic representation of a repeat unit ofthree different polymers. The arrows are 
intended to lead the eye, not represent an actual distance. 
The images shown in Figure 5 demonstrate the increased separation from 
poly( vinyl) backbone to the hydrog~n bonding units (OH, or sugar) ttt. This would 
explain the reduced RI activity of the glycopolymers relative to PV A when the mode 
of action is assumed to follow the absorption-inhibition model. The short separation 
in PV A, would result in the hydrophobic poly( vinyl) backbone being presented close 
to the advancing ice front causing more effective inhibition. In the cases of the 
glycopolymers, the long, flexible linker would allow more backbone flexibility to 
avoid contact with the hydrophilic ice surface and thus effect less efficient inhibition. 
Comparisons with the conformation of native AFGP is hard, owing to the complex 
secondary structures assumed by peptides. Many of the AFPs have however been 
ttt The images were generated using Chem3D, as part of the ChemDraw package. Only a fully 
extended conformation is shown, and is not intended to represent a predicted or experimental 
conformation. For this reason no estimations of the actual distance have been made, and the at:rows are 
there simply to highlight the point. 
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shown to present their hydrophilic residues along a single face of their rod-like helical 
structure, ensuring a large hydrophobic face is presented which gives them their 
astonishingly strong RI behaviour. 
The activity of the glycopolymers was strongly linked to their molecular 
weight. The high molecular weight polymers (DP = 405) showed the highest activity, 
which were comparable to that of PV A at similar molar concentrations. This may be 
due to the increased binding of the polymer to ice relative to PV A by virtue of a 
higher concentration of hydroxyl groups. The increased binding would limit the 
freedom of movement of the backbone giving rise to the requisite hydrophobicity and 
hence RI. 
-252-
Chapter 6 
6.3 CONCLUSIONS 
This chapter describes the first study to investigate the structural features that 
are essential for recrystallisation inhibition activity by water soluble polymers. Firstly, 
the importance of the side chain was demonstrated, showing that hydroxyl groups are 
essential for any effect to be observed, and also that charged side chains completely 
negate any RI. The importance of having a rigid (planar amide bond) polypeptide 
backbone was also investigated and it was demonstrated that poly vinyl backbones are 
sufficient for the desired effect. During this work poly(hydroxy-proline) was 
investigated in a quantitative fashion for the first time, and shown to inhibit 
recrystallisation as well as PV A. A series of glycopolymers bearing either galactosyl 
or glucosyl moieties were found to have a weak, but significant, Rl effect which 
increased with molecular weight, as found in native AFGP. This result is remarkable 
in that it is only the second non-peptidic compound, after PV A to display this effect, 
and the first to contain carbohydrates related to the native variants. By determining 
which features are essential for conservation of activity, we believe it will be possible 
to design new materials with stronger Rl behaviour, without resorting to tedious and 
expensive solid phase peptide synthesis. 
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6.4 EXPERIMENTAL 
Poly (L-glutamic acid) sodium salt and poly(L-lysine) HBr salt were 
synthesised as described in Chapter 3 from their corresponding NCAs. Glycopolymers 
were synthesised by the aqueous RAFT polymerisation26 of their corresponding 
monomers by Mr Seb Spain, or Mr C Barker at the University of Durham. 
Poly(acrylic acid), poly(ethylene oxide) and poly(vinyl alcohol) were all purchased 
from Aldrich and dialysed against UHQ water (18 MQ resistivity) 
Phosphate buffered saline was made using pre-formulated tablets (Aldrich). 
One tablet was dissolved in 200 mL of ultra high quality water (UHQ), I8 MQ 
resistively, to give a buffer with pH 7.4. Ice wafers were annealed on a Linkam 
THMS600 thermostated microscope stage using liquid nitrogen as the coolant. Splat 
tests were conducted according to the method of Knight et a/23 . A I O).l.L sample of 
polymer dissolved in PBS was dropped 1.5 metres down a hollow acrylic tube onto a 
piece of polished aluminium sat on dry ice. Upon hitting the aluminium, a wafer with 
diameter of approximately I Omm was formed instantaneously. The wafer was 
transferred using a chilled blade to a glass slide on the Linkam cool stage, and held at 
-6°C under N2 for 30 minutes. A photograph was taken of the initial wafer to ensure 
that a polycrystalline sample had been obtained, and after 30 mintues through crossed 
polarisers at a resolution of 2 megapixels. ImageJ27 was used to analyse the obtained 
images. A large number of the ice crystals (30+) were then measured to find the 
largest grain dimension. The average of this value from 3 individual wafers was 
calculated to give the mean largest grain size (MLGS). A schematic of the apparatus 
is shown below, (Figure I6). 
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Figure 96. Schematic of the splat test apparatus 
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7. CONCLUSIONS AND SUMMARY 
The objective of this Thesis was the synthesis and characterisation of well 
defined, novel poly(peptide) based materials, with particular attention paid towards 
using them to investigate the mechanism of recrystallisation inhibition by polymeric 
additives. The rationale behind this was discussed in Chapter 1. 
In Chapter 2 a new synthetic strategy was developed for glycosylated. N-
carboxyanhydrides. This involved starting from an N-Boc protected amino acid, 
which was glycosylated in a stereo-specific manner with an activated anomeric 
bromide. Iodine was used as the promoter in place of the highly toxic mercuric 
cyanide previously used in the literature. Subsequent deprotection and treatment with 
triphosgene led to the NCAs in improved yields. The use of an N-Boc protecting 
group expedited the synthesis as the side products were all gaseous and removed 
quantitatively. This methodology was applied to synthesise 4 different glycoNCAs. 
I In Chapter 3 it was shown that L-threonine(O-benzyl)-N-carboxyanhydride 
can be polymerised in a highly controlled fashion without resorting to organometallic 
catalysts or extremely controlled polymerisation environments by using the easily 
dried solvent THF in conjunction with high-purity monomers. The competing 
activated monomer mechanism was not observed. The effects of the purification 
procedure on the polymerisation were also investigated. The controlled/living 
character of this method was shown through kinetic analysis of the polymerisation by 
offline IR spectroscopy, GPC and the re-initiation of the polymerisation by sequential 
monomer addition. 
Chapter 4 demonstrated the synthesis of block-copoly(peptides) containing 
poly(O-benzyl-L-threonine) and either poly(y-benzyl-L-glutamate) or poly(£-N-Boc-
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L-lysine ). This was achieved by polymerisation of the first block followed by addition 
of the second monomer. Characterisation of the resulting block-co-polymers was 
achieved by NMR and GPC analysis, which confirmed the structures, and revealed 
that monomodal distributions were obtained without contamination of homo-
polymers. 
In Chapter 5 the thermoreversible organogelation properties of the block-co-
poly(peptides) synthesised in Chapter 4 were investigated. The polymers gelated 
chlorinated solvents, which the homopolymers were soluble in. Analysis of the gels 
revealed an extended network of fibrous structures ranging in size from 0.3 to 2 
microns, which is significantly larger than the size of the individual polymers. The 
assembly of the fibres was attributed to a change in the conformation of the poly( 0-
benzyl-L-threonine) block from largely unstructured coil to ~-sheet upon conjugation 
to the second (a-helical) block. Wide angle X-ray scattering suggested that this 
assembly was driven by the lamella stacking of the ~-sheets with insulated helices 
protruding from the structure. These could then act to direct formation of hierarchical 
structures, which were seen to contain some right-handed helices by AFM. 
The ability of numerous water-soluble polymers to inhibit recrystallisation of 
ice was assessed in Chapter 6. Vinyl and poly(peptide) based polymers were 
investigated and it was observed that only those polymers bearing hydroxyl moieties 
displayed any recrystallisation inhibition at concentrations as high as 40 mg. mr1• The 
strongest inhibitor was shown to be high molecular weight poly(vinyl alcohol). A 
series of vinyl-based glycopolymers were finally tested. Surprisingly, they showed a 
small but measurable RI activity which increased with molecular weight. The activity 
was shown to be lower than PVA and poly(hydroxy-L-proline) of equivalent 
molecular weight. This demonstrated that it maybe possible to discover new 
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polymeric ice recrystallisation inhibitors which do not require a rigid peptide 
backbone by changing the density and distance of the hydroxyl groups from the 
backbone. 
It is hoped that the work began in this Thesis can be applied to develop new 
and interesting peptide-based materials. The glycosylated NCAs will give rise to 
glyco(peptides) which may act as mimics of naturally occurring proteins, particularly 
the antifreeze glycoproteins. These conclusions are drawn from the data showing that 
simple poly-ols can inhibit ice recrystallisation, when the distance between the 
backbone and alcohol is minimised. These materials could have widespread 
application in medicine, organ-preservation, food storage and industrial cooling 
processes. 
The organogelating peptides can also be studied to elucidate the dependence of 
chain length and composition of the two blocks on the strength of the gels and also 
upon the self assembled structures which were visualised. Particular interest could be 
found in determining origins of the conformational changes seen in the poly( 0-
benzyl-L-threonine) block and whether this is limited to helical peptides as the second 
block or if other, more flexible polymers were also used. 
In summary, it is hoped that this body of work does not only contribute 
significant knowledge to the wider scientific community, but also provoke many more 
questions leading to further discoveries in the exciting areas of peptide self assembly, 
polymeric mimics of natural products and fundamental organic synthesis. 
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